2023-12-11T16:04:58+08:00 weekly 0.8 https://fr.hspchem.com/apis-and-intermediates/oritavancin-cas-171099-57-3.html 2023-12-11T16:04:59+08:00 weekly 0.8 https://fr.hspchem.com/apis-and-intermediates/trans-4-aminocyclohexanol-cas-27489-62-9.html 2023-12-11T16:04:59+08:00 weekly 0.8 https://fr.hspchem.com/apis-and-intermediates/2-benzoylpyridine-cas-91-02-1.html 2024-12-09T09:38:47+08:00 weekly 0.8 https://fr.hspchem.com/apis-and-intermediates/buntanetap-cas-116839-68-0.html 2023-12-11T16:04:59+08:00 weekly 0.8 https://fr.hspchem.com/apis-and-intermediates/1-3-dihydroxypropanone-cas-96-26-4.html 2023-12-11T16:04:59+08:00 weekly 0.8 https://fr.hspchem.com/apis-and-intermediates/3-methyl-2-pyrrolidone-cas-2555-05-7.html 2023-12-11T16:04:59+08:00 weekly 0.8 https://fr.hspchem.com/apis-and-intermediates/diosgenin-cas-512-04-9.html 2023-12-11T16:04:59+08:00 weekly 0.8 https://fr.hspchem.com/apis-and-intermediates/sotorasib-cas-2296729-00-3.html 2023-12-11T16:04:59+08:00 weekly 0.8 https://fr.hspchem.com/apis-and-intermediates/2-chloro-3-pyridinecarboxaldehyde-cas-36404.html 2023-12-11T16:04:59+08:00 weekly 0.8 https://fr.hspchem.com/apis-and-intermediates/6-chloro-3-methylpicolinic-acid-cas-1201924.html 2024-12-09T09:38:39+08:00 weekly 0.8 https://fr.hspchem.com/apis-and-intermediates/12112-bemcentinib-cas-1037624-75-1.html 2023-12-11T16:05:00+08:00 weekly 0.8 https://fr.hspchem.com/apis-and-intermediates/1-6-bromo-3-fluoropyridin-2-yl-ethan-1-one.html 2023-12-11T16:05:00+08:00 weekly 0.8 https://fr.hspchem.com/apis-and-intermediates/3-chloromethyl-5-methylpyridine-hcl-cas.html 2024-12-09T09:38:41+08:00 weekly 0.8 https://fr.hspchem.com/apis-and-intermediates/milvexian-cas-1802425-99-5.html 2023-12-11T16:05:00+08:00 weekly 0.8 https://fr.hspchem.com/apis-and-intermediates/2-bromo-5-fluoropyridine-4-carboxylic-acid.html 2024-12-09T09:38:50+08:00 weekly 0.8 https://fr.hspchem.com/apis-and-intermediates/suzetrigine-vx-548-cas-2649467-58-1.html 2023-12-11T16:05:00+08:00 weekly 0.8 https://fr.hspchem.com/apis-and-intermediates/methyl-6-fluoro-5-methylpyridine-3.html 2023-12-11T16:05:00+08:00 weekly 0.8 https://fr.hspchem.com/apis-and-intermediates/heparin-sodium-cas-9041-08-1.html 2023-12-11T16:05:01+08:00 weekly 0.8 https://fr.hspchem.com/apis-and-intermediates/5-acetyl-2-bromopyridine-cas139042-59-4.html 2023-12-11T16:05:01+08:00 weekly 0.8 https://fr.hspchem.com/apis-and-intermediates/samuraciclib-cas-1805833-75-3.html 2023-12-11T16:05:01+08:00 weekly 0.8 https://fr.hspchem.com/apis-and-intermediates/3-chloro-4-iodopyridin-2-amine-cas-1152617-24.html 2023-12-11T16:05:01+08:00 weekly 0.8 https://fr.hspchem.com/apis-and-intermediates/2-methylamino-pyridine-3-methanol-cas-32399-12.html 2023-12-11T16:05:01+08:00 weekly 0.8 https://fr.hspchem.com/apis-and-intermediates/vidofludimus-cas-717824-30-1.html 2023-12-11T16:05:01+08:00 weekly 0.8 https://fr.hspchem.com/apis-and-intermediates/hyocholic-acid-cas-547-75-1.html 2024-12-09T09:38:39+08:00 weekly 0.8 https://fr.hspchem.com/apis-and-intermediates/pirtobrutinib-cas-2101700-15-4.html 2024-12-09T09:38:39+08:00 weekly 0.8 https://fr.hspchem.com/apis-and-intermediates/pevonedistat-cas-905579-51-3.html 2024-12-09T09:38:42+08:00 weekly 0.8 https://fr.hspchem.com/apis-and-intermediates/orforglipron-cas-2212020-52-3.html 2023-12-11T16:05:02+08:00 weekly 0.8 https://fr.hspchem.com/apis-and-intermediates/4-hydroxypyridine-cas-626-64-2.html 2023-12-11T16:05:02+08:00 weekly 0.8 https://fr.hspchem.com/apis-and-intermediates/lithocholic-acid-glycine-cas-474-74-8.html 2023-12-11T16:05:02+08:00 weekly 0.8 https://fr.hspchem.com/apis-and-intermediates/methyl-2-bromo-5-fluoropyridine-4-carboxylate.html 2023-12-11T16:05:03+08:00 weekly 0.8 https://fr.hspchem.com/apis-and-intermediates/bilirubin-cas-635-65-4.html 2023-12-11T16:05:03+08:00 weekly 0.8 https://fr.hspchem.com/apis-and-intermediates/hyodeoxycholic-acid-cas-83-49-8.html 2023-12-11T16:05:05+08:00 weekly 0.8 https://fr.hspchem.com/apis-and-intermediates/deutivacaftor-cas-1413431-07-8.html 2024-04-12T17:43:00+08:00 weekly 0.8 https://fr.hspchem.com/apis-and-intermediates/glycohyodeoxycholic-acid-sodium-salt-ghdca.html 2024-04-12T17:43:00+08:00 weekly 0.8 https://fr.hspchem.com/apis-and-intermediates/glycodehydrocholic-acid-cas-3415-45-0.html 2024-12-09T10:04:37+08:00 weekly 0.8 https://fr.hspchem.com/apis-and-intermediates/glycolithocholic-acid-sodium-salt-cas-24404.html 2024-04-12T17:43:01+08:00 weekly 0.8 https://fr.hspchem.com/apis-and-intermediates/glycohyodeoxycholic-acid-cas-13042-33-6.html 2024-04-12T17:43:02+08:00 weekly 0.8 https://fr.hspchem.com/apis-and-intermediates/3h-sodium-glycoursodeoxycholate-cas-92411-07.html 2024-12-09T09:38:30+08:00 weekly 0.8 https://fr.hspchem.com/apis-and-intermediates/glycocholic-acid-sodium-salt-cas-863-57-0.html 2024-04-12T17:43:03+08:00 weekly 0.8 https://fr.hspchem.com/apis-and-intermediates/glycoursodeoxycholic-acid-cas-64480-66-6.html 2024-04-12T17:43:03+08:00 weekly 0.8 https://fr.hspchem.com/apis-and-intermediates/glycodeoxycholic-acid-cas-360-65-6.html 2024-04-12T17:43:04+08:00 weekly 0.8 https://fr.hspchem.com/apis-and-intermediates/glycodeoxycholic-acid-sodium-cas-16409-34-0.html 2024-12-09T09:38:38+08:00 weekly 0.8 https://fr.hspchem.com/apis-and-intermediates/taurohyodeoxycholic-acid-sodium-salt-hydrate.html 2024-12-09T09:38:34+08:00 weekly 0.8 https://fr.hspchem.com/apis-and-intermediates/sodium-cholate-cas-361-09-1.html 2024-12-09T09:38:38+08:00 weekly 0.8 https://fr.hspchem.com/apis-and-intermediates/glycochenodeoxycholic-acid-sodium-salt-cas.html 2024-04-12T17:43:05+08:00 weekly 0.8 https://fr.hspchem.com/apis-and-intermediates/glycochenodeoxycholic-acid-cas-640-79-9.html 2024-12-09T09:38:31+08:00 weekly 0.8 https://fr.hspchem.com/apis-and-intermediates/glycocholic-acid-cas-475-31-0.html 2024-04-12T18:46:21+08:00 weekly 0.8 https://fr.hspchem.com/apis-and-intermediates/taurodeoxycholic-acid-sodium-salt-cas-1180-95.html 2024-04-12T18:46:22+08:00 weekly 0.8 https://fr.hspchem.com/apis-and-intermediates/sodium-taurodeoxycholate-hydrate-cas-207737.html 2024-04-12T18:46:22+08:00 weekly 0.8 https://fr.hspchem.com/apis-and-intermediates/lithocholic-acid-cas-434-13-9.html 2024-04-12T18:46:22+08:00 weekly 0.8 https://fr.hspchem.com/apis-and-intermediates/taurodehydrocholate-cas-517-37-3.html 2024-04-12T18:46:22+08:00 weekly 0.8 https://fr.hspchem.com/apis-and-intermediates/taurocholic-acid-sodium-salt-hydrate-cas.html 2024-04-12T18:46:22+08:00 weekly 0.8 https://fr.hspchem.com/apis-and-intermediates/taurodeoxychloic-acid-cas-516-50-7.html 2024-04-12T18:46:24+08:00 weekly 0.8 https://fr.hspchem.com/apis-and-intermediates/sodium-dehydrocholate-cas-145-41-5.html 2024-12-09T09:38:34+08:00 weekly 0.8 https://fr.hspchem.com/apis-and-intermediates/taurolithocholic-acid-sodium-salt-cas-6042-32.html 2024-04-12T18:46:25+08:00 weekly 0.8 https://fr.hspchem.com/apis-and-intermediates/sodium-taurocholate-cas-145-42-6.html 2024-04-12T18:46:25+08:00 weekly 0.8 https://fr.hspchem.com/apis-and-intermediates/sodium-tauroursodesoxycholate-cas-35807-85-3.html 2024-04-12T18:46:25+08:00 weekly 0.8 https://fr.hspchem.com/apis-and-intermediates/deoxycholic-acid-cas-83-44-3.html 2024-04-12T18:46:26+08:00 weekly 0.8 https://fr.hspchem.com/apis-and-intermediates/sodium-deoxycholate-cas-302-95-4.html 2024-04-12T18:46:26+08:00 weekly 0.8 https://fr.hspchem.com/apis-and-intermediates/taurocholate-cas-81-24-3.html 2024-04-12T18:46:27+08:00 weekly 0.8 https://fr.hspchem.com/apis-and-intermediates/lanosterol-cas-79-63-0.html 2024-04-12T18:46:27+08:00 weekly 0.8 https://fr.hspchem.com/apis-and-intermediates/7-dehydrocholesterol-cas-434-16-2.html 2024-12-09T09:38:33+08:00 weekly 0.8 https://fr.hspchem.com/apis-and-intermediates/5-alpha-hydroxy-laxogenin-cas-56786-63-1.html 2024-04-12T18:46:28+08:00 weekly 0.8 https://fr.hspchem.com/apis-and-intermediates/cholesterol-cas-57-88-5.html 2024-04-12T18:46:28+08:00 weekly 0.8 https://fr.hspchem.com/apis-and-intermediates/trifluoroacetic-acid-cas-76-05-1.html 2024-04-12T18:46:28+08:00 weekly 0.8 https://fr.hspchem.com/apis-and-intermediates/taurochenodeoxycholic-acid-sodium-salt-cas.html 2024-04-12T18:46:29+08:00 weekly 0.8 https://fr.hspchem.com/coenzymes-and-nucleotides-series/guanosine-5-diphosphoglucose-disodium-salt.html 2024-12-09T10:04:28+08:00 weekly 0.8 https://fr.hspchem.com/coenzymes-and-nucleotides-series/guanosine-3-5-cyclic-monophosphate-cas-7665.html 2024-04-12T18:46:29+08:00 weekly 0.8 https://fr.hspchem.com/apis-and-intermediates/trifluoroacetic-anhydride-cas-407-25-0.html 2024-12-09T09:38:32+08:00 weekly 0.8 https://fr.hspchem.com/coenzymes-and-nucleotides-series/aprotinin-cas-9087-70-1.html 2024-04-12T18:46:29+08:00 weekly 0.8 https://fr.hspchem.com/coenzymes-and-nucleotides-series/adenosine-5-diphosphoglucose-disodium-salt.html 2024-12-09T09:38:33+08:00 weekly 0.8 https://fr.hspchem.com/coenzymes-and-nucleotides-series/2-deoxyuridine-5-triphosphate-trisodium-cas.html 2024-12-09T09:38:33+08:00 weekly 0.8 https://fr.hspchem.com/coenzymes-and-nucleotides-series/polyinosinic-polycytidylic-acid-potassium.html 2024-12-09T09:38:39+08:00 weekly 0.8 https://fr.hspchem.com/coenzymes-and-nucleotides-series/2-deoxythymidine-5-triphosphate-trisodium-cas.html 2024-04-12T18:46:30+08:00 weekly 0.8 https://fr.hspchem.com/apis-and-intermediates/dehydrocholic-acid-cas-81-23-2.html 2024-12-09T09:38:34+08:00 weekly 0.8 https://fr.hspchem.com/coenzymes-and-nucleotides-series/inosine-5-triphosphate-disodium-salt-cas.html 2024-04-12T18:46:31+08:00 weekly 0.8 https://fr.hspchem.com/coenzymes-and-nucleotides-series/2-thymidine-5-monophosphate-disodium-salt-cas.html 2024-04-12T18:46:31+08:00 weekly 0.8 https://fr.hspchem.com/coenzymes-and-nucleotides-series/n1-methylpseudouridine-5-triphosphate-sodium.html 2024-04-12T18:46:31+08:00 weekly 0.8 https://fr.hspchem.com/coenzymes-and-nucleotides-series/2-deoxyuridine-5-monophosphate-disodium-salt.html 2024-12-09T09:38:34+08:00 weekly 0.8 https://fr.hspchem.com/coenzymes-and-nucleotides-series/2-deoxyadenosine-5-triphosphate-disodium-cas.html 2024-04-12T18:46:32+08:00 weekly 0.8 https://fr.hspchem.com/coenzymes-and-nucleotides-series/cytidine-5-triphosphate-trisodium-salt-cas.html 2024-04-12T18:46:32+08:00 weekly 0.8 https://fr.hspchem.com/coenzymes-and-nucleotides-series/2-deoxyguanosine-5-triphosphate-trisodium.html 2024-04-12T18:46:33+08:00 weekly 0.8 https://fr.hspchem.com/coenzymes-and-nucleotides-series/2-deoxyadenosine-5-diphosphate-disodium-salt.html 2024-12-09T09:38:33+08:00 weekly 0.8 https://fr.hspchem.com/coenzymes-and-nucleotides-series/adenosine-5-diphosphate-trilithium-salt-cas.html 2024-12-09T09:38:35+08:00 weekly 0.8 https://fr.hspchem.com/coenzymes-and-nucleotides-series/polyadenosinic-acid-potassium-salt-cas-26763.html 2024-04-12T18:46:34+08:00 weekly 0.8 https://fr.hspchem.com/coenzymes-and-nucleotides-series/2-deoxythymidine-5-diphosphate-trisodium-salt.html 2024-12-09T09:38:31+08:00 weekly 0.8 https://fr.hspchem.com/apis-and-intermediates/taurohyodeoxycholic-acid-sodium-hydrate-cas.html 2024-04-12T18:46:34+08:00 weekly 0.8 https://fr.hspchem.com/coenzymes-and-nucleotides-series/2-deoxyguanosine-5-diphosphate-disodium-salt.html 2024-12-09T09:38:34+08:00 weekly 0.8 https://fr.hspchem.com/coenzymes-and-nucleotides-series/2-deoxyadenosine-5-monophosphate-cas-220203.html 2024-04-12T18:46:34+08:00 weekly 0.8 https://fr.hspchem.com/coenzymes-and-nucleotides-series/adenosine-5-diphosphate-cas-58-64-0.html 2024-04-12T18:46:34+08:00 weekly 0.8 https://fr.hspchem.com/coenzymes-and-nucleotides-series/ethyl-6-8-dichlorooctanoate-cas-1070-64-0.html 2024-04-12T18:46:34+08:00 weekly 0.8 https://fr.hspchem.com/coenzymes-and-nucleotides-series/2-deoxyadenosine-5-monophosphate-disodium-sa.html 2024-04-12T18:46:34+08:00 weekly 0.8 https://fr.hspchem.com/coenzymes-and-nucleotides-series/uridine-5-triphosphate-diaodium-salt-cas.html 2024-12-09T09:38:37+08:00 weekly 0.8 https://fr.hspchem.com/coenzymes-and-nucleotides-series/2-deoxycytidine-5-diphosphate-disodium-salt.html 2024-04-12T18:46:35+08:00 weekly 0.8 https://fr.hspchem.com/coenzymes-and-nucleotides-series/guanosine-5-diphosphate-disodium-salt-cas.html 2024-12-09T09:38:36+08:00 weekly 0.8 https://fr.hspchem.com/coenzymes-and-nucleotides-series/2-deoxycytidine-5-monophosphate-disodium-salt.html 2024-12-09T09:38:33+08:00 weekly 0.8 https://fr.hspchem.com/coenzymes-and-nucleotides-series/adenosine-5-diphosphate-monopotassium-salt.html 2024-04-12T18:46:35+08:00 weekly 0.8 https://fr.hspchem.com/coenzymes-and-nucleotides-series/2-deoxyuridine-5-diphosphate-disodium-salt.html 2024-12-09T09:38:38+08:00 weekly 0.8 https://fr.hspchem.com/coenzymes-and-nucleotides-series/cytidine-5-diphosphoglucose-disodium-salt-cas.html 2024-12-09T09:38:40+08:00 weekly 0.8 https://fr.hspchem.com/coenzymes-and-nucleotides-series/2-deoxyguanosine-5-monophosphate-disodium.html 2024-04-12T18:46:37+08:00 weekly 0.8 https://fr.hspchem.com/coenzymes-and-nucleotides-series/2-deoxycytidine-5-monophosphate-cas-1032-65-1.html 2024-04-12T18:46:37+08:00 weekly 0.8 https://fr.hspchem.com/coenzymes-and-nucleotides-series/adenosine-5-triphosphate-cas-56-65-5.html 2024-04-12T18:46:37+08:00 weekly 0.8 https://fr.hspchem.com/apis-and-intermediates/o-7-azabenzotriazol-1-yl-uronium-hexafluoro.html 2024-04-12T18:46:37+08:00 weekly 0.8 https://fr.hspchem.com/apis-and-intermediates/glycine-methyl-ester-hydrochloride-cas-5680.html 2024-04-12T18:46:37+08:00 weekly 0.8 https://fr.hspchem.com/apis-and-intermediates/1-bromo-3-methoxypropane-cas-36865-41-5.html 2024-04-12T18:46:37+08:00 weekly 0.8 https://fr.hspchem.com/apis-and-intermediates/methyl-4-acetylamino-3-bromo-2-2-bromoethoxy.html 2024-04-12T18:46:38+08:00 weekly 0.8 https://fr.hspchem.com/apis-and-intermediates/2-4-dichloro-5-methoxyaniline-cas-98446-49-2.html 2024-04-12T18:46:38+08:00 weekly 0.8 https://fr.hspchem.com/apis-and-intermediates/3-5-dichloro-2-pyridinecarboxylic-acid-cas.html 2024-12-09T09:38:39+08:00 weekly 0.8 https://fr.hspchem.com/coenzymes-and-nucleotides-series/adenosine-5-monophosphate-monosodium-salt-cas.html 2024-04-12T18:46:39+08:00 weekly 0.8 https://fr.hspchem.com/apis-and-intermediates/acoramidis-cas-1446711-81-4.html 2024-04-12T18:46:39+08:00 weekly 0.8 https://fr.hspchem.com/apis-and-intermediates/piperazine-anhydrous-cas-110-85-0.html 2024-04-12T18:46:39+08:00 weekly 0.8 https://fr.hspchem.com/apis-and-intermediates/creatine-monohydrate-cas-6020-87-7.html 2024-04-12T18:46:39+08:00 weekly 0.8 https://fr.hspchem.com/apis-and-intermediates/tirzepatide-cas-2023788-19-2.html 2024-04-12T18:46:39+08:00 weekly 0.8 https://fr.hspchem.com/apis-and-intermediates/semaglutide-cas-99291-20-0.html 2024-04-12T18:46:39+08:00 weekly 0.8 https://fr.hspchem.com/apis-and-intermediates/triethylenetetraminetetrahydrochloride-cas.html 2024-04-12T18:46:39+08:00 weekly 0.8 https://fr.hspchem.com/apis-and-intermediates/6-iodo-1h-indazole-cas-261953-36-0.html 2024-04-12T18:46:40+08:00 weekly 0.8 https://fr.hspchem.com/apis-and-intermediates/4-chloro-3-pyridin-2-yl-aniline-cas-879088-41.html 2024-04-12T18:46:40+08:00 weekly 0.8 https://fr.hspchem.com/apis-and-intermediates/3-chloro-2-fluoroaniline-cas-2106-04-9.html 2024-04-12T18:46:40+08:00 weekly 0.8 https://fr.hspchem.com/apis-and-intermediates/4-acetoxystyrene-cas-2628-16-2.html 2024-04-12T18:46:40+08:00 weekly 0.8 https://fr.hspchem.com/apis-and-intermediates/5-bromo-3-nitropyridine-2-carbonitrile-cas.html 2024-04-12T18:46:41+08:00 weekly 0.8 https://fr.hspchem.com/apis-and-intermediates/1-chloromethyl-4-fluoro-1-4-diazoniabicyclo-2.html 2024-12-09T09:38:35+08:00 weekly 0.8 https://fr.hspchem.com/apis-and-intermediates/7-bromo-2-methyl-1h-benzoimidazole-5.html 2024-12-09T09:38:34+08:00 weekly 0.8 https://fr.hspchem.com/apis-and-intermediates/4-benzofurazancarboxaldehyde-cas-32863-32-4.html 2024-12-09T09:38:34+08:00 weekly 0.8 https://fr.hspchem.com/apis-and-intermediates/1h-benzimidazole1h-benzimidazole-5.html 2024-04-12T18:46:42+08:00 weekly 0.8 https://fr.hspchem.com/apis-and-intermediates/5-7-difluorochroman-4-one-cas-844648-22-2.html 2024-04-12T18:46:42+08:00 weekly 0.8 https://fr.hspchem.com/apis-and-intermediates/1-2-cyclohexanedione-cas-765-87-7.html 2024-04-12T18:46:42+08:00 weekly 0.8 https://fr.hspchem.com/apis-and-intermediates/3-3-5-difluorophenoxy-propanenitrile-cas.html 2024-04-12T18:46:42+08:00 weekly 0.8 https://fr.hspchem.com/apis-and-intermediates/salcaprozate-sodium-cas-203787-91-1.html 2024-04-12T18:46:42+08:00 weekly 0.8 https://fr.hspchem.com/apis-and-intermediates/s-5-7-difluorochroman-4-ol-cas-942195-91-7.html 2024-12-09T09:38:35+08:00 weekly 0.8 https://fr.hspchem.com/apis-and-intermediates/sevelamer-carbonate-cas-845273-93-0.html 2024-04-12T18:46:42+08:00 weekly 0.8 https://fr.hspchem.com/apis-and-intermediates/tegoprazan-cas-942195-55-3.html 2024-04-12T18:46:43+08:00 weekly 0.8 https://fr.hspchem.com/apis-and-intermediates/capivasertib-cas-1143532-39-1.html 2024-04-12T18:46:43+08:00 weekly 0.8 https://fr.hspchem.com/apis-and-intermediates/methyl-4-amino-3-bromo-5.html 2024-04-12T18:46:43+08:00 weekly 0.8 https://fr.hspchem.com/apis-and-intermediates/1-pyrenol-cas-5315-79-7.html 2024-04-12T18:46:43+08:00 weekly 0.8 https://fr.hspchem.com/apis-and-intermediates/n-1-3-dimethylbutylidene-3-hydroxy-2.html 2024-04-12T18:46:45+08:00 weekly 0.8 https://fr.hspchem.com/apis-and-intermediates/dimethyl-propiothetin-hydrochlorid-cas-4337.html 2024-04-12T18:46:46+08:00 weekly 0.8 https://fr.hspchem.com/apis-and-intermediates/birinapant-cas-1629229-37-3.html 2024-04-12T18:46:46+08:00 weekly 0.8 https://fr.hspchem.com/apis-and-intermediates/allochenodeoxycholic-acid-cas-15357-34-3.html 2024-04-12T18:47:12+08:00 weekly 0.8 https://fr.hspchem.com/apis-and-intermediates/taurochenodeoxycholic-acid-cas-516-35-8.html 2024-07-18T13:23:13+08:00 weekly 0.8 https://fr.hspchem.com/apis-and-intermediates/lappaconitine-hydrobromide-cas-97792-45-5.html 2024-12-09T09:38:49+08:00 weekly 0.8 https://fr.hspchem.com/apis-and-intermediates/baricitinib-cas-1187594-09-7.html 2024-09-09T21:05:56+08:00 weekly 0.8 https://fr.hspchem.com/buffer/bis-tris-propane-cas-64431-96-5.html 2024-09-09T21:05:57+08:00 weekly 0.8 https://fr.hspchem.com/buffer/sodium-2-chloroethanesulfonate-monohydrate.html 2024-09-09T21:05:57+08:00 weekly 0.8 https://fr.hspchem.com/buffer/dl-dithiothreitol-cas-3483-12-3.html 2024-09-09T21:05:58+08:00 weekly 0.8 https://fr.hspchem.com/buffer/3-morpholinopropanesulfonic-acid-cas-1132-61.html 2024-09-09T21:05:58+08:00 weekly 0.8 https://fr.hspchem.com/apis-and-intermediates/s-2-methylproline-hydrochloride-cas-1508261.html 2024-09-09T21:05:59+08:00 weekly 0.8 https://fr.hspchem.com/buffer/hepes-cas-7365-45-9.html 2024-09-09T21:06:00+08:00 weekly 0.8 https://fr.hspchem.com/apis-and-intermediates/trofinetide-cas-853400-76-7.html 2024-09-09T21:06:00+08:00 weekly 0.8 https://fr.hspchem.com/apis-and-intermediates/3alpha-hydroxy-5beta-cholan-24-oic-acid-3.html 2024-09-09T21:06:00+08:00 weekly 0.8 https://fr.hspchem.com/buffer/4-morpholineethanesulfonic-acid-cas-4432-31-9.html 2024-09-09T21:06:00+08:00 weekly 0.8 https://fr.hspchem.com/apis-and-intermediates/9-acetylcarbazole-cas-574-39-0.html 2024-09-09T21:06:01+08:00 weekly 0.8 https://fr.hspchem.com/fine-chemicals/isophthalic-dihydrazide-dc02-cas-2760-98-7.html 2024-09-09T21:06:01+08:00 weekly 0.8 https://fr.hspchem.com/apis-and-intermediates/eteplirsen-cas-1173755-55-9.html 2024-09-09T21:06:01+08:00 weekly 0.8 https://fr.hspchem.com/buffer/chaps-cas-75621-03-3.html 2024-09-09T21:06:02+08:00 weekly 0.8 https://fr.hspchem.com/apis-and-intermediates/danicopan-cas-1903768-17-1.html 2024-09-09T21:06:02+08:00 weekly 0.8 https://fr.hspchem.com/fine-chemicals/sodium-hexamethylene-1-6-bisthiosulfate.html 2024-12-09T09:38:41+08:00 weekly 0.8 https://fr.hspchem.com/apis-and-intermediates/elinzanetant-cas-929046-33-3.html 2024-09-09T21:06:03+08:00 weekly 0.8 https://fr.hspchem.com/buffer/taps-cas-29915-38-6.html 2024-09-09T21:06:03+08:00 weekly 0.8 https://fr.hspchem.com/apis-and-intermediates/fmoc-lys-boc-isopropyl-oh-cas-201003-48-7.html 2024-09-09T21:06:04+08:00 weekly 0.8 https://fr.hspchem.com/apis-and-intermediates/gepotidacin-cas-1075236-89-3.html 2024-09-09T21:06:04+08:00 weekly 0.8 https://fr.hspchem.com/apis-and-intermediates/thiamidol-cas-1428450-95-6.html 2024-09-09T21:06:04+08:00 weekly 0.8 https://fr.hspchem.com/apis-and-intermediates/n-propylcarbazole-cas-1484-10-2.html 2024-09-09T21:06:04+08:00 weekly 0.8 https://fr.hspchem.com/apis-and-intermediates/carbazole-cas-86-74-8.html 2024-09-09T21:06:05+08:00 weekly 0.8 https://fr.hspchem.com/apis-and-intermediates/repotrectinib-cas-1802220-02-5.html 2024-09-09T21:06:05+08:00 weekly 0.8 https://fr.hspchem.com/apis-and-intermediates/n-ethylcarbazole-cas-86-28-2.html 2024-09-09T21:06:05+08:00 weekly 0.8 https://fr.hspchem.com/buffer/tris-2-carboxyethyl-phosphine-hydrochloride.html 2024-12-09T09:38:41+08:00 weekly 0.8 https://fr.hspchem.com/apis-and-intermediates/iptacopan-cas-1644670-37-0.html 2024-09-09T21:06:05+08:00 weekly 0.8 https://fr.hspchem.com/apis-and-intermediates/survodutide-cas-2805997-46-8.html 2024-09-09T21:06:05+08:00 weekly 0.8 https://fr.hspchem.com/apis-and-intermediates/5-3-4-6-tri-o-acetyl-2-acetylamido-2-deoxy-b.html 2024-09-09T21:06:06+08:00 weekly 0.8 https://fr.hspchem.com/apis-and-intermediates/fruquintinib-cas-1194506-26-7.html 2024-09-09T21:06:06+08:00 weekly 0.8 https://fr.hspchem.com/apis-and-intermediates/crotonic-acid-cas-107-93-7.html 2024-09-09T21:06:07+08:00 weekly 0.8 https://fr.hspchem.com/apis-and-intermediates/r-3-methylpiperazin-2-one-cas-922178-61-8.html 2024-09-09T21:06:07+08:00 weekly 0.8 https://fr.hspchem.com/apis-and-intermediates/3r-5s-5-bis-4-methoxyphenyl-phenyl-methoxy.html 2024-09-09T21:06:07+08:00 weekly 0.8 https://fr.hspchem.com/apis-and-intermediates/metadoxine-cas-74536-44-0.html 2024-09-09T21:06:08+08:00 weekly 0.8 https://fr.hspchem.com/apis-and-intermediates/keratin-cas-68238-35-7.html 2024-09-09T21:06:08+08:00 weekly 0.8 https://fr.hspchem.com/buffer/tricine-5704-04-1.html 2024-09-09T21:06:08+08:00 weekly 0.8 https://fr.hspchem.com/apis-and-intermediates/1-2-3-4-tetrahydrocarbazole-cas-942-01-8.html 2024-09-09T21:06:08+08:00 weekly 0.8 https://fr.hspchem.com/apis-and-intermediates/carbazole-9-ethanol-cas-1484-14-6.html 2024-09-09T21:06:08+08:00 weekly 0.8 https://fr.hspchem.com/apis-and-intermediates/vitamin-d3-cas-67-97-0.html 2024-09-09T21:06:09+08:00 weekly 0.8 https://fr.hspchem.com/apis-and-intermediates/7-amino-3-1-methyl-5-tetrazolylthio-methyl-3.html 2024-12-09T09:38:45+08:00 weekly 0.8 https://fr.hspchem.com/apis-and-intermediates/1-6-bis-n-n-dibenzylthiocarbamoyldithio.html 2024-09-09T21:06:10+08:00 weekly 0.8 https://fr.hspchem.com/apis-and-intermediates/sisomicin-base-cas-32385-11-8.html 2024-09-09T21:06:11+08:00 weekly 0.8 https://fr.hspchem.com/apis-and-intermediates/cisplatin-cas-15663-27-1.html 2024-09-09T21:06:13+08:00 weekly 0.8 https://fr.hspchem.com/apis-and-intermediates/adagrasib-cas-2326521-71-3.html 2024-09-09T21:06:13+08:00 weekly 0.8 https://fr.hspchem.com/apis-and-intermediates/glucosamine-cas-3416-24-8.html 2024-09-09T21:06:14+08:00 weekly 0.8 https://fr.hspchem.com/apis-and-intermediates/aprocitentan-cas-1103522-45-7.html 2024-09-09T21:06:14+08:00 weekly 0.8 https://fr.hspchem.com/apis-and-intermediates/carboplatin-cas-41575-94-4.html 2024-09-09T21:06:14+08:00 weekly 0.8 https://fr.hspchem.com/apis-and-intermediates/sisomicin-sulfate-cas-53179-09-2.html 2024-09-09T21:07:47+08:00 weekly 0.8 https://fr.hspchem.com/apis-and-intermediates/pimicotinib-cas-2253123-16-7.html 2024-09-09T21:08:19+08:00 weekly 0.8 https://fr.hspchem.com/apis-and-intermediates/netilmicin-sulfate-cas-56391-57-2.html 2020-01-06T14:49:15+08:00 weekly 0.9 https://fr.hspchem.com/newslist-386294-1 2020-01-06T16:00:32+08:00 weekly 0.9 https://fr.hspchem.com/newslist-386341-1 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/prospects-for-the-development-of-chinese-apis-29500739.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/larger-aminophenol-gap-29500770.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/the-most-basic-conditions-for-pharmaceutical-i-29500771.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/technical-requirements-for-pharmaceutical-inte-29500772.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/increased-demand-for-pharmaceutical-intermedia-29528224.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/the-track-of-pharmaceutical-intermediates-came-29528225.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/problems-in-the-development-of-china-s-apis-29528248.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/fluorinated-pyridine-intermediates-become-hot-29528287.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/large-gap-in-pharmaceutical-intermediates-29528288.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/pharmaceutical-intermediate-characteristics-29528289.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/introduction-to-pharmaceutical-intermediates-29560457.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/pharmaceutical-preparation-29560474.html 2019-12-01T08:28:56+08:00 weekly 0.8 https://fr.hspchem.com/news/china-s-raw-material-development-status-29590047.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/introduction-to-intermediates-29618653.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/intermediate-type-29618686.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/introduction-of-api-29675552.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/domestic-and-international-environment-for-the-29695710.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/drug-supplies-concept-29722013.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/domestic-production-of-api-29790744.html 2019-12-09T19:20:15+08:00 weekly 0.8 https://fr.hspchem.com/news/development-status-of-raw-materials-29827631.html 2020-01-15T21:22:17+08:00 weekly 0.8 https://fr.hspchem.com/news/nature-amazing-the-thin-metal-membrane-deliv-31185034.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/development-history-of-gv971-31185035.html 2020-01-15T21:20:03+08:00 weekly 0.8 https://fr.hspchem.com/news/china-s-original-anti-cancer-drug-zanubrutinib-31185070.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/trimethylhydroquinone-has-a-promising-market-31185108.html 2020-01-15T21:24:00+08:00 weekly 0.8 https://fr.hspchem.com/news/nad-anti-aging-31185109.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/olaparib-combination-therapy-receives-priority-31185110.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/immunity-chinese-scientists-have-revealed-tha-31185156.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/scientists-have-pried-the-bone-of-cancer-treat-31185157.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/u-s-research-team-assembles-living-robot-wi-31185158.html 2020-01-15T21:23:59+08:00 weekly 0.8 https://fr.hspchem.com/news/the-efficacy-and-prospect-of-ibrutinib-31185159.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/china-s-original-new-drug-for-treating-alzheim-31185195.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/nampt-linking-nad-biology-metabolism-and-canc-31185196.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/incyte-and-morphosys-reach-cooperation-to-deve-31185197.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/progress-in-the-analysis-and-evolution-of-nad-31212259.html 2020-01-16T12:29:46+08:00 weekly 0.8 https://fr.hspchem.com/news/the-new-generation-antiepileptic-drug-of-fycom-31212376.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/new-research-promises-to-stop-some-sand-viruse-31212433.html 2020-01-16T21:58:32+08:00 weekly 0.8 https://fr.hspchem.com/news/new-drugs-for-schizophrenia-intra-cellular-th-31232670.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/researchers-find-brain-receptors-that-change-m-31232705.html 2020-01-17T22:51:51+08:00 weekly 0.8 https://fr.hspchem.com/news/nmpa-publishes-guidelines-for-the-research-on-31271233.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/merck-successfully-completes-the-acquisition-o-33415756.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/takeda-s-potent-egfr-small-molecule-tyrosine-k-33415757.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/lymphoma-new-drug-tg-therapeutics-next-genera-33415759.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/treatment-of-rare-lung-diseases-boehringer-ing-33415799.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/lynparza-the-first-parpi-to-treat-homologous-33415825.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/sanofi-s-brain-permeable-btk-inhibitor-sar-33415849.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/inter-j-cancer-cocoon-trigger-melanoma-suici-33420210.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/the-first-steroid-refractory-acute-graft-versu-33420214.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/nejm-new-coronavirus-2019-ncov-covid-19-pos-33425601.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/can-chloroquine-and-hydroxychloroquine-treat-c-33427639.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/fda-delays-review-of-intercept-s-potential-nas-33430772.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/fda-issues-15-orphan-drugs-a-week-33430774.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/fda-advisory-committee-fails-to-agree-on-appro-33430775.html 2020-04-29T21:22:42+08:00 weekly 0.8 https://fr.hspchem.com/news/cgh-gastroenterologists-and-patients-with-chr-33430776.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/acs-cent-sci-study-summarizes-potential-covid-33430777.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/front-oncol-new-discovery-lactic-acid-may-pr-33430778.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/break-the-textbook-the-nature-sub-discovery-f-33430779.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/key-clinical-trials-to-test-chloroquine-and-az-33430780.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/comprehensive-analysis-where-does-the-new-cor-33430781.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/new-drug-for-type-2-diabetes-dorzagliatin-33430782.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/three-nature-on-the-same-day-provides-new-per-33430834.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/a-brief-history-of-coronavirus-take-you-to-un-33430870.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/takeda-and-prothera-cooperate-to-develop-a-new-33435648.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/cheap-drug-may-alleviate-treatment-resistance-33435675.html 2020-04-30T00:33:07+08:00 weekly 0.8 https://fr.hspchem.com/news/nejm-the-new-coronavirus-sars-cov-2-maintains-33435705.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/fda-approves-clenbuterol-ointment-2-for-sup-33435772.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/novo-nordisk-announces-the-official-launch-of-33439653.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/fda-approves-new-indication-for-somaglutide-to-33439679.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/breakthrough-using-live-virus-to-identify-33439680.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/nature-medicine-paper-points-out-a-new-coronav-33439681.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/chemrxiv-breakthrough-researchers-screened-ne-33439781.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/the-national-drug-administration-nmpa-accept-33439928.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/chinese-scientists-found-that-nearly-half-of-p-33444613.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/parp-inhibitor-olaparib-prostate-cancer-market-33444614.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/cancer-immunotherapy-upgrade-33444615.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/by-inhibiting-the-body-s-own-proteins-it-is-e-33444654.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/dostarlimab-shows-strong-efficacy-in-the-treat-33444688.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/ajr-chinese-scientists-have-found-that-chest-33444773.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/new-evidence-obesity-is-linked-to-covid-19-s-33448355.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/yovant-oral-relugolix-a-gnrh-receptor-antagon-33448472.html 2020-04-30T13:39:03+08:00 weekly 0.8 https://fr.hspchem.com/news/notice-on-spring-festival-holiday-in-33454768.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/johnson-johnson-s-heavyweight-cd38-targeted-33454772.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/bristol-myers-squibb-nektar-star-immunostimu-33459122.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/a-new-class-of-antihyperglycemic-drugs-imeglim-33477709.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/genome-company-s-first-anti-cancer-microbiot-33662041.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/low-dose-doxorubicin-may-overcome-leukemia-res-33662042.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/the-new-generation-pi3k-inhibitor-new-cd20-33662043.html 2020-05-07T20:15:43+08:00 weekly 0.8 https://fr.hspchem.com/news/cell-reveal-how-tissue-protects-dna-from-dama-33662044.html 2020-05-07T20:13:43+08:00 weekly 0.8 https://fr.hspchem.com/news/breakthrough-pruritus-therapy-reaches-phase-33662045.html 2020-05-07T20:11:42+08:00 weekly 0.8 https://fr.hspchem.com/news/otsuka-and-esperion-sign-an-exclusive-agreemen-33662046.html 2020-05-07T20:19:31+08:00 weekly 0.8 https://fr.hspchem.com/news/j-comput-biol-a-new-method-to-predict-the-tar-33662047.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/the-key-clinical-study-of-the-first-non-dopami-33662048.html 2020-05-07T20:19:31+08:00 weekly 0.8 https://fr.hspchem.com/news/yangzijiang-bomadiamine-capsule-application-fo-33662049.html 2020-05-07T20:15:41+08:00 weekly 0.8 https://fr.hspchem.com/news/remdesivir-early-medication-can-prevent-the-d-33662050.html 2020-05-07T20:13:43+08:00 weekly 0.8 https://fr.hspchem.com/news/astrazeneca-s-antidiabetic-drug-farxiga-was-ap-33662051.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/plos-pathog-real-hammer-antiviral-drug-baloxa-33662147.html 2020-05-07T20:19:32+08:00 weekly 0.8 https://fr.hspchem.com/news/nejm-new-drug-can-be-used-to-treat-schizophre-33662148.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/heplatin-s-batoclimab-phase-1b-2a-clinical-s-33662149.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/bms-exelixis-combination-therapy-cabometyx-33662150.html 2020-05-07T20:17:38+08:00 weekly 0.8 https://fr.hspchem.com/news/roche-multiple-sclerosis-new-drug-ocrevus-prog-33662151.html 2020-05-07T20:17:37+08:00 weekly 0.8 https://fr.hspchem.com/news/japanese-team-finds-natural-plants-that-can-ef-33662152.html 2020-05-07T20:19:31+08:00 weekly 0.8 https://fr.hspchem.com/news/boehringer-ingelheim-ofev-is-approved-by-the-e-33662153.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/beigene-s-first-line-treatment-of-advanced-ind-33662154.html 2020-05-07T20:19:32+08:00 weekly 0.8 https://fr.hspchem.com/news/sci-rep-potential-therapy-can-be-used-to-trea-33662155.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/ebola-heavy-news-the-regenerative-third-antib-33662156.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/pfizer-eucrisa-ointment-has-been-approved-by-t-33662157.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/novartis-reached-an-agreement-with-the-us-fda-33662165.html 2020-05-07T20:17:39+08:00 weekly 0.8 https://fr.hspchem.com/news/the-first-non-surgical-treatment-for-low-grade-33662237.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/breakthrough-pruritus-therapy-reaches-phase-33662238.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/use-chloroquine-to-treat-new-coronary-pneumoni-33662239.html 2020-05-07T20:21:38+08:00 weekly 0.8 https://fr.hspchem.com/news/alnylam-s-another-rnai-therapy-gets-fda-fast-t-33662240.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/zaiding-pharmaceutical-zele-nilapali-supple-33662241.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/vitrakvi-is-approved-in-the-uk-for-the-treatme-33662302.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/sanofi-pcsk9-inhibitor-polyida-launched-in-ch-33662304.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/a-total-of-20-domestic-first-class-new-drugs-h-33662305.html 2020-05-07T20:17:38+08:00 weekly 0.8 https://fr.hspchem.com/news/the-helsen-akynzeo-intravenous-preparation-has-33662306.html 2020-05-07T20:19:34+08:00 weekly 0.8 https://fr.hspchem.com/news/surufatinib-was-awarded-2-fast-track-qualifica-33662308.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/the-first-phase-iii-project-of-oral-non-azole-33662311.html 2020-05-07T20:19:32+08:00 weekly 0.8 https://fr.hspchem.com/news/alcohol-is-harmful-so-how-does-alcohol-weaken-33662314.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/nerlynx-neratinib-is-listed-in-singapore-re-33662398.html 2020-05-07T20:19:32+08:00 weekly 0.8 https://fr.hspchem.com/news/heavy-weight-immunotherapy-drug-tecentriq-laun-33662399.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/dapoxetine-hydrochloride-tablets-and-cinacalce-33662450.html 2020-05-07T21:48:30+08:00 weekly 0.8 https://fr.hspchem.com/news/the-bms-immune-combination-opdivo-yervoy-fir-33663963.html 2020-05-07T21:54:53+08:00 weekly 0.8 https://fr.hspchem.com/news/novartis-mayzent-treatment-continues-to-slow-d-33663964.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/transcon-human-growth-hormone-obtains-u-s-and-33664015.html 2020-05-07T21:52:54+08:00 weekly 0.8 https://fr.hspchem.com/news/novartis-zolgensma-intrathecal-injection-shows-33664016.html 2020-05-07T21:48:31+08:00 weekly 0.8 https://fr.hspchem.com/news/jama-cardiol-be-alert-unstable-blood-pressur-33664018.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/transcon-pth-a-long-acting-alternative-therap-33664061.html 2020-05-07T21:50:38+08:00 weekly 0.8 https://fr.hspchem.com/news/cinda-bio-partners-incyte-s-powerful-fgfr-kina-33664062.html 2020-05-07T21:52:55+08:00 weekly 0.8 https://fr.hspchem.com/news/astrazeneca-kinase-inhibitor-koselugo-selumet-33664151.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/jbc-new-research-shows-that-redoxivir-can-eff-33664227.html 2020-05-07T22:42:39+08:00 weekly 0.8 https://fr.hspchem.com/news/trodelvy-the-first-trop-2-targeted-antibody-d-33664967.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/breast-cancer-diagnosis-and-treatment-guidelin-33665127.html 2020-05-07T22:54:34+08:00 weekly 0.8 https://fr.hspchem.com/news/preventive-immunotherapy-monoclonal-antibody-t-33665129.html 2020-05-07T22:52:36+08:00 weekly 0.8 https://fr.hspchem.com/news/visen-pharma-announces-transcontm-human-growth-33665147.html 2020-05-07T22:52:35+08:00 weekly 0.8 https://fr.hspchem.com/news/terlipressin-is-under-review-in-the-united-sta-33665193.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/johnson-johnson-imbruvica-ibrutini-was-a-33665248.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/roche-abbvie-venclexta-combination-therapy-p-33666391.html 2020-06-09T01:16:17+08:00 weekly 0.8 https://fr.hspchem.com/news/the-adc-jointly-developed-by-astrazeneca-and-d-34696681.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/the-new-antibacterial-drug-mgb-bp-3-has-a-cure-34696682.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/treatment-of-gastric-cancer-cd39-inhibitor-k-34696683.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/fda-approves-first-new-kaposi-sarcoma-drug-in-34696684.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/china-lung-cancer-rare-mutual-collaboration-gr-34696685.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/fennec-s-pedmark-sodium-thiosulfate-received-34696686.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/abbvie-completes-all-acquisitions-of-aierjian-34696687.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/aveo-targeted-anticancer-drug-tivozanib-is-app-34696688.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/the-us-fda-grants-astrazeneca-enhertu-a-breakt-34696689.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/kaposi-s-sarcoma-ks-heavyweight-the-only-or-34696690.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/merck-and-iavi-have-jointly-developed-the-covi-34696693.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/qinlock-the-first-four-line-drug-kinase-inhib-34696694.html 2020-06-09T01:16:17+08:00 weekly 0.8 https://fr.hspchem.com/news/olapali-combination-therapy-approved-by-fda-34696695.html 2020-06-09T01:16:20+08:00 weekly 0.8 https://fr.hspchem.com/news/fda-approves-kynmobi-apomorphine-sublingual-f-34696696.html 2020-06-09T01:16:16+08:00 weekly 0.8 https://fr.hspchem.com/news/small-molecule-drug-onc201-brings-hope-to-pati-34696697.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/gilead-s-jak1-inhibitor-filgotinib-is-successf-34696698.html 2020-06-09T01:16:19+08:00 weekly 0.8 https://fr.hspchem.com/news/ocaliva-oca-obeticholic-acid-was-postponed-34696699.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/abbvie-s-oral-jak1-inhibitor-rinvoq-submitted-34696700.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/jelmyto-the-first-low-grade-upper-urothelial-34696769.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/amgen-s-new-myocardial-myosin-activator-omecam-34696771.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/merck-tepmetko-approved-the-world-s-first-ora-34696772.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/gilead-s-remdesvir-veklury-received-the-wor-34696774.html 2020-06-09T09:34:39+08:00 weekly 0.8 https://fr.hspchem.com/news/the-us-fda-granted-moderna-s-vaccine-product-m-34714996.html 2020-06-09T09:34:40+08:00 weekly 0.8 https://fr.hspchem.com/news/epclusa-approved-for-children-with-hepatitis-c-34714997.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/treatment-of-specific-lung-cancer-eli-lilly-s-34714998.html 2020-06-09T09:34:42+08:00 weekly 0.8 https://fr.hspchem.com/news/sanofi-regenerative-dupixent-s-phase-iii-clini-34714999.html 2020-06-09T09:34:42+08:00 weekly 0.8 https://fr.hspchem.com/news/the-world-s-first-deuterated-drug-austedo-was-34715000.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/nash-new-drug-reaches-phase-2-clinical-end-poi-34715260.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/cytiva-the-global-leader-in-life-sciences-is-34715261.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/dapoxetine-hydrochloride-tablets-and-cinacalce-34715262.html 2020-06-09T09:38:59+08:00 weekly 0.8 https://fr.hspchem.com/news/oral-gnrh-receptor-antagonist-prostate-cancer-34715268.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/roche-ocrevus-new-infusion-solution-approved-b-34727525.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/merck-announces-strong-data-for-evobrutinib-mu-34727526.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/astrazeneca-takes-back-the-global-rights-of-il-34727528.html 2020-06-09T15:16:04+08:00 weekly 0.8 https://fr.hspchem.com/news/epidiolex-received-priority-review-by-the-us-f-34727588.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/the-first-farinyl-transferase-inhibitor-zokinv-34727589.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/the-second-phase-iii-trial-of-sanclifi-cd38-an-34734368.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/fda-approves-clinical-trial-of-anti-tumor-drug-34737777.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/the-cornerstone-pharmaceutical-partner-bluepri-34737778.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/takeda-targeted-anticancer-drug-cabometyx-cab-34737817.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/roche-tecentriq-avastin-first-line-treatment-s-34741576.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/pi3k-inhibitor-me-401-is-qualified-by-the-us-34769870.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/bayer-s-targeted-anti-cancer-drug-vitrakvi-has-34953496.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/pfizer-oral-jak1-inhibitor-releases-complete-p-35499595.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/fda-gives-green-light-to-astrazeneca-ticagrelo-35499597.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/abbvie-oriahnn-approved-for-menstrual-bleeding-35499598.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/the-first-antibody-drug-conjugate-adc-for-rh-35499599.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/treatment-of-atopic-dermatitis-pfizer-jak1-inh-35499600.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/pfizer-s-new-generation-of-oral-jak1-inhibitor-35499601.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/merck-pfizer-bavencio-maintenance-treatment-ph-35499602.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/sanofi-cd38-antibody-sarclisa-was-approved-by-35499603.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/novo-nordisk-glp-1-agonist-semaglutide-weight-35499610.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/pfizer-s-biosimilar-nyvepria-pefegrastim-is-35499647.html 2020-06-29T17:35:39+08:00 weekly 0.8 https://fr.hspchem.com/news/sanofi-cd38-antibody-sarclisa-combination-ther-35499648.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/the-first-nuclear-export-inhibitor-xpovio-was-35500064.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/eisai-double-acting-orexin-receptor-antagonist-35500621.html 2020-06-29T17:53:23+08:00 weekly 0.8 https://fr.hspchem.com/news/wanchun-medicine-s-first-in-class-new-drug-rea-35500622.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/otsuka-triple-reuptake-inhibitor-centanafadine-35500623.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/merck-gardasil-9-approved-by-the-fda-for-the-p-35500624.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/fda-approves-pfizer-mylotarg-treatment-1-mon-35500625.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/roche-releases-new-data-on-risdiplam-treatment-35500626.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/oral-gnrh-receptor-antagonist-prostate-cancer-35501069.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/leaf-lead-anticancer-drug-leaf-140-preclinical-35501070.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/merck-recarbrio-is-approved-by-the-us-fda-for-35501078.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/luye-pharmaceutical-s-innovative-drug-zepzelca-35501082.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/2-new-mechanism-drugs-nexletol-nexlizet-are-la-35501084.html 2020-06-29T18:04:38+08:00 weekly 0.8 https://fr.hspchem.com/news/treatment-of-hospital-acquired-bacterial-pneum-35501435.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/eli-lilly-s-lyumjev-is-approved-by-the-us-fda-35501440.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/hualing-pharmaceutical-completes-seed-study-of-35501441.html 2020-06-29T18:04:40+08:00 weekly 0.8 https://fr.hspchem.com/news/bristol-myers-opdivo-is-approved-by-the-us-fda-35501445.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/sanofi-pompe-disease-second-generation-enzyme-35501903.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/novartis-anti-inflammatory-drug-ilaris-is-appr-35502711.html 2020-06-29T18:42:20+08:00 weekly 0.8 https://fr.hspchem.com/news/fda-approves-first-tivicay-dispersible-tablet-35503866.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/roche-ocrevus-new-infusion-solution-approved-b-35504601.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/abbvie-s-btk-inhibitor-imbruvica-us-prescripti-36490118.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/the-new-igg-antibody-cleaving-enzyme-idefirix-36490119.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/astrazeneca-farxiga-has-obtained-the-us-fda-fa-36490120.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/albumin-bound-rapamycin-nab-sirolimus-is-app-36490121.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/abbvox-botox-botox-enters-the-us-for-review-36490122.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/gilead-biktarvy-is-safe-and-effective-in-the-e-36490123.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/eisai-s-fycompa-perampanel-new-fine-particle-36490126.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/beigene-parp1-2-inhibitor-pamiparib-pamiparib-36490128.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/jnj-invokana-approved-by-the-european-union-t-36490396.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/new-rare-disease-drug-lumasiran-approved-in-th-36490398.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/astrazeneca-s-antidiabetic-drug-farxiga-dapag-36490399.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/qutenza-receives-fda-approval-for-the-treatmen-36490400.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/eisai-s-anti-insomnia-drug-lemborexant-submits-36490401.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/for-the-treatment-of-lupus-nephritis-voclospo-36490402.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/boehringer-ingelheim-trajenta-linagliptin-h-36490403.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/eisai-meiji-s-new-selective-mao-b-inhibitor-eq-36490404.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/pfizer-hedgehog-pathway-inhibitor-daurismo-app-36490406.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/qinlock-the-first-fourth-line-drug-announces-36490735.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/oral-innovative-therapy-for-advanced-prostate-36490736.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/the-triple-therapy-trikafta-phase-iii-was-succ-36490737.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/fda-granted-axs-05-dextromethorphan-bupropion-36490738.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/gilead-veklury-is-approved-the-first-european-36490741.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/alexion-s-ultomiris-subcutaneous-preparation-p-36490745.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/the-us-fda-gives-priority-to-reviewing-brilint-36491027.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/the-u-s-fda-granted-assembly-the-second-gener-36491661.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/otsuka-samsca-tolvaptan-approved-in-japan-t-36491663.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/fda-has-accepted-the-supplementary-new-drug-ap-36491664.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/novartis-five-new-drugs-received-japanese-app-36491907.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/the-first-peptide-drug-conjugate-melflufen-is-36491908.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/roche-and-blueprint-signed-a-1-7-billion-agre-36492647.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/gilead-s-oral-jak1-inhibitor-jyseleca-filgoti-36929763.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/the-new-non-opioid-painkiller-zynrelef-bupiva-36929764.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/beigene-s-parp1-2-inhibitor-pamiparib-new-drug-36929765.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/astrazeneca-s-farxiga-dapagliflozin-phase-ii-36929766.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/astrazeneca-s-btk-inhibitor-calquence-has-been-36929767.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/neupharma-class-1-new-drug-completes-first-pat-36929769.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/novartis-p-selectin-inhibitor-adakveo-has-been-36930120.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/avapritinib-will-be-approved-in-the-eu-in-sept-36930404.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/biomarin-s-c-type-natriuretic-peptide-analogue-36930405.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/johnson-johnson-imbruvica-ibrutinib-combin-36930410.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/egfr-targeted-drug-cures-early-stage-lung-canc-36930792.html 2020-08-10T17:27:55+08:00 weekly 0.8 https://fr.hspchem.com/news/roche-s-tecentriq-three-drug-regimen-was-appro-36931149.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/pfizer-and-merck-s-bavencio-inlyta-combination-37132696.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/merck-eisai-submitted-a-new-indication-applica-37132697.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/takeda-s-first-nae-inhibitor-pevonedistat-has-37133361.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/johnson-johnson-s-spravato-nasal-spray-was-a-37134763.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/qilu-pharmaceutical-and-sesen-bio-reached-a-37135016.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/welcome-to-visit-cphi-china-2020-our-booth-num-37407184.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/the-us-fda-granted-the-breakthrough-drug-desig-37407186.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/dovato-a-complete-two-drug-regimen-of-glaxosm-37407190.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/pfizer-and-gilead-signed-a-multi-year-agreemen-37407196.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/a-new-class-of-hypoglycemic-drug-imeglimin-sub-37408321.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/canbridge-nerlynx-neratinib-is-approved-for-37409516.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/bayer-lampit-nifurolimus-easily-dispersible-37411373.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/the-u-s-fda-granted-the-pan-pi3k-inhibitor-pa-37411884.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/progress-in-the-construction-of-chiral-1-4-dia-37411889.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/cstone-s-ret-inhibitor-pratinib-s-marketing-ap-37779057.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/the-new-igg-antibody-cutting-enzyme-idefirix-h-37779058.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/merck-s-met-inhibitor-tepotinib-has-been-given-37779060.html 2020-09-04T15:13:00+08:00 weekly 0.8 https://fr.hspchem.com/news/for-small-cell-lung-cancer-luye-pharma-s-intr-37779149.html 2020-09-04T15:12:59+08:00 weekly 0.8 https://fr.hspchem.com/news/treatment-of-specific-non-small-cell-lung-canc-37779150.html 2020-09-04T15:12:59+08:00 weekly 0.8 https://fr.hspchem.com/news/beyondspring-first-in-class-new-drug-plenabuli-37779151.html 2020-09-04T15:13:00+08:00 weekly 0.8 https://fr.hspchem.com/news/merck-s-keytruda-obtains-two-latest-approvals-37779152.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/erleada-was-approved-in-china-for-a-new-indica-37779153.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/trilaciclib-s-treatment-of-small-cell-lung-can-37779154.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/abbvie-s-oral-jak-inhibitor-rinvoq-upadacitin-37779155.html 2020-09-04T15:12:59+08:00 weekly 0.8 https://fr.hspchem.com/news/biomarin-s-c-type-natriuretic-peptide-analogue-37779157.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/hepanova-s-first-in-class-nash-new-drug-is-cli-37779784.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/astrazeneca-forxiga-significantly-reduces-the-37780825.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/the-u-s-fda-granted-fast-track-qualification-37786930.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/disk-sogroya-is-approved-by-the-us-fda-the-fi-38069007.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/bristol-myers-zeposia-has-long-term-efficacy-a-38069010.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/novartis-powerful-met-inhibitor-tabrecta-has-38069012.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/the-us-fda-approves-onureg-the-first-aml-cont-38069017.html 2020-09-15T15:01:05+08:00 weekly 0.8 https://fr.hspchem.com/news/amgen-s-pcsk9-inhibitor-repatha-pediatric-phas-38078183.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/a-retrospective-study-of-giotag-afatinib-os-38078417.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/vimpat-phase-iii-clinical-success-in-the-treat-38098382.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/antengene-atg-010-selinexor-for-the-treatmen-38481808.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/construction-of-dual-kras-inhibitor-combinatio-38481810.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/gilead-galapagos-selective-atx-inhibitor-zirit-38481811.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/chi-med-surufatinib-s-second-nda-accepted-for-38481812.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/bms-exelixis-combination-therapy-opdivo-cabome-38481813.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/mallinckrodt-kidney-failure-drug-rejected-by-f-38481814.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/spectrum-s-next-generation-tki-zai-lab-submits-38481815.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/eli-lilly-abemaciclib-significantly-reduces-hr-38481816.html 2020-09-28T15:10:22+08:00 weekly 0.8 https://fr.hspchem.com/news/the-successful-phase-iii-of-the-potent-ileal-b-38489958.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/gilead-acquires-immunomedics-a-developer-of-n-38489960.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/merck-s-p2x3-receptor-antagonist-gefapixant-ha-38489961.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/johnson-johnson-imbruvica-ibrutinib-combin-38489962.html 2020-09-28T15:10:27+08:00 weekly 0.8 https://fr.hspchem.com/news/lynparza-olaparib-first-line-maintenance-tre-38489963.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/eli-lilly-verzenio-the-first-cdk4-6-inhibitor-38489964.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/the-first-dpp1-inhibitor-brensocatib-significa-38489965.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/boehringer-ingelheim-terminates-the-aoc3-inhib-38490068.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/astrazeneca-acquires-next-generation-oral-pcsk-38490069.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/eli-lilly-olumiant-s-new-indication-has-been-r-38490070.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/the-combination-of-merck-eisai-keytruda-lenvim-38490071.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/3-years-after-one-time-administration-of-nbib-38490073.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/ayvakit-shows-strong-efficacy-in-the-treatment-38490219.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/tagrisso-osimertinib-adjuvant-treatment-of-e-38507569.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/bayer-adempas-riociguat-phase-iv-study-is-su-38523749.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/novartis-tafinlar-mekinist-targeted-therapy-fo-38549145.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/ryplazim-plasminogen-once-again-applied-for-38570906.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/the-eu-chmp-recommends-the-approval-of-zejula-38617201.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/new-medicine-for-acute-treatment-of-migraine-38799486.html 2020-10-14T10:22:18+08:00 weekly 0.8 https://fr.hspchem.com/news/for-juvenile-idiopathic-arthritis-pfizer-xelj-38799487.html 2020-10-14T10:22:19+08:00 weekly 0.8 https://fr.hspchem.com/news/the-us-fda-granted-farxiga-dapagliflozin-bre-38799492.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/the-us-fda-approves-palynziq-label-update-the-38799493.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/the-world-s-first-siderophore-cephalosporin-fe-38799495.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/pfizer-once-a-week-long-acting-drug-somatrogon-38799798.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/three-year-phase-iii-clinical-data-of-glaxosmi-38799801.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/the-european-union-approves-the-new-non-opioid-38799802.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/concord-kylin-crysvita-has-been-approved-by-th-38800546.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/kynmobi-apomorphine-hcl-launched-in-the-us-38801083.html 2020-10-14T14:33:02+08:00 weekly 0.8 https://fr.hspchem.com/news/the-us-fda-granted-imgn632-a-breakthrough-drug-38806978.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/eli-lilly-s-dulaglutide-is-approved-for-patie-38807103.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/the-unique-cationic-hydroxybutyrate-therapy-xy-39153476.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/96-week-phase-iii-clinical-data-of-glaxosmithk-39158244.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/alks3831-olanzapine-samidorphan-is-about-to-39158246.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/savolitinib-has-many-surprises-and-has-great-p-39158429.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/innovative-introduction-boao-lecheng-landed-c-39161718.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/the-phase-3-clinical-study-of-lumasiran-in-the-39167133.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/merck-s-2dr-first-line-treatment-of-hiv-phase-39167611.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/fintepla-is-recommended-and-approved-by-the-eu-40064284.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/gilead-s-oral-jak1-inhibitor-jyseleca-has-appl-40064287.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/the-phase-3-clinical-effect-of-merck-eisai-imm-40064296.html 2020-11-25T10:44:37+08:00 weekly 0.8 https://fr.hspchem.com/news/menarini-elzonris-is-about-to-be-approved-in-t-40064310.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/nurtec-odt-is-under-review-in-the-united-state-40064498.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/bristol-myers-squibb-takes-oral-tyk2-inhibitor-40064499.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/daxibotulinumtoxina-phase-3-clinical-trial-was-40064500.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/the-first-oral-selective-complement-c5a-recept-40064501.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/the-new-deuterated-jak1-2-inhibitor-ctp-543-ha-40064835.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/pfizer-s-new-generation-of-oral-jak1-inhibitor-40065063.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/alnylam-s-third-rnai-therapy-lumasiran-is-abou-40065064.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/gsk-ileal-bile-acid-transporter-inhibitor-line-40065187.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/bristol-myers-squibb-took-oral-tyk2-inhibitor-40065907.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/sanofi-dupixent-for-the-first-time-showed-sign-40066362.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/bayer-xarelto-rivaroxaban-is-about-to-be-app-40067257.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/the-first-phase-3-clinical-trial-of-xpovio-th-40067381.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/glaxosmithkline-zejula-niraparib-approved-by-40067783.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/astrazeneca-s-btk-inhibitor-calquence-acalabr-40068115.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/eli-lilly-acquired-disarm-therapeutics-for-us-40068325.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/merck-and-the-gates-foundation-cooperate-to-c-40069234.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/biomarin-s-c-type-natriuretic-peptide-analogue-40069809.html 2020-11-25T13:03:57+08:00 weekly 0.8 https://fr.hspchem.com/news/eli-lilly-olumiant-baricitinib-has-long-term-40069811.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/russia-approves-the-second-covid-19-vaccine-e-40075665.html 2020-11-25T16:33:55+08:00 weekly 0.8 https://fr.hspchem.com/news/eli-lilly-olumiant-s-baricitinib-new-indicati-40078578.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/long-acting-injection-of-cabotegravir-once-eve-40079223.html 2020-11-25T17:13:21+08:00 weekly 0.8 https://fr.hspchem.com/news/roche-tecentriq-immune-combination-therapy-pro-40080162.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/bayer-s-first-drug-finerenone-phase-3-clinical-40084288.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/pradaxa-dabigatran-etexilate-the-first-drug-40084674.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/roche-evrysdi-applied-for-listing-in-japan-and-40091605.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/bayer-s-first-drug-finerenone-applied-for-li-40094302.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/gsk-strong-growth-effect-intramuscular-injecti-40098824.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/astrazeneca-amgen-tslp-targeted-monoclonal-ant-40103445.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/astellas-xtandi-is-approved-to-treat-non-meta-40104080.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/astrazeneca-s-hypoglycemic-drug-forxiga-dapag-40106456.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/u-s-fda-approved-vimpat-lacosamide-for-the-41870753.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/braf-v600e-mcrc-targeting-program-braftovi-tw-41870944.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/gilead-s-oral-jak1-inhibitor-jyseleca-filgoti-41870946.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/pfizer-s-third-generation-alk-inhibitor-lorbr-41870947.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/the-us-fda-approved-orgovyx-a-gnrh-receptor-a-41870950.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/best-in-class-gnrh-receptor-antagonist-yselty-41871504.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/the-eu-approves-sanofi-menquadfi-the-first-al-41871505.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/the-first-new-drug-to-treat-obesity-caused-by-41871507.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/the-roche-abbvie-venclexta-ritual-solution-ha-41871509.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/us-fda-granted-amgen-sotorasib-breakthrough-dr-41871510.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/alks3831-olanzapine-samidorphan-is-re-accept-41871511.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/the-fda-granted-the-new-liposomal-anthracyclin-41871512.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/novo-nordisk-s-glp-1-agonist-semaglutide-appli-41871516.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/novartis-pioneering-sirna-cholesterol-lowerin-41872221.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/gilead-s-oral-jak1-inhibitor-jyseleca-is-launc-41872227.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/astellas-evrenzo-roxadustat-approved-in-ja-41872561.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/cabometyx-cabozantinib-phase-3-clinical-tria-41872562.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/the-world-s-first-long-acting-injection-regime-41872563.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/u-s-fda-approved-takeda-s-third-generation-tk-41872564.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/abbvie-btk-inhibitor-imbruvica-ibrutinib-us-41872566.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/hutchison-medical-s-surufatinib-was-approved-41872567.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/novartis-stamp-inhibitor-asciminib-phase-iii-e-41872570.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/roche-s-cd79b-targeted-drug-polivy-bendamustin-41872950.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/eli-lilly-verzenio-the-first-cdk4-6-inhibitor-41873237.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/new-powerful-aak1-inhibitor-lx9211-enters-phas-41873238.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/eprenetapopt-azacitidine-is-better-than-azacit-41873626.html 2021-01-19T14:22:11+08:00 weekly 0.8 https://fr.hspchem.com/news/the-eu-approves-the-symkevi-and-kalydeco-joint-41873627.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/novartis-jak-inhibitor-jakavi-successfully-tre-41873827.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/gnrh-receptor-antagonist-yselty-linzagolix-e-41873828.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/verrica-s-vp-102-cantharidin-0-7-topical-so-41873830.html 2021-01-19T14:26:32+08:00 weekly 0.8 https://fr.hspchem.com/news/eli-lilly-loxo-305-has-shown-strong-efficacy-i-41873832.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/the-us-fda-approves-novo-nordisk-glp-1-recepto-41873833.html 2021-01-19T14:26:33+08:00 weekly 0.8 https://fr.hspchem.com/news/astrazeneca-s-btk-inhibitor-calquence-acalabr-41873836.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/eisai-lenvima-lenvatinib-post-marketing-stud-41873999.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/china-s-first-bcl-2-inhibitor-approved-veneto-41874000.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/astrazeneca-s-btk-inhibitor-calquence-acalabr-41874001.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/the-review-of-evrenzo-astrazeneca-evrenzo-ros-41874264.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/eisai-fycompa-perampanel-has-been-approved-b-41874598.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/the-first-phase-3-nuclear-export-inhibitor-xpo-41874698.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/research-progress-on-biomimetic-total-synthesi-41874699.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/axs-05-dextromethorphan-bupropion-modified-re-41874702.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/takeda-s-oral-tyrosine-kinase-inhibitor-cabome-41874703.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/fintepla-fenfluramine-is-approved-by-the-eur-41874704.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/3-adrenergic-receptor-agonist-gemtesa-vibegr-41874900.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/axsome-s-new-oral-multi-mechanism-drug-axs-41874907.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/astellas-xospata-gilteritinib-first-line-tre-41874911.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/fda-approved-vimpat-lacosamide-for-the-treat-41876142.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/astrazeneca-forxiga-dapagliflozin-approved-i-41876583.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/the-first-phase-3-nuclear-export-inhibitor-xpo-41881154.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/the-first-adjuvant-postoperative-therapy-eg-41884797.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/novartis-and-mesoblast-signed-a-license-agreem-41887941.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/pfizer-s-third-generation-alk-inhibitor-lorbr-41888292.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/amgen-sotorasib-submitted-a-marketing-applicat-41888542.html 2021-01-19T20:14:09+08:00 weekly 0.8 https://fr.hspchem.com/news/the-first-and-powerful-mc4r-agonist-imcivree-41888724.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/zelgen-biopharmaceuticals-obeticholate-magnesi-41889426.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/the-world-s-first-multiple-myeloma-drug-seline-42486144.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/cstone-pharmaceuticals-agios-pioneered-idh1-in-42486145.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/eli-lilly-and-merus-reach-1-6-billion-coopera-42486147.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/gsk-single-dose-kozenis-tafenoquine-effecti-42486376.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/pfizer-s-pf-06939926-phase-iii-clinical-study-42486377.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/opdivo-cabometyx-program-was-approved-by-the-u-42486583.html 2021-02-04T17:16:10+08:00 weekly 0.8 https://fr.hspchem.com/news/roche-s-super-flu-drug-xofluza-was-approved-by-42486584.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/sgl1-2-inhibitor-zynquista-sotagliflozin-rec-42498777.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/acalabrutinib-vs-ibrutinib-in-the-treatment-o-42498993.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/abbvie-s-oral-jak1-inhibitor-rinvoq-upadaciti-42498999.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/the-us-fda-approved-the-inhibitor-lupkynis-for-42511687.html 2021-02-05T07:53:24+08:00 weekly 0.8 https://fr.hspchem.com/news/menarini-elzonris-approved-in-the-eu-treatmen-42511688.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/roche-esbriet-pirfenidone-received-priority-42511689.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/progress-in-the-development-of-new-and-efficie-42511690.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/visen-pharmaceuticals-transcon-c-type-natriure-42511811.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/astrazeneca-calquence-has-higher-clinical-safe-42512079.html 2021-02-05T11:40:50+08:00 weekly 0.8 https://fr.hspchem.com/news/fda-approves-johnson-johnson-darzalex-faspro-42519424.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/cxcl-8-inhibitor-ladrixin-enters-phase-3-clini-42541056.html 2021-02-05T20:30:29+08:00 weekly 0.8 https://fr.hspchem.com/news/u-s-fda-approves-bayer-nubeqa-arolutamide-p-42541273.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/zokinvy-is-listed-in-the-us-life-expectancy-i-43380068.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/takeda-s-next-generation-alk-inhibitor-alunbri-43380077.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/the-us-fda-approves-tepmetko-the-world-s-firs-43380266.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/bayer-s-first-drug-finerenone-applied-for-li-43380388.html 2021-03-11T18:41:51+08:00 weekly 0.8 https://fr.hspchem.com/news/takeda-maribavir-phase-3-clinical-success-43380389.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/lamotrigine-is-approved-for-new-indications-b-43380391.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/abbvie-submitted-its-first-new-drug-listing-ap-43380400.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/cstone-s-pralsetinib-in-the-treatment-of-chine-43380403.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/oxbryta-voxelotor-enters-the-review-in-the-e-43380405.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/oral-tyk2-inhibitor-deucravacitinib-was-succes-43380417.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/the-european-union-approves-sanofi-plavix-clo-43380587.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/opdivo-cabometyx-combination-phase-3-clinical-43380588.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/seattle-genetics-her2-targeted-tki-oral-drug-43380799.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/lynparza-olaparib-adjuvant-treatment-of-brca-43380802.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/astellas-xospata-gilteritinib-approved-trea-43380804.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/sanofi-terminates-multiple-r-d-plans-such-as-p-43381224.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/vertex-s-triple-therapy-trikafta-has-been-give-43381438.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/antengene-atg-010-new-drug-marketing-applicati-43382604.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/the-world-s-first-chemotherapy-and-bone-marrow-43382766.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/johnson-johnson-erlead-apalutamide-zytig-43382769.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/the-us-fda-granted-novartis-stamp-inhibitor-as-43382772.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/glaxosmithkline-rukobia-approved-by-eu-new-an-43382778.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/the-new-generation-of-oral-pi3k-ck1-dual-in-43382945.html 2021-03-11T19:14:27+08:00 weekly 0.8 https://fr.hspchem.com/news/roche-s-faricimab-is-successful-in-the-treatme-43383111.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/the-new-dosage-form-of-ruxolitinib-has-been-re-43383121.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/u-s-fda-approves-short-acting-cdk4-6-inhibito-43384010.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/oral-non-hormonal-therapy-fezolinetant-treatme-43384121.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/astellas-gilteritinib-obtains-nmpa-conditional-43384125.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/eli-lilly-s-gip-glp-1-dual-receptor-agonist-ti-43384130.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/eli-lilly-and-rigel-reached-a-us-960-million-a-43384450.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/inhibitor-odevixibat-has-been-given-priority-r-43384728.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/the-national-food-and-drug-administration-of-c-43384836.html 2021-03-11T19:35:08+08:00 weekly 0.8 https://fr.hspchem.com/news/in-february-2021-the-world-s-first-batch-of-43384904.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/pfizer-submits-a-long-acting-human-growth-horm-43384989.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/spring-festival-holiday-notice-43385103.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/biogen-waives-parkinson-s-disease-drug-cineman-43385109.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/zeposia-ozanimod-for-the-treatment-of-ulcera-43386000.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/smo-inhibitor-treatment-of-basal-cell-carcinom-43868876.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/successful-phase-ii-proof-of-concept-study-of-43868878.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/roche-evrysdi-will-soon-be-approved-for-listin-43868880.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/use-artificial-intelligence-to-develop-innovat-43869081.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/sanofi-s-cd38-targeting-antibody-sarclisa-s-se-43869675.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/gilead-inhibitor-lenacapavir-maintained-high-v-43869676.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/pfizer-s-third-generation-alk-inhibitor-lorbre-43869677.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/bayer-s-pi3k-inhibitors-apply-for-listing-in-c-43869892.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/galapagos-releases-mid-term-clinical-safety-da-43870680.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/eli-lilly-incyte-olumiant-successfully-treats-43871616.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/glaxosmithkline-s-long-acting-il-5-inhibitor-g-45725174.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/johnson-johnson-ponvory-ponesimod-was-appr-45725175.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/abbvie-s-oral-rinvoq-upadacitinib-new-indica-45725177.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/fda-accepts-abbvie-atogepant-new-drug-applicat-45725921.html 2021-05-17T13:32:25+08:00 weekly 0.8 https://fr.hspchem.com/news/astellas-myrbetriq-mirabegron-is-approved-by-45725922.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/eu-approved-ontozry-cenobamate-adjuvant-tre-45725923.html 2021-05-17T13:32:26+08:00 weekly 0.8 https://fr.hspchem.com/news/bristol-myers-ipsen-immune-targeting-combina-45725924.html 2021-05-17T13:32:26+08:00 weekly 0.8 https://fr.hspchem.com/news/pfizer-abrocitinib-phase-3-clinical-effect-is-45725925.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/pfizer-and-celcuity-have-reached-a-partnership-45725926.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/pfizer-announces-evidence-of-the-efficacy-of-i-45725927.html 2021-05-17T13:32:27+08:00 weekly 0.8 https://fr.hspchem.com/news/3-adrenergic-receptor-agonist-gemtesa-vibegr-45725928.html 2021-05-17T13:32:25+08:00 weekly 0.8 https://fr.hspchem.com/news/the-u-s-fda-granted-the-inhibitor-futibatinib-45725929.html 2021-05-17T13:32:27+08:00 weekly 0.8 https://fr.hspchem.com/news/astrazeneca-s-acquisition-of-alexion-successfu-45725930.html 2021-05-17T13:32:25+08:00 weekly 0.8 https://fr.hspchem.com/news/retevmo-is-very-effective-in-treating-various-45725931.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/bayer-s-broad-spectrum-targeted-anticancer-dru-45725932.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/blueprint-cstone-kit-inhibitor-ayvakit-avapri-45725933.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/2021-aacr-bayer-plans-to-announce-inhl-phase-45726694.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/bayer-merck-adempas-riociguat-has-a-strong-45726695.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/merck-s-first-atr-inhibitor-berzosertib-topo-45726696.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/covalent-fgfr-inhibitor-futibatinib-in-the-tre-45726697.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/darovasertib-in-the-treatment-of-metastatic-uv-45726698.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/the-first-peptide-drug-conjugate-pepaxto-app-45726699.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/simcere-and-kazia-signed-a-us-292-million-agre-45726700.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/eli-lilly-s-jak-inhibitor-baritinib-is-expecte-45726701.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/inhibitor-lupkynis-regardless-of-the-biopsy-t-45726702.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/sanofi-fabrazyme-the-only-enzyme-replacement-45739133.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/the-us-fda-approves-kimyrsa-oritavancin-tre-45739134.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/targeting-immunity-combination-keytruda-le-45739135.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/takeda-takhzyro-applied-for-listing-in-japan-45739136.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/gilead-and-novo-nordisk-join-forces-expand-cl-45739137.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/everest-medicines-xerava-eravacycline-was-ac-45739138.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/pegcetacoplan-is-effective-in-treating-paroxys-45739139.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/gilead-and-merck-jointly-develop-lenacapavir-i-45739140.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/the-first-peptide-drug-conjugate-pepaxto-was-i-45739141.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/researchers-have-developed-a-new-generation-of-45739142.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/eli-lilly-verzenio-abemaciclib-combined-end-45739143.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/u-s-fda-approves-zegalogue-for-use-in-childre-45739144.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/oral-next-generation-vegf-tki-fotivda-is-launc-45739145.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/astellas-xtandi-enzalutamide-new-indication-45739146.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/eli-lilly-incyte-olumiant-s-second-phase-3-tri-45739147.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/semaglutide-oral-50mg-enters-phase-3-clinic-45739148.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/novo-nordisk-s-glp-1-receptor-agonist-saxenda-45739150.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/vertex-s-triple-therapy-kaftrio-and-ivacaftor-45739151.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/oxbryta-voxelotor-treatment-for-72-weeks-sig-45739152.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/zepzelca-lurbinectedin-was-included-in-the-c-45739153.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/novo-nordisk-semaglutide-is-effective-18-2-w-45739154.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/bristol-myers-breyanzi-liso-cel-approved-in-45739155.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/johnson-johnson-ponvory-ponesimod-eu-is-ab-45739157.html 2021-05-18T00:14:47+08:00 weekly 0.8 https://fr.hspchem.com/news/the-inhibitor-belumosudil-has-a-strong-effect-45748204.html 2021-05-18T00:14:48+08:00 weekly 0.8 https://fr.hspchem.com/news/relugolix-compound-tablet-enters-phase-3-clini-45748205.html 2021-06-03T19:16:20+08:00 weekly 0.8 https://fr.hspchem.com/news/roche-abbvie-s-venclyxto-hypomethylation-agen-46363507.html 2021-06-03T19:16:20+08:00 weekly 0.8 https://fr.hspchem.com/news/the-listing-application-of-hua-medicine-s-new-46363508.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/the-merck-eisai-keytruda-lenvima-program-submi-46363687.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/daiichi-sankyo-tarlige-mirogabalin-applies-f-46363688.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/novo-nordisk-ozempic-semaglutide-injection-a-46363690.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/us-fda-approves-farxiga-the-first-sglt2-inhib-46363692.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/the-us-fda-approved-the-inhibitor-empaveli-to-46363693.html 2021-06-03T19:27:34+08:00 weekly 0.8 https://fr.hspchem.com/news/notification-of-address-change-46363871.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/plasma-kallikrein-inhibitor-orladeyo-berotral-46363872.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/the-new-indication-of-astellas-xtandi-enzalut-46367746.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/an-imported-anti-inflammatory-drug-otezla-is-u-46367747.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/takeda-maribavir-receives-priority-review-by-u-46367748.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/the-us-fda-approves-the-new-non-opioid-dual-ac-46367749.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/novo-nordisk-will-initiate-a-pivotal-phase-3a-46367877.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/bayer-s-finerenone-phase-3-cardiovascular-outc-46370388.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/eu-chmp-recommends-the-approval-of-onureg-aza-46370390.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/gilead-jyseleca-applied-for-a-new-indication-i-46370392.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/servier-tibsovo-has-been-given-priority-review-46372936.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/bylvay-odevixibat-is-about-to-be-approved-in-46928364.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/wegovy-semaglutide-18-weight-loss-after-46928365.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/ipsen-palovarotene-has-entered-priority-review-46928366.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/novartis-oral-inhibitor-iptacopan-significant-46928367.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/us-fda-approves-amgen-lumakras-the-world-s-fi-46928368.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/the-us-fda-approved-ryplazim-plasminogen-th-46928566.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/pi3k-inhibitor-zandelisib-in-the-treatment-of-46928567.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/lynparza-olaparib-adjuvant-treatment-of-brca-46928568.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/gavreto-pralsetinib-has-shown-strong-and-lon-46928569.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/oral-gnrh-receptor-antagonist-relugolix-compou-46928904.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/amgen-lumakras-has-strong-efficacy-in-treating-46944813.html 2021-06-23T13:50:20+08:00 weekly 0.8 https://fr.hspchem.com/news/bristol-myers-opdivo-yervoy-program-is-recomme-46944977.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/empaveli-has-a-strong-first-line-treatment-for-46944978.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/the-us-fda-approved-tembexa-brincidofovir-t-46944979.html 2021-06-23T13:50:21+08:00 weekly 0.8 https://fr.hspchem.com/news/the-u-s-fda-accepts-a-new-generation-of-pi3k-46944980.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/novo-nordisk-submitted-ozempic-semaglutide-h-46945308.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/the-new-indication-of-boehringer-lilly-jardian-46945309.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/olumiant-baricitinib-effectively-improves-pa-46945310.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/abbvie-imbruvica-venclexta-fixed-course-of-fir-46945314.html 2021-06-23T23:02:15+08:00 weekly 0.8 https://fr.hspchem.com/news/the-us-fda-approved-truseltiq-infigratinib-46967296.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/eli-lilly-verzenio-abemaciclib-endocrine-t-46967297.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/the-long-term-data-of-vitrakvi-larotrectinib-46987034.html 2021-06-24T11:37:52+08:00 weekly 0.8 https://fr.hspchem.com/news/erleada-apalutamide-long-term-treatment-pro-46996715.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/the-inhibitor-iptacopan-is-effective-in-treati-49914761.html 2021-09-26T12:11:06+08:00 weekly 0.8 https://fr.hspchem.com/news/efgartigimod-significantly-improved-strength-a-49914762.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/beigene-brukinsa-zanubrutinib-was-approved-f-49914763.html 2021-09-26T12:11:06+08:00 weekly 0.8 https://fr.hspchem.com/news/onureg-5-azacytidine-tablets-approved-by-the-49914764.html 2021-09-26T12:11:06+08:00 weekly 0.8 https://fr.hspchem.com/news/kras-inhibitor-adagrasib-has-been-certified-as-49914765.html 2021-09-26T12:11:06+08:00 weekly 0.8 https://fr.hspchem.com/news/bayer-verquvo-vericiguat-is-approved-in-japa-49914766.html 2021-09-26T12:11:07+08:00 weekly 0.8 https://fr.hspchem.com/news/novartis-resubmitted-its-cholesterol-lowering-49914767.html 2021-09-26T12:11:06+08:00 weekly 0.8 https://fr.hspchem.com/news/kimyrsa-oritavancin-launched-treatment-of-a-49914768.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/the-us-fda-revoked-the-breakthrough-therapy-de-49914769.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/gilead-epclusa-has-been-approved-by-the-us-fda-49914770.html 2021-09-26T12:11:07+08:00 weekly 0.8 https://fr.hspchem.com/news/bayer-s-first-drug-kerendia-finerenone-was-49914771.html 2021-09-26T12:11:07+08:00 weekly 0.8 https://fr.hspchem.com/news/plasma-kallikrein-inhibitor-orladeyo-berotral-49914772.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/fetcroja-cefiderocol-strong-activity-agains-49914773.html 2021-09-26T12:11:12+08:00 weekly 0.8 https://fr.hspchem.com/news/eprenetapopt-azacitidine-is-effective-49914774.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/a-new-class-of-hypoglycemic-drug-twymeeg-imeg-49914775.html 2021-09-26T12:11:09+08:00 weekly 0.8 https://fr.hspchem.com/news/cabenuva-can-be-successfully-implemented-in-a-49914776.html 2021-09-26T12:11:08+08:00 weekly 0.8 https://fr.hspchem.com/news/phase-1b-study-of-oral-tyk2-inhibitor-glpg-49914777.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/the-listing-application-of-pemigatinib-was-acc-49914778.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/wakix-pitolisant-submitted-a-marketing-appl-49914779.html 2021-09-26T12:11:05+08:00 weekly 0.8 https://fr.hspchem.com/news/j-med-chem-research-and-development-of-new-49914780.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/oral-sulopenem-for-the-treatment-of-simple-uri-49914781.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/the-us-fda-approves-dalvance-dalbavancin-si-49914782.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/science-sub-journal-defeat-drug-resistance-an-49914783.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/beigene-kyprolis-carfilzomib-for-injection-a-49914784.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/eprenetapopt-azacitidine-49914785.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/parp-inhibitor-lynparza-olaparib-approved-t-49914786.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/u-s-fda-refuses-to-approve-nhe3-inhibitor-ten-49914787.html 2021-09-26T12:11:11+08:00 weekly 0.8 https://fr.hspchem.com/news/roche-evrysdi-risdiplam-significantly-sma-49914788.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/eu-approved-imcivree-setmelanotide-rebuild-49914789.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/eisai-s-next-generation-anti-epileptic-drug-fy-49914790.html 2021-09-26T12:11:11+08:00 weekly 0.8 https://fr.hspchem.com/news/the-u-s-fda-granted-takeda-s-oral-orexin-rece-49914791.html 2021-09-26T12:11:11+08:00 weekly 0.8 https://fr.hspchem.com/news/pfizer-s-tofacitinib-phase-3-clinical-phase-re-49914792.html 2021-09-26T12:11:12+08:00 weekly 0.8 https://fr.hspchem.com/news/the-first-oral-pkr-allosteric-activator-mitapi-49914793.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/gilead-lenacapavir-gs-6207-enters-the-review-49915158.html 2021-09-26T12:22:15+08:00 weekly 0.8 https://fr.hspchem.com/news/gilead-lenacapavir-gs-6207-enters-the-review-49915159.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/the-u-s-fda-approves-the-innovative-periphera-49915160.html 2021-09-26T12:22:11+08:00 weekly 0.8 https://fr.hspchem.com/news/the-european-union-approves-xeljanz-tofacitin-49915161.html 2021-09-26T12:22:12+08:00 weekly 0.8 https://fr.hspchem.com/news/bayer-s-first-antagonist-elinzanetant-enters-p-49915162.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/the-bms-immunomodulator-orencia-abatacept-ha-49915163.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/the-european-union-approves-the-c-type-natriur-49915164.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/astrazeneca-s-forxiga-dapagliflozin-is-appro-49915165.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/bayer-s-first-drug-kerendia-finerenone-has-r-49915167.html 2021-09-26T12:22:12+08:00 weekly 0.8 https://fr.hspchem.com/news/novartis-pioneering-sirna-cholesterol-lowerin-49915169.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/eli-lilly-and-daiichi-sankyo-reached-a-commerc-49915170.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/fda-approved-johnson-johnson-invega-hafyera-49915171.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/igf-1r-targeting-monoclonal-antibody-tepezza-e-49915172.html 2021-09-26T12:22:12+08:00 weekly 0.8 https://fr.hspchem.com/news/bayer-s-eliapixant-phase-2-clinical-effect-rea-49915173.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/pfizer-s-new-generation-of-oral-jak1-inhibitor-49915174.html 2021-09-26T12:22:13+08:00 weekly 0.8 https://fr.hspchem.com/news/pfizer-s-new-generation-of-oral-jak1-inhibitor-49915175.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/lupkynis-applied-for-listing-in-the-eu-it-can-49915176.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/fda-narrows-indications-for-biogen-s-alzheimer-49915177.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/the-us-fda-approves-darzalex-faspro-combined-49915178.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/jyseleca-quickly-improve-symptoms-and-lasting-49915179.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/eli-lilly-s-1-billion-acquisition-of-protomer-49915180.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/fexinidazole-is-approved-by-the-us-fda-only-n-49915181.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/alnylam-and-peptidream-have-reached-a-strategi-49915182.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/the-clinical-study-of-ibi362-in-chinese-overwe-49915183.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/u-s-fda-granted-vivet-pfizer-vtx-801-fast-tra-49915184.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/cstone-pharmaceuticals-ivosidenib-has-released-49915185.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/astellas-and-minovia-reached-a-strategic-coope-49915186.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/otsuka-rexulti-brexpiprazole-orally-disinteg-49915187.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/fibrogen-astellas-evrenzo-rosarestat-approve-49915718.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/pfizer-s-new-generation-of-oral-jak1-inhibitor-49915724.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/u-s-fda-grants-jardiance-empagliflozin-brea-49915725.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/low-throughput-screening-finds-anti-malarial-d-49921442.html 2021-09-26T16:11:00+08:00 weekly 0.8 https://fr.hspchem.com/news/astrazeneca-completes-the-acquisition-of-alexi-49921443.html 2021-09-26T16:11:01+08:00 weekly 0.8 https://fr.hspchem.com/news/the-first-presbyopia-eye-drops-agn-190584-pil-49921444.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/u-s-fda-approves-update-of-aduhelm-label-for-49921445.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/the-us-fda-granted-alk-001-c20-d3-vitamin-a-49921446.html 2021-09-26T16:11:03+08:00 weekly 0.8 https://fr.hspchem.com/news/jakavi-jakafi-is-effective-in-treating-steroid-49921447.html 2021-09-26T16:11:04+08:00 weekly 0.8 https://fr.hspchem.com/news/the-uk-approves-the-third-indication-of-epidyo-49921448.html 2021-09-26T16:11:06+08:00 weekly 0.8 https://fr.hspchem.com/news/fda-approves-merck-s-innovative-tumor-drug-49921449.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/eu-approves-powerful-ileal-bile-acid-transport-49921547.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/eisai-inhibitor-tazverik-is-approved-for-marke-49921548.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/jardiance-empagliflozin-the-first-drug-to-s-49921549.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/merck-s-oral-antiviral-drug-molnupiravir-enter-49921550.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/us-fda-approves-merck-s-innovative-tumor-drug-49921551.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/concord-kirin-nourianz-was-rejected-by-the-eu-49921552.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/us-fda-approves-new-acne-drug-twyneo-tretinoi-49921554.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/fibrogen-astellas-evrenzo-rosarestat-approve-49921686.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/premier-research-acquires-camargo-a-u-s-phar-49926823.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/sofatinib-was-approved-for-a-new-indication-t-49926824.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/fetcroja-cefiderocol-strong-activity-key-49926825.html 2021-09-26T19:52:58+08:00 weekly 0.8 https://fr.hspchem.com/news/new-immunological-drug-spesolimab-obtained-cde-49926826.html 2021-09-26T19:52:57+08:00 weekly 0.8 https://fr.hspchem.com/news/us-fda-granted-breakthrough-therapy-designatio-49926827.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/u-s-fda-refuses-to-approve-nhe3-inhibitor-ten-49926828.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/jakavi-jakafi-is-effective-in-treating-steroid-49926829.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/pfizer-s-2-jak-inhibitors-abrocitinib-tofaci-49927034.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/takeda-s-new-drug-brigatinib-tablets-introduce-49927035.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/u-s-fda-grants-jardiance-empagliflozin-brea-49927455.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/cstone-pharmaceuticals-obtains-fda-approval-fo-49932525.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/universal-targeted-drugs-can-reduce-the-risk-o-49935589.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/venclyxto-gazyvaro-fixed-course-of-treatment-w-49937433.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/zynlonta-is-effective-in-treating-malignant-ly-49937435.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/oral-sulopenem-for-the-treatment-of-simple-uri-49937487.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/roche-evrysdi-risdiplam-significantly-improv-49937608.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/sanofi-aubagio-teriflunomide-approved-by-the-49939570.html 2021-11-05T16:58:19+08:00 weekly 0.8 https://fr.hspchem.com/news/cstone-s-multispecific-antibody-clinical-trial-51127130.html 2021-11-05T16:58:19+08:00 weekly 0.8 https://fr.hspchem.com/news/us-fda-accepts-application-for-new-indication-51127131.html 2021-11-05T16:58:19+08:00 weekly 0.8 https://fr.hspchem.com/news/erleada-apalutamide-rapid-deep-and-lasting-51127132.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/cabometyx-opdivo-has-a-good-effect-whether-51127133.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/researchers-announce-important-research-on-dor-51127134.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/astrazeneca-daiichi-sankyo-enhertu-head-to-hea-51127135.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/the-us-fda-approves-gilead-tecartus-a-single-51127136.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/inhibitor-deucravacitinib-in-the-treatment-of-51127137.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/cs5001-ror1-adc-research-data-from-cstone-ph-51127138.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/the-first-peptide-drug-conjugate-pepaxto-in-th-51127139.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/gilead-galapagos-oral-jyseleca-will-soon-be-ap-51127140.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/erleada-apalutamide-rapid-deep-and-lasting-51127387.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/zymeworks-her2-targeting-bispecific-antibody-s-51127388.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/giredestrant-neoadjuvant-treatment-of-er-her-51127389.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/bristol-myers-squibb-s-cardiac-myosin-alloster-51127390.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/selective-estrogen-receptor-degrading-agent-s-51127391.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/xtandi-enzalutamide-phase-3-clinically-signi-51127392.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/roche-gavreto-pralsetinib-is-about-to-be-app-51127393.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/the-us-fda-approves-abbvie-qulipta-the-first-51127394.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/rinvoq-upadacitinib-phase-3-clinical-success-51127395.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/u-s-fda-postpones-nefecon-targeted-release-b-51127396.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/a-new-generation-of-selective-nuclear-export-i-51127676.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/the-us-fda-approves-gilead-low-dose-biktarvy-f-51127677.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/eli-lilly-s-gip-glp-1-dual-agonist-tirzepatide-51127683.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/roche-and-neuexcell-have-reached-a-strategic-c-51148995.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/verzenio-abemaciclib-the-first-cdk4-6-inhib-51148996.html 2021-11-05T21:04:53+08:00 weekly 0.8 https://fr.hspchem.com/news/cabometyx-opdivo-has-a-good-effect-whether-51148997.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/tyrvaya-varenicline-the-first-nasal-spray-t-51149760.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/lybalvi-olanzapine-samidorphan-is-launched-i-51149761.html 2021-11-05T23:57:02+08:00 weekly 0.8 https://fr.hspchem.com/news/xtandi-enzalutamide-phase-3-clinically-signi-51158334.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/the-first-peptide-drug-conjugate-pepaxto-in-th-51158335.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/verzenio-abemaciclib-the-first-cdk4-6-inhib-51158339.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/tyvaso-dpi-treprostinil-dry-powder-inhaler-51158341.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/roche-gavreto-pralsetinib-is-about-to-be-app-51158562.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/twymeeg-imeglimin-goes-on-sale-in-japan-tar-51158563.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/us-fda-accepts-application-for-new-indication-51158564.html 2021-11-06T01:27:16+08:00 weekly 0.8 https://fr.hspchem.com/news/u-s-fda-approves-tivdak-the-first-tissue-fac-51163832.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/zeposia-is-about-to-be-approved-in-the-eu-the-51163833.html 2021-11-06T01:27:16+08:00 weekly 0.8 https://fr.hspchem.com/news/pfizer-biontech-announces-phase-3-clinical-dat-51163834.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/cstone-pharmaceuticals-esmo-announces-ivosiden-51163835.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/new-immuno-oncology-therapy-ono-4685-enters-ph-51168664.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/tatacept-iga-nephropathy-phase-ii-data-present-51990576.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/zuranolone-treatment-of-major-depression-mdd-51990577.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/ozawade-pitolisant-was-approved-by-the-europ-51990580.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/novartis-s-first-complement-factor-b-inhibitor-51990598.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/roche-and-bicycle-expand-cooperation-develop-51995541.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/abbvie-s-abbv-951-head-to-head-phase-3-study-i-51995542.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/tebipenem-hbr-filed-for-listing-treatment-of-51995543.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/u-s-fda-approved-abbvie-vuity-pilocarpine-51995544.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/otsuka-pharmaceutical-deltyba-dilamani-51995545.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/bardoxolone-a-new-oral-nrf2-activator-applie-51995546.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/merck-s-ridgeback-oral-antiviral-drug-molnupir-51995547.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/opzelura-cream-enters-eu-review-the-first-top-51995548.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/merck-ridgeback-antiviral-drug-lagevrio-molnu-51995549.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/wegovy-semaglutide-is-about-to-be-approved-i-51995552.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/wegovy-semaglutide-2-4mg-significantly-con-52001550.html 2021-11-26T18:49:39+08:00 weekly 0.8 https://fr.hspchem.com/news/vutrisiran-18-month-new-data-effective-treatm-52001552.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/novartis-first-complement-factor-b-inhibitor-52001852.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/jardiance-enpagliflozin-shows-sustained-hear-52001858.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/merck-bayer-initiates-a-new-phase-3-study-of-v-52006907.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/gilead-mersk-s-lenacapavir-islatravir-once-a-w-52006910.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/lumykras-sotorasib-is-about-to-be-approved-i-52007206.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/evobrutinib-the-first-btk-inhibitor-to-reduce-52010402.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/the-inhibitor-tavneos-is-about-to-be-approved-53060234.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/inhibitor-duvroq-daprodustat-significant-ef-53060418.html 2021-12-29T20:10:45+08:00 weekly 0.8 https://fr.hspchem.com/news/the-eu-approves-pfizer-s-new-generation-of-ora-53060420.html 2021-12-29T20:10:44+08:00 weekly 0.8 https://fr.hspchem.com/news/inhibitor-vanflyta-chemotherapy-first-line-t-53060421.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/deucravacitinib-enters-the-review-in-the-unite-53060422.html 2021-12-29T20:10:45+08:00 weekly 0.8 https://fr.hspchem.com/news/rinvoq-upadacitinib-effective-in-patients-w-53060423.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/scemblix-new-data-efficacy-and-safety-continu-53060425.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/kerendia-finerenone-started-a-phase-3-study-53060431.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/targeted-immune-combination-cabometyx-tece-53060712.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/abbvie-oral-jak1-inhibitor-rinvoq-upadacitini-53060713.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/taiwanese-medicine-hua-pharmaceutical-besremi-53064311.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/c3-targeting-inhibitor-empaveli-pegcetacoplan-53064312.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/bristol-myers-squibb-inhibitor-mavacamten-53064315.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/merck-suspends-clinical-development-of-non-nuc-53064316.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/pioneering-sirna-cholesterol-lowering-drug-leq-53066087.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/eli-lilly-s-head-to-head-study-begins-to-enrol-53067099.html 2021-12-29T23:50:45+08:00 weekly 0.8 https://fr.hspchem.com/news/inhibitor-duvroq-daprodustat-significant-ef-53067334.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/inhibitor-nerlynx-neratinib-phase-2-clinical-53067336.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/ozempic-semaglutide-high-dose-2-0mg-is-about-53067663.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/calquence-follow-up-data-for-3-years-the-risk-53067665.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/u-s-fda-approves-c-type-natriuretic-peptide-a-53068032.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/u-s-fda-approves-c-type-natriuretic-peptide-a-53068033.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/the-inhibitor-xeljanz-tofacitinib-was-approv-53746708.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/inhibitor-parsaclisib-the-total-remission-rat-53746709.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/the-united-kingdom-approved-qinlock-ripretini-53746710.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/eu-approves-aspaveli-treatment-of-paroxysmal-53746904.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/fda-approves-pfizer-s-next-generation-oral-jak-53759163.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/amgen-s-lumykras-sotorasib-approved-by-the-e-53771490.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/rinvoq-applies-for-a-new-indication-the-treat-53783297.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/eisai-and-gilead-sign-a-new-agreement-to-distr-53783304.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/us-fda-granted-priority-review-for-topical-jak-53797103.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/u-s-fda-approves-abbvie-s-second-indication-f-53826391.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/syk-inhibitor-tavalisse-fatantinib-phase-3-s-53832084.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/lorviqua-lorlatinib-is-about-to-be-approved-53876361.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/hefei-home-sunshine-pharma-successfully-renewe-61974633.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/welcome-to-visit-cphi-china-2023-shanghai-our-68159313.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/welcome-to-visit-cphi-china-2023-guangzhou-ou-68159314.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/merry-christmas-and-a-happy-new-year-76632223.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/welcome-to-visit-cphi-china-2023-shanghai-our-76632224.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/welcome-to-visit-28th-tine-tashkent-uzbekista-76632225.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/notice-on-spring-festival-holiday-in-76632226.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/exhibition-record-of-uzbekistan-tihe-exhibitio-78064415.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/welcome-to-visit-cphi-worldwide-europe-2024-mi-78064419.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/new-era-natural-health-exercise-79625837.html 2026-01-09T09:41:20+08:00 weekly 0.8 https://fr.hspchem.com/news/the-new-oral-antibiotic-orlynvah-has-been-appr-84713156.html 2019-11-15T15:07:54+08:00 weekly 0.8 https://fr.hspchem.com/info/industry-scale-of-medicine-41090423.html 2019-11-27T13:15:00+08:00 weekly 0.8 https://fr.hspchem.com/info/fine-chemical-classification-41090424.html 2019-11-15T15:05:09+08:00 weekly 0.8 https://fr.hspchem.com/info/fluorinated-pyridine-41090425.html 2019-11-15T15:14:44+08:00 weekly 0.8 https://fr.hspchem.com/info/current-status-of-fine-chemical-industry-41090471.html 2019-11-27T13:15:02+08:00 weekly 0.8 https://fr.hspchem.com/info/prospects-for-the-development-of-apis-41090472.html 2019-11-15T15:09:36+08:00 weekly 0.8 https://fr.hspchem.com/info/medical-development-41090474.html 2019-11-28T19:07:10+08:00 weekly 0.8 https://fr.hspchem.com/info/medical-introduction-41121071.html 2019-11-15T15:10:39+08:00 weekly 0.8 https://fr.hspchem.com/info/development-status-of-raw-materials-41121141.html 2019-11-15T15:04:30+08:00 weekly 0.8 https://fr.hspchem.com/info/lactam-gap-41141050.html 2019-11-15T15:13:00+08:00 weekly 0.8 https://fr.hspchem.com/info/production-of-apis-41141135.html 2019-11-15T15:08:33+08:00 weekly 0.8 https://fr.hspchem.com/info/pharmaceutical-industry-41141188.html 2019-11-15T15:03:19+08:00 weekly 0.8 https://fr.hspchem.com/info/status-of-lactams-41141263.html 2019-11-15T15:02:06+08:00 weekly 0.8 https://fr.hspchem.com/info/drug-supplies-41152812.html 2019-11-15T15:07:18+08:00 weekly 0.8 https://fr.hspchem.com/info/classification-of-medicine-41152953.html 2019-11-15T15:05:39+08:00 weekly 0.8 https://fr.hspchem.com/info/o-chlorobenzoic-acid-41190964.html 2019-11-15T15:09:01+08:00 weekly 0.8 https://fr.hspchem.com/info/biomedical-engineering-industry-41226667.html 2019-12-02T13:28:10+08:00 weekly 0.8 https://fr.hspchem.com/info/introduction-to-fine-chemicals-41226760.html 2019-11-15T15:16:11+08:00 weekly 0.8 https://fr.hspchem.com/info/fine-chemical-characteristics-41260530.html 2019-11-15T15:06:17+08:00 weekly 0.8 https://fr.hspchem.com/info/what-is-biphenoldiol-41260563.html 2019-11-15T15:10:07+08:00 weekly 0.8 https://fr.hspchem.com/info/classification-of-apis-41342284.html 2020-01-06T17:40:56+08:00 weekly 0.8 https://fr.hspchem.com/info/azz-pharma-new-recombinant-erwinia-asparaginas-42743661.html 2020-01-06T17:10:47+08:00 weekly 0.8 https://fr.hspchem.com/info/combination-of-antiangiogenic-drugs-and-cancer-42743662.html 2020-01-15T21:22:19+08:00 weekly 0.8 https://fr.hspchem.com/info/ready-to-use-car-t-therapy-an-expedient-or-a-42743665.html 2020-01-03T17:18:11+08:00 weekly 0.8 https://fr.hspchem.com/info/the-application-of-human-neural-stem-cells-alz-42743667.html 2020-01-15T21:24:00+08:00 weekly 0.8 https://fr.hspchem.com/info/functions-of-coenzyme-q10-42744151.html 2020-01-15T21:24:00+08:00 weekly 0.8 https://fr.hspchem.com/info/study-explores-emerging-role-of-nad-in-innate-42744155.html 2020-01-15T21:22:18+08:00 weekly 0.8 https://fr.hspchem.com/info/nicotinamide-mononucleotide-nmn-production-42744244.html 2020-01-03T13:58:00+08:00 weekly 0.8 https://fr.hspchem.com/info/science-increasing-collagen-affinity-improves-42744245.html 2020-01-07T15:55:17+08:00 weekly 0.8 https://fr.hspchem.com/info/study-on-the-mechanism-of-nad-regulating-plant-42744248.html 2020-01-15T10:20:10+08:00 weekly 0.8 https://fr.hspchem.com/info/phase-iii-clinical-success-of-akari-complement-42744249.html 2020-01-03T17:29:41+08:00 weekly 0.8 https://fr.hspchem.com/info/the-preparation-method-of-protein-aie-nano-poi-42744393.html 2020-01-07T14:23:05+08:00 weekly 0.8 https://fr.hspchem.com/info/history-synthesis-and-function-of-nad-nic-42744395.html 2020-01-15T09:25:30+08:00 weekly 0.8 https://fr.hspchem.com/info/nature-reveals-section-clocks-that-regulate-h-42752450.html 2020-01-15T11:03:06+08:00 weekly 0.8 https://fr.hspchem.com/info/nat-cell-biol-scientists-successfully-cultiva-42752451.html 2020-01-03T16:41:22+08:00 weekly 0.8 https://fr.hspchem.com/info/nature-the-key-cause-of-t-cell-depletion-in-42803699.html 2020-01-17T22:55:09+08:00 weekly 0.8 https://fr.hspchem.com/info/sintilimab-achieves-primary-study-endpoint-in-42825095.html 2020-05-07T20:15:41+08:00 weekly 0.8 https://fr.hspchem.com/info/commun-biol-special-protein-in-brain-may-help-45272973.html 2020-05-07T20:11:41+08:00 weekly 0.8 https://fr.hspchem.com/info/stm-genetic-modification-of-stem-cells-can-im-45272974.html 2020-05-07T20:15:42+08:00 weekly 0.8 https://fr.hspchem.com/info/sitting-and-watching-tv-for-a-long-time-will-a-45272975.html 2020-05-07T20:19:34+08:00 weekly 0.8 https://fr.hspchem.com/info/axsome-s-new-oral-multi-mechanism-drug-axs-45272976.html 2020-05-07T20:17:38+08:00 weekly 0.8 https://fr.hspchem.com/info/nature-promoting-il-17a-production-could-impr-45272979.html 2020-05-07T20:19:33+08:00 weekly 0.8 https://fr.hspchem.com/info/cell-challenge-the-textbook-reveal-the-mecha-45272980.html 2020-05-07T20:13:44+08:00 weekly 0.8 https://fr.hspchem.com/info/the-us-fda-approved-the-first-intravenous-anal-45273146.html 2020-05-07T20:15:45+08:00 weekly 0.8 https://fr.hspchem.com/info/cinda-bio-s-fgfr-inhibitor-pemigatinib-registe-45273147.html 2020-05-07T09:46:57+08:00 weekly 0.8 https://fr.hspchem.com/info/astrazeneca-s-imfinzi-infineon-single-drug-a-45273148.html 2020-05-07T20:17:38+08:00 weekly 0.8 https://fr.hspchem.com/info/cell-reports-how-does-dopamine-tell-you-that-45273149.html 2020-05-07T20:19:31+08:00 weekly 0.8 https://fr.hspchem.com/info/neurology-shocked-not-sleeping-for-one-night-45273150.html 2020-05-07T09:50:12+08:00 weekly 0.8 https://fr.hspchem.com/info/the-us-fda-approved-the-first-sustained-releas-45273152.html 2020-05-07T20:15:43+08:00 weekly 0.8 https://fr.hspchem.com/info/pfizer-lilly-tanezumab-entered-the-review-in-45273153.html 2020-05-07T20:21:40+08:00 weekly 0.8 https://fr.hspchem.com/info/india-approves-ppar-dual-agonist-for-the-first-45273154.html 2020-05-07T20:19:34+08:00 weekly 0.8 https://fr.hspchem.com/info/the-world-s-first-iron-carrier-cephalosporin-f-45273155.html 2020-05-07T20:19:32+08:00 weekly 0.8 https://fr.hspchem.com/info/alks3831-olanzapine-samidorphan-phase-iii-45273156.html 2020-05-07T20:19:33+08:00 weekly 0.8 https://fr.hspchem.com/info/science-how-does-dopamine-cause-cocaine-addic-45273157.html 2020-05-07T20:15:42+08:00 weekly 0.8 https://fr.hspchem.com/info/fda-publishes-q-a-guides-on-related-product-45273158.html 2020-05-07T20:21:39+08:00 weekly 0.8 https://fr.hspchem.com/info/novartis-new-generation-s1p-receptor-modulato-45273159.html 2020-05-07T20:17:39+08:00 weekly 0.8 https://fr.hspchem.com/info/roche-risdiplam-significantly-improves-the-sur-45273160.html 2020-05-07T20:17:40+08:00 weekly 0.8 https://fr.hspchem.com/info/cell-rep-the-mechanism-of-action-of-dopamine-45273302.html 2020-04-30T16:18:02+08:00 weekly 0.8 https://fr.hspchem.com/info/novartis-cosentyx-is-approved-by-the-european-45273304.html 2020-05-07T11:15:00+08:00 weekly 0.8 https://fr.hspchem.com/info/the-us-fda-approves-isturisa-osilodrostat-t-45273305.html 2020-05-07T20:15:43+08:00 weekly 0.8 https://fr.hspchem.com/info/cancer-cell-new-discovery-acute-myeloid-leuk-45273306.html 2020-04-30T17:04:04+08:00 weekly 0.8 https://fr.hspchem.com/info/nemolizumab-treatment-of-nodular-pruritus-pn-45273307.html 2020-05-07T09:26:01+08:00 weekly 0.8 https://fr.hspchem.com/info/the-potent-farnesyl-transferase-inhibitor-tipi-45273308.html 2020-05-07T20:17:41+08:00 weekly 0.8 https://fr.hspchem.com/info/adrecizumab-s-phase-2-proof-of-concept-study-i-45273309.html 2020-05-07T20:19:35+08:00 weekly 0.8 https://fr.hspchem.com/info/yoshino-iron-carrier-cephalosporin-fetcroja-c-45273310.html 2020-04-30T17:06:41+08:00 weekly 0.8 https://fr.hspchem.com/info/tg6002-treatment-of-liver-metastasis-colorecta-45273311.html 2020-04-30T17:10:37+08:00 weekly 0.8 https://fr.hspchem.com/info/covid-19-detection-tips-45273312.html 2020-05-07T20:21:40+08:00 weekly 0.8 https://fr.hspchem.com/info/karyopharm-s-first-nuclear-export-inhibitor-xp-45273313.html 2020-05-07T20:21:38+08:00 weekly 0.8 https://fr.hspchem.com/info/valtoco-diazepam-nasal-spray-the-first-nasa-45273314.html 2020-05-07T20:17:38+08:00 weekly 0.8 https://fr.hspchem.com/info/elife-long-term-setbacks-will-inhibit-the-pro-45273447.html 2020-05-07T20:19:34+08:00 weekly 0.8 https://fr.hspchem.com/info/science-reveals-nerve-cell-types-associated-w-45273448.html 2020-04-29T08:48:41+08:00 weekly 0.8 https://fr.hspchem.com/info/clin-cancer-res-the-key-to-breast-cancer-cell-45273449.html 2020-05-07T09:54:25+08:00 weekly 0.8 https://fr.hspchem.com/info/ono-pharmaceutical-s-braftovi-three-drug-progr-45273451.html 2020-04-30T16:41:56+08:00 weekly 0.8 https://fr.hspchem.com/info/bristol-myers-opdivo-odivo-received-the-firs-45273452.html 2020-05-07T20:19:33+08:00 weekly 0.8 https://fr.hspchem.com/info/oral-rock2-inhibitor-kd025-treatment-after-2-m-45273453.html 2020-05-07T20:17:40+08:00 weekly 0.8 https://fr.hspchem.com/info/nat-neurosci-key-genes-regulate-autism-and-ad-45273456.html 2020-05-07T20:19:33+08:00 weekly 0.8 https://fr.hspchem.com/info/jama-s-latest-analysis-the-median-r-d-cost-45273459.html 2020-05-07T20:19:34+08:00 weekly 0.8 https://fr.hspchem.com/info/consumption-of-trans-fatty-acids-may-increase-45273466.html 2020-04-30T17:09:03+08:00 weekly 0.8 https://fr.hspchem.com/info/roche-ace-biologic-rituxan-adds-a-new-indicati-45273605.html 2020-05-07T20:21:40+08:00 weekly 0.8 https://fr.hspchem.com/info/mylan-pakang-myl-1402-bevacizumab-biosimila-45273606.html 2020-04-29T08:59:49+08:00 weekly 0.8 https://fr.hspchem.com/info/j-neurosci-dopamine-may-regulate-sex-differen-45273608.html 2020-05-07T20:25:40+08:00 weekly 0.8 https://fr.hspchem.com/info/targeting-ccr5-to-treat-new-coronavirus-pneumo-45273609.html 2020-05-07T11:39:38+08:00 weekly 0.8 https://fr.hspchem.com/info/apg-2575-has-obtained-three-clinical-licenses-45273610.html 2020-05-07T09:13:24+08:00 weekly 0.8 https://fr.hspchem.com/info/alnylam-s-highly-innovative-drug-givlaari-is-a-45273611.html 2020-05-07T20:19:33+08:00 weekly 0.8 https://fr.hspchem.com/info/new-drug-naizilai-granules-approved-for-clinic-45273612.html 2020-05-07T11:16:54+08:00 weekly 0.8 https://fr.hspchem.com/info/the-world-s-second-rnai-drug-givlaari-is-appro-45273613.html 2020-04-30T16:08:27+08:00 weekly 0.8 https://fr.hspchem.com/info/the-9-biosimilars-approved-by-the-us-fda-are-a-45273614.html 2020-05-07T20:23:35+08:00 weekly 0.8 https://fr.hspchem.com/info/gsk-strong-growth-effect-intramuscular-injec-45273617.html 2020-01-20T14:11:33+08:00 weekly 0.8 https://fr.hspchem.com/info/science-journal-pancreatitis-is-actually-a-st-45273618.html 2020-05-07T11:36:26+08:00 weekly 0.8 https://fr.hspchem.com/info/tetaxipu-global-original-innovative-drugs-fro-45273623.html 2020-01-20T15:16:23+08:00 weekly 0.8 https://fr.hspchem.com/info/j-med-chem-hiv-drug-efavirenz-could-potential-45273730.html 2020-05-07T20:21:39+08:00 weekly 0.8 https://fr.hspchem.com/info/sanofi-cablivi-is-approved-by-canada-for-the-t-45273731.html 2020-01-20T14:51:12+08:00 weekly 0.8 https://fr.hspchem.com/info/ajhg-new-study-reveals-effects-of-pten-mutati-45273732.html 2020-04-30T16:30:57+08:00 weekly 0.8 https://fr.hspchem.com/info/rocre-s-multiple-sclerosis-drug-ocrevus-signif-45273733.html 2020-04-29T09:05:29+08:00 weekly 0.8 https://fr.hspchem.com/info/neuron-the-yin-yang-side-of-dopamine-45273734.html 2020-05-07T20:25:38+08:00 weekly 0.8 https://fr.hspchem.com/info/novo-nordisk-fiasp-fast-acting-insulin-aspart-45273735.html 2020-05-07T20:27:50+08:00 weekly 0.8 https://fr.hspchem.com/info/howerson-s-innovative-drug-almonertinib-tablet-45273737.html 2020-05-07T11:55:26+08:00 weekly 0.8 https://fr.hspchem.com/info/boehringer-multi-kinase-kinase-inhibitor-ofev-45273831.html 2020-05-07T13:49:01+08:00 weekly 0.8 https://fr.hspchem.com/info/abbvie-global-supply-of-hiv-drug-kreizil-lop-45273832.html 2020-05-07T20:25:38+08:00 weekly 0.8 https://fr.hspchem.com/info/ascentage-pharma-apg-2575-global-phase-ib-ii-45273833.html 2020-05-07T20:23:35+08:00 weekly 0.8 https://fr.hspchem.com/info/johnson-johnson-s-egfr-met-bispecific-antibo-45273834.html 2020-05-07T11:25:16+08:00 weekly 0.8 https://fr.hspchem.com/info/the-first-cluster-headache-medicine-eli-lilly-45273835.html 2020-05-07T20:27:48+08:00 weekly 0.8 https://fr.hspchem.com/info/eli-lilly-s-jak-inhibitor-anti-inflammatory-dr-45273836.html 2020-05-07T20:27:47+08:00 weekly 0.8 https://fr.hspchem.com/info/bristol-myers-squibb-opdivo-is-approved-for-th-45273921.html 2020-05-07T13:58:49+08:00 weekly 0.8 https://fr.hspchem.com/info/takeda-oral-proteasome-inhibitor-ninlaro-ixaz-45273970.html 2020-05-07T20:31:49+08:00 weekly 0.8 https://fr.hspchem.com/info/pfizer-and-ideaya-sign-clinical-r-d-cooperat-45273974.html 2020-05-07T20:31:49+08:00 weekly 0.8 https://fr.hspchem.com/info/multi-system-atrophy-new-drug-fda-granted-the-45273975.html 2020-05-07T20:28:42+08:00 weekly 0.8 https://fr.hspchem.com/info/epidyolex-europe-applies-for-new-indications-f-45273976.html 2020-05-07T20:27:47+08:00 weekly 0.8 https://fr.hspchem.com/info/strong-growth-effect-intramuscular-injection-c-45273977.html 2020-05-07T20:29:45+08:00 weekly 0.8 https://fr.hspchem.com/info/gilead-s-epclusa-bentongsha-is-approved-by-t-45273979.html 2020-05-07T15:37:08+08:00 weekly 0.8 https://fr.hspchem.com/info/sglt2-inhibitor-receives-fda-fast-track-qualif-45274053.html 2020-05-07T15:28:37+08:00 weekly 0.8 https://fr.hspchem.com/info/nurtec-odt-the-first-cgrp-receptor-antagonist-45274055.html 2020-05-07T15:53:24+08:00 weekly 0.8 https://fr.hspchem.com/info/johnson-johnson-s-anti-inflammatory-drug-ste-45274057.html 2020-05-07T16:15:27+08:00 weekly 0.8 https://fr.hspchem.com/info/oral-mpo-inhibitors-are-eligible-for-fda-fast-45274191.html 2020-05-07T21:46:23+08:00 weekly 0.8 https://fr.hspchem.com/info/nature-a-major-breakthrough-in-parkinson-s-di-45275200.html 2020-04-30T16:04:22+08:00 weekly 0.8 https://fr.hspchem.com/info/vir-s-sirna-drug-vir-2218-administered-subcuta-45275201.html 2020-05-07T21:54:54+08:00 weekly 0.8 https://fr.hspchem.com/info/cd19-targeting-new-fc-optimized-immune-enhanci-45275202.html 2020-04-30T17:21:10+08:00 weekly 0.8 https://fr.hspchem.com/info/the-glaxosmithkline-parp-inhibitor-zejula-zer-45275204.html 2020-05-07T21:54:54+08:00 weekly 0.8 https://fr.hspchem.com/info/independent-research-and-development-of-antide-45275205.html 2020-05-07T21:52:52+08:00 weekly 0.8 https://fr.hspchem.com/info/zhimeng-pharmaceutical-is-researching-hbv-caps-45275207.html 2020-05-07T11:06:15+08:00 weekly 0.8 https://fr.hspchem.com/info/the-therapeutic-effect-of-narsoplimab-on-trans-45275208.html 2020-05-07T10:10:15+08:00 weekly 0.8 https://fr.hspchem.com/info/abbvie-maviret-aino-is-approved-by-the-europ-45275210.html 2020-05-07T21:48:31+08:00 weekly 0.8 https://fr.hspchem.com/info/three-in-one-capsule-talicia-omeprazole-amo-45275272.html 2020-04-29T09:15:16+08:00 weekly 0.8 https://fr.hspchem.com/info/nat-commun-brain-scientists-delve-into-the-me-45275273.html 2020-05-07T21:58:57+08:00 weekly 0.8 https://fr.hspchem.com/info/the-us-fda-granted-boehringer-lilly-sglt2-in-45275328.html 2020-04-30T16:38:44+08:00 weekly 0.8 https://fr.hspchem.com/info/anti-cancer-drug-rozlytrek-approved-in-japan-f-45275368.html 2020-05-07T21:52:53+08:00 weekly 0.8 https://fr.hspchem.com/info/science-journal-reveals-thrombin-and-platelet-45275374.html 2020-05-07T11:29:05+08:00 weekly 0.8 https://fr.hspchem.com/info/the-third-indication-for-otezla-a-blockbuster-45275434.html 2020-05-07T22:03:01+08:00 weekly 0.8 https://fr.hspchem.com/info/astrazeneca-s-parp-inhibitor-lynparza-is-quali-45275507.html 2020-05-07T16:42:12+08:00 weekly 0.8 https://fr.hspchem.com/info/novartis-pioneering-sirna-cholesterol-lowerin-45275658.html 2020-05-07T22:54:35+08:00 weekly 0.8 https://fr.hspchem.com/info/the-first-new-anti-epileptic-drug-from-plant-c-45276201.html 2020-05-07T22:54:33+08:00 weekly 0.8 https://fr.hspchem.com/info/roche-s-first-unlimited-cancer-species-targete-45276283.html 2020-05-07T15:19:04+08:00 weekly 0.8 https://fr.hspchem.com/info/the-bristol-myers-squibb-opdivo-yervoy-combi-45276323.html 2020-05-07T16:24:56+08:00 weekly 0.8 https://fr.hspchem.com/info/pfizer-s-next-generation-jak1-inhibitor-abroci-45276324.html 2020-05-07T16:21:50+08:00 weekly 0.8 https://fr.hspchem.com/info/johnson-johnson-s1p1-regulator-ponesimod-app-45276343.html 2020-05-07T14:52:31+08:00 weekly 0.8 https://fr.hspchem.com/info/ror1-targeted-monoclonal-antibody-cirmtuzumab-45276700.html 2020-05-07T15:31:39+08:00 weekly 0.8 https://fr.hspchem.com/info/abbvie-venclyxto-gazyvaro-fixed-course-witho-45277110.html 2020-04-29T08:54:57+08:00 weekly 0.8 https://fr.hspchem.com/info/immunity-dopamine-may-be-the-culprit-in-child-45277357.html 2020-04-30T16:53:17+08:00 weekly 0.8 https://fr.hspchem.com/info/eli-lilly-trulicity-is-approved-by-the-us-fda-45277438.html 2020-04-30T17:24:13+08:00 weekly 0.8 https://fr.hspchem.com/info/takeda-alunbrig-s-new-indication-enters-the-pr-45277853.html 2020-05-08T01:15:04+08:00 weekly 0.8 https://fr.hspchem.com/info/johnson-johnson-s1p1-regulator-ponesimod-app-45278245.html 2020-04-30T16:43:43+08:00 weekly 0.8 https://fr.hspchem.com/info/sihuan-pharmaceutical-acquires-all-rights-and-45278579.html 2020-05-08T09:38:19+08:00 weekly 0.8 https://fr.hspchem.com/info/viralym-m-an-allogeneic-multivirus-specific-t-46302989.html 2020-06-09T01:16:14+08:00 weekly 0.8 https://fr.hspchem.com/info/south-korea-s-sk-biopharmaceutical-xcopri-cen-46302990.html 2020-05-27T11:43:19+08:00 weekly 0.8 https://fr.hspchem.com/info/hisun-s-favivir-tablets-are-fully-supplied-to-46302991.html 2020-05-27T11:52:51+08:00 weekly 0.8 https://fr.hspchem.com/info/roche-s-unlimited-cancer-species-targeting-dru-46302992.html 2020-06-02T18:04:41+08:00 weekly 0.8 https://fr.hspchem.com/info/zhong-nanshan-li-lanjuan-zhang-boli-s-latest-46302993.html 2020-05-15T10:53:33+08:00 weekly 0.8 https://fr.hspchem.com/info/the-us-fda-approved-jelmyto-mittomycin-with-46302994.html 2020-06-09T01:16:18+08:00 weekly 0.8 https://fr.hspchem.com/info/the-first-domestic-btk-inhibitor-zebutinib-wil-46302995.html 2020-06-03T16:07:19+08:00 weekly 0.8 https://fr.hspchem.com/info/roche-rozlytrek-is-about-to-be-approved-by-the-46302996.html 2020-05-14T10:19:57+08:00 weekly 0.8 https://fr.hspchem.com/info/the-gsk-anti-inflammatory-drug-nucala-iii-has-46302997.html 2020-05-14T10:29:48+08:00 weekly 0.8 https://fr.hspchem.com/info/bayer-eylea-abercept-pre-filled-syringes-are-46302998.html 2020-06-03T15:16:32+08:00 weekly 0.8 https://fr.hspchem.com/info/abbvie-oriahnn-is-approved-by-the-us-fda-the-46302999.html 2020-05-08T09:41:34+08:00 weekly 0.8 https://fr.hspchem.com/info/astrazeneca-s-new-hyperkalemia-drug-lokelma-wa-46303133.html 2020-05-14T10:23:37+08:00 weekly 0.8 https://fr.hspchem.com/info/acceleron-bms-tgf-ligand-trap-soterercept-46303134.html 2020-05-15T10:52:51+08:00 weekly 0.8 https://fr.hspchem.com/info/fda-granted-2-fast-track-qualifications-for-so-46303135.html 2020-05-14T10:13:50+08:00 weekly 0.8 https://fr.hspchem.com/info/how-to-save-the-chaotic-biological-clock-scie-46303136.html 2020-06-02T18:05:52+08:00 weekly 0.8 https://fr.hspchem.com/info/67-of-patients-have-significantly-improved-sy-46303137.html 2020-05-21T09:55:02+08:00 weekly 0.8 https://fr.hspchem.com/info/otezla-the-oral-anti-inflammatory-drug-acquir-46303138.html 2020-06-09T01:21:10+08:00 weekly 0.8 https://fr.hspchem.com/info/eli-lilly-s-anti-inflammatory-drug-taltz-was-a-46303140.html 2020-05-20T18:13:59+08:00 weekly 0.8 https://fr.hspchem.com/info/uk-nice-approves-roche-kadcyla-for-early-breas-46326223.html 2020-05-21T14:19:28+08:00 weekly 0.8 https://fr.hspchem.com/info/interview-with-mr-wang-lei-executive-vice-pr-46326430.html 2020-05-27T11:47:44+08:00 weekly 0.8 https://fr.hspchem.com/info/the-first-nuclear-export-inhibitor-xpovio-subm-46326431.html 2020-06-09T09:38:48+08:00 weekly 0.8 https://fr.hspchem.com/info/us-fda-approves-intravenous-injection-of-artes-46326432.html 2020-06-03T14:34:22+08:00 weekly 0.8 https://fr.hspchem.com/info/bristol-myers-squibb-multiple-sclerosis-drug-z-46326434.html 2020-06-03T14:38:21+08:00 weekly 0.8 https://fr.hspchem.com/info/opdivo-yervoy-combined-chemotherapy-received-f-46326438.html 2020-06-03T15:33:36+08:00 weekly 0.8 https://fr.hspchem.com/info/astrazeneca-brinlinta-ticagrelor-was-approve-46326621.html 2020-05-27T11:38:05+08:00 weekly 0.8 https://fr.hspchem.com/info/1-long-term-injection-of-cabotegravir-defeated-46341845.html 2020-06-02T18:07:56+08:00 weekly 0.8 https://fr.hspchem.com/info/the-new-best-in-class-calcineurin-inhibitor-vo-46341846.html 2020-05-27T11:13:17+08:00 weekly 0.8 https://fr.hspchem.com/info/pfizer-pf-06939926-latest-data-protein-stable-46341847.html 2020-05-08T09:51:11+08:00 weekly 0.8 https://fr.hspchem.com/info/bms-s-first-erythrocyte-maturation-agent-reblo-46341909.html 2020-05-08T09:44:45+08:00 weekly 0.8 https://fr.hspchem.com/info/bristol-myers-squibb-multiple-sclerosis-drug-z-46342052.html 2020-05-20T18:10:19+08:00 weekly 0.8 https://fr.hspchem.com/info/novartis-capmatinib-approved-to-treat-nsclc-do-46350382.html 2020-05-15T11:08:52+08:00 weekly 0.8 https://fr.hspchem.com/info/novartis-multiple-sclerosis-drug-sinimod-table-46350384.html 2020-06-03T14:40:17+08:00 weekly 0.8 https://fr.hspchem.com/info/alzheimer-s-disease-imaging-diagnosis-breakthr-46354614.html 2020-05-21T13:35:08+08:00 weekly 0.8 https://fr.hspchem.com/info/enhertu-developed-by-az-daiichi-sankyo-is-ap-46357099.html 2020-06-10T01:40:58+08:00 weekly 0.8 https://fr.hspchem.com/info/astellas-vesicare-solinaxin-succinate-oral-s-46357148.html 2020-05-27T11:49:42+08:00 weekly 0.8 https://fr.hspchem.com/info/evarenzo-astellas-evrenzo-rosastat-entered-46358613.html 2020-05-21T13:31:49+08:00 weekly 0.8 https://fr.hspchem.com/info/myokardia-innovative-oral-cardiomyopathy-targe-46359388.html 2020-06-10T05:38:01+08:00 weekly 0.8 https://fr.hspchem.com/info/sanofi-regeneron-dupixent-approved-in-the-unit-46359389.html 2020-06-03T16:04:32+08:00 weekly 0.8 https://fr.hspchem.com/info/bristol-myers-squibb-s-oral-s1p-receptor-modul-46359411.html 2020-06-03T15:04:17+08:00 weekly 0.8 https://fr.hspchem.com/info/johnson-johnson-sirturo-bedaquiline-pediat-46359413.html 2020-05-14T10:26:37+08:00 weekly 0.8 https://fr.hspchem.com/info/regeneration-yuan-and-zaiding-pharmaceutical-r-46361365.html 2020-05-14T10:16:17+08:00 weekly 0.8 https://fr.hspchem.com/info/where-did-the-new-drug-development-go-against-46473926.html 2020-06-03T15:22:57+08:00 weekly 0.8 https://fr.hspchem.com/info/eli-lilly-cyramza-and-erlotinib-combination-th-46486858.html 2020-05-27T11:17:38+08:00 weekly 0.8 https://fr.hspchem.com/info/the-bms-star-immune-combination-opdivo-yervo-46489654.html 2020-05-21T10:01:04+08:00 weekly 0.8 https://fr.hspchem.com/info/the-us-fda-awarded-ilixadencel-advanced-regene-46574229.html 2020-06-17T14:48:06+08:00 weekly 0.8 https://fr.hspchem.com/info/another-neulasta-biosimilar-drug-approved-for-47053086.html 2020-06-24T11:37:10+08:00 weekly 0.8 https://fr.hspchem.com/info/abbvie-s-first-phase-iii-study-of-oral-jak-inh-47053087.html 2020-06-10T15:01:21+08:00 weekly 0.8 https://fr.hspchem.com/info/treatment-of-specific-lung-cancer-eli-lilly-s-47053088.html 2020-06-17T16:05:40+08:00 weekly 0.8 https://fr.hspchem.com/info/the-astrazeneca-hypoglycemic-drug-farxiga-sign-47053089.html 2020-06-10T16:35:46+08:00 weekly 0.8 https://fr.hspchem.com/info/the-third-indication-of-boehringer-ingelheim-o-47053090.html 2020-06-10T15:06:10+08:00 weekly 0.8 https://fr.hspchem.com/info/abbvie-s-oral-jak1-inhibitor-rinvoq-submitted-47053091.html 2020-06-24T13:40:43+08:00 weekly 0.8 https://fr.hspchem.com/info/treatment-of-aggressive-lymphoma-fda-accelerat-47053095.html 2020-06-24T13:27:04+08:00 weekly 0.8 https://fr.hspchem.com/info/roche-pi3k-akt-pathway-inhibitor-ipatasertib-p-47053096.html 2020-06-24T15:45:49+08:00 weekly 0.8 https://fr.hspchem.com/info/boehringer-lilly-sglt2-inhibitor-jardiance-em-47053097.html 2020-06-24T13:35:35+08:00 weekly 0.8 https://fr.hspchem.com/info/fruquintinib-gets-fda-fast-track-qualification-47053099.html 2020-06-24T11:30:58+08:00 weekly 0.8 https://fr.hspchem.com/info/xi-an-janssen-releases-4-years-clinical-data-o-47053155.html 2020-06-17T15:04:06+08:00 weekly 0.8 https://fr.hspchem.com/info/novo-nordisk-glp-1-agonist-semaglutide-loss-ph-47053156.html 2020-06-24T13:47:34+08:00 weekly 0.8 https://fr.hspchem.com/info/myovant-oral-gnrh-receptor-antagonist-relugoli-47053157.html 2020-06-10T16:07:53+08:00 weekly 0.8 https://fr.hspchem.com/info/the-world-s-first-iron-carrier-cephalosporin-f-47053158.html 2020-06-10T16:08:08+08:00 weekly 0.8 https://fr.hspchem.com/info/colorectal-cancer-news-braf-v600e-mcrc-s-firs-47053159.html 2020-06-18T11:08:00+08:00 weekly 0.8 https://fr.hspchem.com/info/lrrk2-in-1-cas-1234480-84-2-biological-activit-47053161.html 2020-06-10T15:04:16+08:00 weekly 0.8 https://fr.hspchem.com/info/bristol-myers-squibb-s1p-receptor-modulator-re-47053523.html 2020-06-29T17:44:34+08:00 weekly 0.8 https://fr.hspchem.com/info/beigene-s-application-for-zebutinib-listing-in-47053524.html 2020-06-10T16:27:24+08:00 weekly 0.8 https://fr.hspchem.com/info/evrenzo-rosastat-is-a-non-inferior-phase-iii-47053525.html 2020-06-17T14:56:08+08:00 weekly 0.8 https://fr.hspchem.com/info/astrazeneca-btk-inhibitor-calquence-monotherap-47053526.html 2020-05-20T18:04:32+08:00 weekly 0.8 https://fr.hspchem.com/info/four-key-elements-and-development-trends-of-ad-47053535.html 2020-06-17T14:44:33+08:00 weekly 0.8 https://fr.hspchem.com/info/the-us-fda-approved-tivicay-pd-dotelavir-disp-47053967.html 2020-06-29T17:53:22+08:00 weekly 0.8 https://fr.hspchem.com/info/the-european-union-approves-fluad-quadrivalent-47053968.html 2020-06-10T15:00:00+08:00 weekly 0.8 https://fr.hspchem.com/info/eli-lilly-s-il-17a-inhibitor-won-the-5th-fda-a-47054348.html 2020-06-17T14:37:32+08:00 weekly 0.8 https://fr.hspchem.com/info/roche-abbvie-venclexta-azacitidine-phase-iii-47054575.html 2020-06-29T18:04:38+08:00 weekly 0.8 https://fr.hspchem.com/info/roche-glofitamab-is-a-powerful-treatment-for-r-47054576.html 2020-06-29T18:04:39+08:00 weekly 0.8 https://fr.hspchem.com/info/roche-risdiplam-significantly-improve-motor-f-47054578.html 2020-06-17T14:40:35+08:00 weekly 0.8 https://fr.hspchem.com/info/merck-s-gardasil-9-was-approved-by-the-us-fda-47055179.html 2020-06-10T16:31:35+08:00 weekly 0.8 https://fr.hspchem.com/info/the-us-fda-granted-dpp1-inhibitor-brensocatib-47055181.html 2020-06-17T15:02:18+08:00 weekly 0.8 https://fr.hspchem.com/info/novo-nordisk-glp-1-agonist-semaglutide-weight-47055182.html 2020-06-24T11:40:16+08:00 weekly 0.8 https://fr.hspchem.com/info/epizyme-epigenetics-drug-tazverik-has-been-app-47055871.html 2020-06-17T14:27:44+08:00 weekly 0.8 https://fr.hspchem.com/info/novartis-new-generation-of-ophthalmic-drug-be-47056072.html 2020-07-09T17:40:38+08:00 weekly 0.8 https://fr.hspchem.com/info/the-us-fda-approved-fintepla-fenfluramine-ora-48763122.html 2020-07-09T17:43:57+08:00 weekly 0.8 https://fr.hspchem.com/info/the-first-axl-kinase-inhibitor-bemcentinib-com-48763125.html 2020-07-09T17:16:36+08:00 weekly 0.8 https://fr.hspchem.com/info/cancer-vitamin-d-can-open-the-protective-umbr-48763126.html 2020-07-09T18:07:22+08:00 weekly 0.8 https://fr.hspchem.com/info/the-new-long-acting-growth-hormone-transcon-hg-48763127.html 2020-07-17T18:36:39+08:00 weekly 0.8 https://fr.hspchem.com/info/biogen-submits-application-for-listing-of-alca-48763776.html 2020-08-05T10:21:12+08:00 weekly 0.8 https://fr.hspchem.com/info/fda-approves-the-marketing-of-innovative-narco-48763777.html 2020-07-17T18:20:16+08:00 weekly 0.8 https://fr.hspchem.com/info/europe-s-first-biosimilar-for-insulin-aspart-48763778.html 2020-07-17T18:33:47+08:00 weekly 0.8 https://fr.hspchem.com/info/astrazeneca-mercapto-lynparza-received-eu-appr-48763779.html 2020-07-17T18:30:58+08:00 weekly 0.8 https://fr.hspchem.com/info/u-s-fda-grants-new-deuterated-jak1-2-inhibito-48763780.html 2020-07-24T10:56:37+08:00 weekly 0.8 https://fr.hspchem.com/info/zai-lab-s-china-listing-application-for-ripret-48763781.html 2020-08-05T16:42:17+08:00 weekly 0.8 https://fr.hspchem.com/info/astrazeneca-s-breztri-aerosphere-budi-gefu-h-48763782.html 2020-08-06T09:46:47+08:00 weekly 0.8 https://fr.hspchem.com/info/abbvie-s-oral-cgrp-receptor-antagonist-atogepa-48763783.html 2020-08-12T18:11:11+08:00 weekly 0.8 https://fr.hspchem.com/info/simcere-pharmaceuticals-signed-an-exclusive-li-48763784.html 2020-08-05T10:28:50+08:00 weekly 0.8 https://fr.hspchem.com/info/the-us-fda-approves-wynzora-calccipotriol-bet-48763785.html 2020-08-12T18:04:55+08:00 weekly 0.8 https://fr.hspchem.com/info/roche-rozlytrek-is-approved-in-the-eu-treat-n-48763786.html 2020-08-12T18:07:47+08:00 weekly 0.8 https://fr.hspchem.com/info/the-us-fda-has-given-priority-to-reviewing-het-48763787.html 2020-08-05T18:09:47+08:00 weekly 0.8 https://fr.hspchem.com/info/the-european-union-approves-xenleta-lefamulin-48763788.html 2020-08-06T09:51:28+08:00 weekly 0.8 https://fr.hspchem.com/info/cstone-pharmaceuticals-avapritinib-was-include-48763790.html 2020-07-20T15:53:12+08:00 weekly 0.8 https://fr.hspchem.com/info/terlipressin-was-approved-by-the-us-fda-commit-48763792.html 2020-07-09T17:25:46+08:00 weekly 0.8 https://fr.hspchem.com/info/brensocatib-phase-ii-clinical-significantly-r-48764538.html 2020-07-10T17:10:55+08:00 weekly 0.8 https://fr.hspchem.com/info/glaxosmithkline-s-hif-ph-inhibitor-duvroq-dap-48764548.html 2020-08-05T10:08:19+08:00 weekly 0.8 https://fr.hspchem.com/info/the-new-best-in-class-calcineurin-inhibitor-vo-48764549.html 2020-07-17T18:26:10+08:00 weekly 0.8 https://fr.hspchem.com/info/otsuka-anticancer-drug-inqovi-cedazuridine-48764552.html 2020-07-20T14:55:55+08:00 weekly 0.8 https://fr.hspchem.com/info/two-pfizer-biontech-mrna-vaccines-under-develo-48764553.html 2020-08-05T18:14:52+08:00 weekly 0.8 https://fr.hspchem.com/info/the-chi-med-met-inhibitor-savolitinib-was-incl-48764557.html 2020-07-20T15:24:57+08:00 weekly 0.8 https://fr.hspchem.com/info/boehringer-ingelheim-ofev-nintedanib-is-appr-48764558.html 2020-08-06T09:58:00+08:00 weekly 0.8 https://fr.hspchem.com/info/boehringer-lilly-s-sglt2-inhibitor-jardiance-48764559.html 2020-08-05T18:05:41+08:00 weekly 0.8 https://fr.hspchem.com/info/the-third-phase-iii-study-of-abbvie-s-oral-jak-48764560.html 2020-07-20T15:48:29+08:00 weekly 0.8 https://fr.hspchem.com/info/merck-s-bayer-s-first-sgc-stimulant-vericiguat-48765362.html 2020-07-09T18:05:02+08:00 weekly 0.8 https://fr.hspchem.com/info/vertex-s-innovative-triple-therapy-kaftrio-eu-48766227.html 2020-07-10T17:07:20+08:00 weekly 0.8 https://fr.hspchem.com/info/ultomiris-new-indication-is-approved-by-the-e-48766228.html 2020-08-05T16:37:56+08:00 weekly 0.8 https://fr.hspchem.com/info/new-drug-for-diabetic-foot-neuralgia-qutenza-48766240.html 2020-08-05T10:14:01+08:00 weekly 0.8 https://fr.hspchem.com/info/the-us-fda-approved-the-unique-cationic-hydrox-48766241.html 2020-08-05T11:56:36+08:00 weekly 0.8 https://fr.hspchem.com/info/novartis-jakafi-ruxolitinib-successfully-tre-48766242.html 2020-07-20T15:35:32+08:00 weekly 0.8 https://fr.hspchem.com/info/astrazeneca-brilinta-aspirin-the-first-dual-48766243.html 2020-07-17T18:28:54+08:00 weekly 0.8 https://fr.hspchem.com/info/novartis-laba-lama-ics-product-enerzair-breezh-48766346.html 2020-08-06T09:36:32+08:00 weekly 0.8 https://fr.hspchem.com/info/breast-cancer-precision-medicine-novartis-pi-48766587.html 2020-08-05T10:19:20+08:00 weekly 0.8 https://fr.hspchem.com/info/dojolvi-is-launched-in-the-united-states-the-48767156.html 2020-07-17T18:39:15+08:00 weekly 0.8 https://fr.hspchem.com/info/bayer-finerenone-phase-iii-clinical-success-s-48767157.html 2020-07-20T14:57:53+08:00 weekly 0.8 https://fr.hspchem.com/info/janssen-tremfya-the-first-il-23-inhibitor-for-48767158.html 2020-07-20T15:09:10+08:00 weekly 0.8 https://fr.hspchem.com/info/baoyuan-pharmaceutical-and-south-korea-s-newg-48767159.html 2020-07-24T11:02:47+08:00 weekly 0.8 https://fr.hspchem.com/info/the-second-phase-iii-study-of-abbvie-s-oral-ja-48767705.html 2020-07-10T16:54:16+08:00 weekly 0.8 https://fr.hspchem.com/info/sarepta-s-third-exon-jump-therapy-casimersen-a-48767708.html 2020-07-24T11:00:09+08:00 weekly 0.8 https://fr.hspchem.com/info/daiichi-sankyo-prasugrel-is-better-than-clopid-48768249.html 2020-07-09T18:02:50+08:00 weekly 0.8 https://fr.hspchem.com/info/fda-approves-fintepla-48769072.html 2020-08-06T09:27:26+08:00 weekly 0.8 https://fr.hspchem.com/info/he-us-fda-granted-merck-s-hif-2-inhibitor-mk-48770082.html 2020-08-17T18:06:48+08:00 weekly 0.8 https://fr.hspchem.com/info/betta-pharma-ensartinib-first-line-treatment-49086473.html 2020-08-17T15:25:44+08:00 weekly 0.8 https://fr.hspchem.com/info/cstone-pharmaceuticals-a-drug-under-developmen-49087021.html 2020-08-25T09:10:39+08:00 weekly 0.8 https://fr.hspchem.com/info/chi-med-sofatinib-in-the-treatment-of-neuroend-49087448.html 2020-08-17T16:30:40+08:00 weekly 0.8 https://fr.hspchem.com/info/boehringer-ingelheim-ofev-nintedanib-signifi-49087452.html 2020-08-17T15:52:55+08:00 weekly 0.8 https://fr.hspchem.com/info/zai-lab-ripretinib-was-included-in-the-priorit-49088961.html 2020-08-17T16:19:25+08:00 weekly 0.8 https://fr.hspchem.com/info/next-generation-selective-immunomodulator-imu-49089694.html 2020-08-17T16:03:41+08:00 weekly 0.8 https://fr.hspchem.com/info/the-world-s-first-hepatitis-d-treatment-drug-49091427.html 2020-08-17T15:32:08+08:00 weekly 0.8 https://fr.hspchem.com/info/the-eu-approves-pretomanid-to-treat-highly-dru-49092567.html 2020-08-17T16:10:32+08:00 weekly 0.8 https://fr.hspchem.com/info/ppar-agonist-seladelpar-phase-iii-clinical-su-49095280.html 2020-08-17T15:37:44+08:00 weekly 0.8 https://fr.hspchem.com/info/merck-and-korea-american-pharmaceuticals-signe-49095924.html 2020-09-01T11:08:28+08:00 weekly 0.8 https://fr.hspchem.com/info/sub-journal-of-nature-repair-the-heart-small-49460939.html 2020-09-01T10:52:34+08:00 weekly 0.8 https://fr.hspchem.com/info/the-us-fda-approved-the-first-cysteamine-eye-d-49460940.html 2020-09-01T11:05:41+08:00 weekly 0.8 https://fr.hspchem.com/info/better-than-pfizer-s-bosutinib-novartis-oral-49460941.html 2020-09-01T11:25:38+08:00 weekly 0.8 https://fr.hspchem.com/info/novartis-s-first-complement-factor-b-inhibitor-49460942.html 2020-09-01T11:13:40+08:00 weekly 0.8 https://fr.hspchem.com/info/glaxosmithkline-blenrep-was-approved-by-the-eu-49460943.html 2020-09-01T11:16:29+08:00 weekly 0.8 https://fr.hspchem.com/info/winlevi-cream-a-local-androgen-receptor-inhib-49461559.html 2020-09-01T11:29:52+08:00 weekly 0.8 https://fr.hspchem.com/info/boehringer-lilly-jardiance-empagliflozin-sig-49461562.html 2020-08-25T13:40:10+08:00 weekly 0.8 https://fr.hspchem.com/info/boehringer-ingelheim-ofev-nintedanib-launche-49461563.html 2020-08-25T10:42:22+08:00 weekly 0.8 https://fr.hspchem.com/info/protalix-casey-s-long-acting-galactosidase-a-49461564.html 2020-08-25T10:21:25+08:00 weekly 0.8 https://fr.hspchem.com/info/real-world-retrospective-research-giotag-afat-49461565.html 2020-08-25T13:49:40+08:00 weekly 0.8 https://fr.hspchem.com/info/roche-abbvie-venclexta-azacitidine-phase-iii-49461960.html 2020-09-01T11:01:41+08:00 weekly 0.8 https://fr.hspchem.com/info/novartis-stamp-inhibitor-asciminib-phase-iii-e-49462478.html 2020-09-04T16:07:24+08:00 weekly 0.8 https://fr.hspchem.com/info/eisai-lenvima-lenvatinib-post-marketing-stud-49462972.html 2020-09-08T11:57:51+08:00 weekly 0.8 https://fr.hspchem.com/info/cstone-s-ret-inhibitor-pratinib-has-been-accep-49741701.html 2020-09-08T12:09:38+08:00 weekly 0.8 https://fr.hspchem.com/info/glaxosmithkline-s-new-oral-hif-ph-inhibitor-du-49741702.html 2020-09-08T11:45:04+08:00 weekly 0.8 https://fr.hspchem.com/info/eli-lilly-s-unlimited-cancer-species-precision-49741704.html 2020-09-08T13:38:04+08:00 weekly 0.8 https://fr.hspchem.com/info/the-third-generation-of-potent-comt-inhibitor-49748467.html 2020-09-08T12:07:00+08:00 weekly 0.8 https://fr.hspchem.com/info/merck-tepotinib-the-world-s-first-met-inhibit-49755396.html 2020-09-08T11:37:52+08:00 weekly 0.8 https://fr.hspchem.com/info/the-us-fda-approves-eli-lilly-s-glp-1ra-hypogl-49755733.html 2020-09-08T13:41:31+08:00 weekly 0.8 https://fr.hspchem.com/info/the-new-and-powerful-aak1-inhibitor-lx9211-ent-49755737.html 2020-09-08T11:54:19+08:00 weekly 0.8 https://fr.hspchem.com/info/the-us-fda-approves-the-ret-inhibitor-gavreto-49764431.html 2020-09-22T17:59:52+08:00 weekly 0.8 https://fr.hspchem.com/info/astrazeneca-and-dogma-reached-an-agreement-to-50121828.html 2020-09-15T14:10:34+08:00 weekly 0.8 https://fr.hspchem.com/info/can-treat-asthma-and-copd-at-the-same-time-gs-50121830.html 2020-09-22T09:39:35+08:00 weekly 0.8 https://fr.hspchem.com/info/eli-lilly-incyte-oral-jak-inhibitor-olumiant-50121831.html 2020-09-22T17:47:04+08:00 weekly 0.8 https://fr.hspchem.com/info/phase-iii-clinical-success-of-ganachone-for-ra-50121833.html 2020-09-15T14:01:41+08:00 weekly 0.8 https://fr.hspchem.com/info/bayer-s-non-steroidal-androgen-receptor-antago-50121835.html 2020-09-22T17:54:11+08:00 weekly 0.8 https://fr.hspchem.com/info/heat-shock-inducer-arimoclomol-has-been-review-50121836.html 2020-09-22T18:06:21+08:00 weekly 0.8 https://fr.hspchem.com/info/the-efficacy-of-bristol-myers-immunization-com-50121837.html 2020-09-22T10:06:27+08:00 weekly 0.8 https://fr.hspchem.com/info/another-major-deal-for-antibody-drug-conjugate-50121838.html 2020-09-22T09:04:07+08:00 weekly 0.8 https://fr.hspchem.com/info/eli-lilly-reyvow-has-positive-clinical-results-50131091.html 2020-09-15T14:41:30+08:00 weekly 0.8 https://fr.hspchem.com/info/vertex-s-innovative-triple-therapy-trikafta-su-50131209.html 2020-09-22T09:09:28+08:00 weekly 0.8 https://fr.hspchem.com/info/eli-lilly-reyvow-has-positive-clinical-results-50131214.html 2020-09-15T14:31:44+08:00 weekly 0.8 https://fr.hspchem.com/info/the-next-generation-immunomodulator-imu-838-q-50131219.html 2020-09-15T14:17:10+08:00 weekly 0.8 https://fr.hspchem.com/info/novartis-mayzent-improves-cognition-slows-do-50148051.html 2020-09-22T17:56:27+08:00 weekly 0.8 https://fr.hspchem.com/info/eli-lilly-and-amgen-join-forces-produce-neutr-50148052.html 2020-09-22T09:48:13+08:00 weekly 0.8 https://fr.hspchem.com/info/another-major-deal-for-antibody-drug-conjugate-50148237.html 2020-09-22T09:25:45+08:00 weekly 0.8 https://fr.hspchem.com/info/terlipressin-was-rejected-by-the-us-fda-and-ha-50163509.html 2020-09-30T11:15:05+08:00 weekly 0.8 https://fr.hspchem.com/info/shorten-patient-recovery-time-jak-inhibitor-re-50192834.html 2020-10-01T14:30:14+08:00 weekly 0.8 https://fr.hspchem.com/info/fintepla-fenfluramine-in-the-treatment-of-dr-50244937.html 2020-09-22T17:44:11+08:00 weekly 0.8 https://fr.hspchem.com/info/another-major-deal-for-antibody-drug-conjugate-50245215.html 2020-10-14T10:22:17+08:00 weekly 0.8 https://fr.hspchem.com/info/pfizer-xalkori-has-been-reviewed-by-the-us-fda-50439565.html 2020-10-12T15:31:35+08:00 weekly 0.8 https://fr.hspchem.com/info/the-us-fda-granted-fosdenopterin-priority-revi-50439731.html 2020-09-30T11:21:22+08:00 weekly 0.8 https://fr.hspchem.com/info/a-new-class-of-hypoglycemic-drug-imeglimin-un-50439737.html 2020-09-30T11:57:11+08:00 weekly 0.8 https://fr.hspchem.com/info/daiichi-sankyo-enhertu-is-approved-it-signifi-50439738.html 2020-10-12T15:51:06+08:00 weekly 0.8 https://fr.hspchem.com/info/researchers-have-developed-a-btk-kinase-inhibi-50439743.html 2020-10-12T15:41:18+08:00 weekly 0.8 https://fr.hspchem.com/info/otsuka-s-topical-pde4-inhibitor-difamilast-app-50439754.html 2020-09-30T11:47:55+08:00 weekly 0.8 https://fr.hspchem.com/info/ayvakyt-avapritinib-was-approved-by-the-euro-50440216.html 2020-09-30T11:42:26+08:00 weekly 0.8 https://fr.hspchem.com/info/a-new-class-of-hypoglycemic-drug-imeglimin-un-50440370.html 2020-10-12T16:52:17+08:00 weekly 0.8 https://fr.hspchem.com/info/natural-drug-genkwadaphnin-can-block-cholester-50440371.html 2020-10-12T14:58:07+08:00 weekly 0.8 https://fr.hspchem.com/info/pacritinib-applied-for-listing-treatment-of-m-50440374.html 2020-10-12T16:21:37+08:00 weekly 0.8 https://fr.hspchem.com/info/the-world-s-first-photoimmunotherapy-drug-is-a-50440525.html 2020-10-12T14:54:55+08:00 weekly 0.8 https://fr.hspchem.com/info/the-first-first-line-long-term-survival-data-f-50440809.html 2020-09-30T11:11:07+08:00 weekly 0.8 https://fr.hspchem.com/info/eisai-fycompa-perampanel-is-recommended-and-50440908.html 2020-10-12T15:47:19+08:00 weekly 0.8 https://fr.hspchem.com/info/us-fda-approved-alkindi-sprinkle-to-treat-pedi-50441031.html 2020-10-12T15:45:32+08:00 weekly 0.8 https://fr.hspchem.com/info/johnson-johnson-s-uptravi-intravenous-prepar-50447264.html 2020-10-22T09:57:17+08:00 weekly 0.8 https://fr.hspchem.com/info/otsuka-v2-receptor-antagonist-opc-61815-phase-50807323.html 2020-10-22T09:46:43+08:00 weekly 0.8 https://fr.hspchem.com/info/gilead-jak1-inhibitor-phase-2b-3-clinical-resu-50807324.html 2020-10-22T09:54:19+08:00 weekly 0.8 https://fr.hspchem.com/info/pacritinib-will-be-on-the-market-in-2021-trea-50807526.html 2020-10-22T10:00:09+08:00 weekly 0.8 https://fr.hspchem.com/info/shionoyi-s-world-s-first-siderophore-cephalosp-50810200.html 2020-10-22T10:02:52+08:00 weekly 0.8 https://fr.hspchem.com/info/bayer-pi3k-inhibitor-aliqopa-combined-with-rit-50810292.html 2020-10-22T09:51:08+08:00 weekly 0.8 https://fr.hspchem.com/info/astrazeneca-antibody-cocktail-therapy-azd7442-50811652.html 2020-10-20T16:03:11+08:00 weekly 0.8 https://fr.hspchem.com/info/zelgen-pharmaceutical-s-application-for-a-new-50811765.html 2020-10-28T15:59:16+08:00 weekly 0.8 https://fr.hspchem.com/info/gilead-veklury-remdesivir-was-approved-by-th-51540524.html 2020-11-25T11:11:19+08:00 weekly 0.8 https://fr.hspchem.com/info/arikayce-is-approved-in-the-eu-the-first-drug-51540527.html 2020-11-10T10:31:01+08:00 weekly 0.8 https://fr.hspchem.com/info/pfizer-s-oral-jak-inhibitor-xeljanz-tofacitin-51540789.html 2020-11-17T10:46:49+08:00 weekly 0.8 https://fr.hspchem.com/info/novartis-sirna-cholesterol-lowering-drug-leqv-51540791.html 2020-11-17T10:27:45+08:00 weekly 0.8 https://fr.hspchem.com/info/new-side-effects-emerge-sanofi-alnylam-hemoph-51540793.html 2020-11-17T10:57:57+08:00 weekly 0.8 https://fr.hspchem.com/info/amgen-s-new-cardiac-myosin-activator-omecamti-51540796.html 2020-10-28T16:13:08+08:00 weekly 0.8 https://fr.hspchem.com/info/novartis-s-potent-and-selective-factor-b-inhib-51541164.html 2020-11-10T10:24:05+08:00 weekly 0.8 https://fr.hspchem.com/info/astrazeneca-s-forxiga-dapagliflozin-approved-51542017.html 2020-10-28T15:45:17+08:00 weekly 0.8 https://fr.hspchem.com/info/astrazeneca-s-forxiga-dapagliflozin-is-about-51542150.html 2020-11-04T11:45:20+08:00 weekly 0.8 https://fr.hspchem.com/info/gradual-frost-disease-is-expected-to-usher-in-51542152.html 2020-11-10T10:27:53+08:00 weekly 0.8 https://fr.hspchem.com/info/astrazeneca-brilinta-ticagrelor-was-approved-51542153.html 2020-10-28T15:52:12+08:00 weekly 0.8 https://fr.hspchem.com/info/roche-abbvie-venclexta-is-fully-approved-by-th-51542439.html 2020-11-17T10:42:18+08:00 weekly 0.8 https://fr.hspchem.com/info/tivicay-pd-dotegravir-dispersible-tablets-is-51545103.html 2020-11-04T10:54:44+08:00 weekly 0.8 https://fr.hspchem.com/info/scientists-synthesize-new-antibiotics-through-51547125.html 2020-11-10T09:58:37+08:00 weekly 0.8 https://fr.hspchem.com/info/kalydeco-is-approved-by-the-european-union-it-51547127.html 2020-10-28T16:05:33+08:00 weekly 0.8 https://fr.hspchem.com/info/leo-pharma-enstilar-foam-has-a-long-term-treat-51547130.html 2020-11-10T09:40:08+08:00 weekly 0.8 https://fr.hspchem.com/info/bms-original-deuterated-tyk2-new-drug-51547229.html 2020-11-17T10:38:22+08:00 weekly 0.8 https://fr.hspchem.com/info/roche-s-super-flu-drug-xofluza-is-about-to-be-51547344.html 2020-10-28T15:54:25+08:00 weekly 0.8 https://fr.hspchem.com/info/abbvie-rinvoq-submitted-a-new-indication-appli-51551271.html 2020-11-25T18:52:08+08:00 weekly 0.8 https://fr.hspchem.com/info/the-new-mechanism-drug-nexletol-significantly-51555169.html 2020-11-25T18:53:39+08:00 weekly 0.8 https://fr.hspchem.com/info/merck-s-acquisition-of-velosbio-the-first-ant-51555202.html 2020-11-04T11:11:50+08:00 weekly 0.8 https://fr.hspchem.com/info/astrazeneca-daiichi-sankyo-enhertu-receives-pr-51559727.html 2020-10-28T15:48:08+08:00 weekly 0.8 https://fr.hspchem.com/info/egfr-targeted-drug-cures-early-stage-lung-canc-51562899.html 2020-11-17T10:30:38+08:00 weekly 0.8 https://fr.hspchem.com/info/glaxosmithkline-medicago-adjuvant-plant-derive-51563303.html 2020-11-04T11:48:48+08:00 weekly 0.8 https://fr.hspchem.com/info/johnson-johnson-paliperidone-palmitate-long-51566137.html 2020-11-04T11:58:26+08:00 weekly 0.8 https://fr.hspchem.com/info/novartis-aimovig-the-first-phase-4-clinical-s-51566141.html 2020-11-10T10:13:26+08:00 weekly 0.8 https://fr.hspchem.com/info/lynparza-approved-in-the-eu-treatment-of-brca-51567150.html 2020-11-04T11:39:25+08:00 weekly 0.8 https://fr.hspchem.com/info/clofenac-meglumine-soft-capsule-breaking-the-p-51570991.html 2020-11-17T10:22:48+08:00 weekly 0.8 https://fr.hspchem.com/info/pfizer-s-abrocitinib-in-the-treatment-of-sever-51572971.html 2021-01-19T13:48:18+08:00 weekly 0.8 https://fr.hspchem.com/info/the-us-fda-approves-viatris-pediatric-dolutegr-53281385.html 2020-12-02T11:22:01+08:00 weekly 0.8 https://fr.hspchem.com/info/us-fda-approved-oxlumo-the-first-drug-to-trea-53281386.html 2020-12-02T11:50:51+08:00 weekly 0.8 https://fr.hspchem.com/info/kyprolis-darzalex-dexamethasone-three-drug-reg-53281388.html 2020-12-25T14:00:39+08:00 weekly 0.8 https://fr.hspchem.com/info/bristol-myers-squibb-jak2-inhibitor-inrebic-f-53281390.html 2021-01-19T13:48:26+08:00 weekly 0.8 https://fr.hspchem.com/info/the-us-fda-approves-roche-xofluza-for-people-53281391.html 2020-12-25T14:17:42+08:00 weekly 0.8 https://fr.hspchem.com/info/the-merck-eisai-keytruda-lenvima-phase-3-confi-53281392.html 2020-11-25T11:29:54+08:00 weekly 0.8 https://fr.hspchem.com/info/gilead-inhibitor-lenacapavir-gs-6207-phase-53281900.html 2020-12-02T11:27:35+08:00 weekly 0.8 https://fr.hspchem.com/info/alkindi-sprinkle-is-launched-in-the-united-sta-53281901.html 2020-12-25T14:07:51+08:00 weekly 0.8 https://fr.hspchem.com/info/the-eu-chmp-recommends-approval-of-sanofi-plav-53281902.html 2021-01-19T13:53:43+08:00 weekly 0.8 https://fr.hspchem.com/info/daiichi-sankyo-tarlige-mirogabalin-is-succes-53281903.html 2020-11-25T11:45:39+08:00 weekly 0.8 https://fr.hspchem.com/info/the-us-fda-approved-zokinvy-the-first-farnesy-53281904.html 2020-11-25T11:26:05+08:00 weekly 0.8 https://fr.hspchem.com/info/jardiance-empagliflozin-milestone-phase-3-cl-53281906.html 2021-01-07T10:42:16+08:00 weekly 0.8 https://fr.hspchem.com/info/innovative-drug-orelabrutinib-was-approved-by-53282240.html 2021-01-07T10:47:40+08:00 weekly 0.8 https://fr.hspchem.com/info/bms-oral-s1p-receptor-modulator-zeposia-ozani-53282242.html 2020-12-25T13:51:47+08:00 weekly 0.8 https://fr.hspchem.com/info/glaxosmithkline-s-first-adhesion-inhibitor-ruk-53282245.html 2020-12-15T14:42:40+08:00 weekly 0.8 https://fr.hspchem.com/info/takeda-s-oral-tyrosine-kinase-inhibitor-cabome-53282396.html 2020-12-11T15:05:26+08:00 weekly 0.8 https://fr.hspchem.com/info/eisai-lenvima-lenvatinib-post-marketing-stud-53282398.html 2021-01-19T14:04:16+08:00 weekly 0.8 https://fr.hspchem.com/info/basilea-pfizer-cresemba-isavuconazole-was-ac-53282401.html 2020-12-15T14:52:34+08:00 weekly 0.8 https://fr.hspchem.com/info/the-us-fda-approves-hetlioz-tasimelteon-the-53282546.html 2020-11-25T11:18:26+08:00 weekly 0.8 https://fr.hspchem.com/info/the-u-s-fda-granted-sanofi-rilzabrutinib-fast-53282549.html 2020-12-02T11:47:53+08:00 weekly 0.8 https://fr.hspchem.com/info/soxgliflozin-treatment-of-heart-failure-result-53282550.html 2021-01-14T10:14:46+08:00 weekly 0.8 https://fr.hspchem.com/info/antengene-submits-selinexor-new-drug-listing-a-53282551.html 2021-01-14T10:52:07+08:00 weekly 0.8 https://fr.hspchem.com/info/pfizer-s-once-a-week-long-acting-drug-somatrog-53282552.html 2020-12-25T13:38:34+08:00 weekly 0.8 https://fr.hspchem.com/info/abbvie-jak-inhibitor-in-the-treatment-of-ulcer-53282553.html 2020-12-11T15:08:42+08:00 weekly 0.8 https://fr.hspchem.com/info/us-fda-approves-viatris-pediatric-dolutegravir-53282554.html 2021-01-07T11:28:58+08:00 weekly 0.8 https://fr.hspchem.com/info/pfizer-and-myovant-sciences-collaborate-to-dev-53282555.html 2020-11-25T11:39:11+08:00 weekly 0.8 https://fr.hspchem.com/info/gsk-single-dose-krintafel-tafenoquine-is-eff-53282556.html 2021-01-19T14:11:07+08:00 weekly 0.8 https://fr.hspchem.com/info/pfizer-s-third-generation-alk-inhibitor-lorbre-53282856.html 2020-12-15T14:39:35+08:00 weekly 0.8 https://fr.hspchem.com/info/astellas-evrenzo-roxadustat-approved-in-ja-53283028.html 2020-12-15T14:17:58+08:00 weekly 0.8 https://fr.hspchem.com/info/kyprolis-darzalex-dexamethasone-three-drug-reg-53283498.html 2020-12-15T15:01:39+08:00 weekly 0.8 https://fr.hspchem.com/info/the-u-s-fda-approves-the-plasma-kallikrein-in-53283499.html 2020-12-25T14:05:51+08:00 weekly 0.8 https://fr.hspchem.com/info/new-and-potent-aak1-inhibitors-obtained-fda-fa-53283501.html 2020-12-02T11:37:33+08:00 weekly 0.8 https://fr.hspchem.com/info/basilea-pfizer-cresemba-isavuconazole-was-ac-53283502.html 2020-12-25T13:57:03+08:00 weekly 0.8 https://fr.hspchem.com/info/novartis-new-generation-therapy-beovu-2-phase-53283503.html 2020-12-25T13:48:08+08:00 weekly 0.8 https://fr.hspchem.com/info/novartis-pioneering-sirna-cholesterol-lowerin-53283504.html 2021-01-14T10:47:36+08:00 weekly 0.8 https://fr.hspchem.com/info/astrazeneca-s-farxiga-dapagliflozin-has-rece-53283505.html 2021-01-14T10:28:38+08:00 weekly 0.8 https://fr.hspchem.com/info/visen-pharmaceuticals-announces-approval-of-it-53283506.html 2020-12-11T15:10:38+08:00 weekly 0.8 https://fr.hspchem.com/info/alkindi-sprinkle-is-launched-in-the-united-sta-53283672.html 2021-01-14T10:10:21+08:00 weekly 0.8 https://fr.hspchem.com/info/acoladine-from-traditional-chinese-medicine-n-53283673.html 2020-12-25T14:29:22+08:00 weekly 0.8 https://fr.hspchem.com/info/the-powerful-kit-inhibitor-ayvakit-applied-for-53283674.html 2020-12-15T14:22:01+08:00 weekly 0.8 https://fr.hspchem.com/info/braf-v600e-mcrc-targeting-program-braftovi-tw-53284348.html 2020-11-25T11:35:39+08:00 weekly 0.8 https://fr.hspchem.com/info/eli-lilly-has-been-granted-the-second-emergenc-53284614.html 2020-11-25T11:08:08+08:00 weekly 0.8 https://fr.hspchem.com/info/c3-inhibitor-pegcetacoplan-receives-priority-r-53284625.html 2020-12-25T14:21:37+08:00 weekly 0.8 https://fr.hspchem.com/info/the-u-s-fda-granted-novartis-the-breakthrough-53284626.html 2020-12-25T14:10:35+08:00 weekly 0.8 https://fr.hspchem.com/info/the-second-generation-oral-thrombopoietin-rece-53285013.html 2021-01-07T10:35:11+08:00 weekly 0.8 https://fr.hspchem.com/info/bojian-plegridy-pegylated-interferon-1a-in-53285435.html 2020-12-24T16:24:39+08:00 weekly 0.8 https://fr.hspchem.com/info/eli-lilly-s-gip-glp-1-dual-receptor-agonist-ti-53285903.html 2020-12-15T12:02:24+08:00 weekly 0.8 https://fr.hspchem.com/info/sotagliflozin-treatment-of-heart-failure-resul-53286385.html 2020-12-15T15:08:41+08:00 weekly 0.8 https://fr.hspchem.com/info/us-fda-approves-blueprint-roche-gavreto-to-tre-53286386.html 2020-12-02T11:33:06+08:00 weekly 0.8 https://fr.hspchem.com/info/merck-tepmetko-the-world-s-first-oral-met-inh-53286496.html 2020-12-25T13:45:58+08:00 weekly 0.8 https://fr.hspchem.com/info/abbvie-s-oral-jak-inhibitor-rinvoq-phase-3-cli-53286497.html 2021-01-07T11:09:23+08:00 weekly 0.8 https://fr.hspchem.com/info/hutchison-medicine-sofatinib-is-rolling-in-the-53286600.html 2020-12-11T15:20:14+08:00 weekly 0.8 https://fr.hspchem.com/info/merck-tepmetko-the-world-s-first-oral-met-inh-53286910.html 2021-01-07T10:55:43+08:00 weekly 0.8 https://fr.hspchem.com/info/peripheral-opioid-receptor-kor-agonist-kor-53290658.html 2020-11-25T11:14:41+08:00 weekly 0.8 https://fr.hspchem.com/info/the-u-s-fda-granted-cabotegravir-a-breakthrou-53290671.html 2021-01-07T11:33:01+08:00 weekly 0.8 https://fr.hspchem.com/info/novo-nordisk-eu-submits-an-application-ozempi-53291115.html 2021-01-07T10:33:52+08:00 weekly 0.8 https://fr.hspchem.com/info/parp-inhibitor-rubraca-treats-brca-mutant-ovar-53303078.html 2021-01-07T11:14:55+08:00 weekly 0.8 https://fr.hspchem.com/info/zai-lab-cullinan-oncology-reached-an-exclusive-53308177.html 2021-01-07T10:58:17+08:00 weekly 0.8 https://fr.hspchem.com/info/astrazeneca-mersk-s-lynparza-olaparib-japan-53313720.html 2021-01-21T11:27:02+08:00 weekly 0.8 https://fr.hspchem.com/info/astellas-mirabegron-has-been-reviewed-by-the-u-53916137.html 2021-01-21T11:33:58+08:00 weekly 0.8 https://fr.hspchem.com/info/xalkori-approved-in-the-united-states-the-fir-53916138.html 2021-01-21T11:37:19+08:00 weekly 0.8 https://fr.hspchem.com/info/shiono-xofluza-was-approved-in-taiwan-china-53916140.html 2021-02-04T10:27:58+08:00 weekly 0.8 https://fr.hspchem.com/info/the-first-oral-pkr-allosteric-activator-mitabi-53916143.html 2021-01-29T17:21:02+08:00 weekly 0.8 https://fr.hspchem.com/info/fda-approves-first-new-oral-drug-for-lupus-nep-53916145.html 2021-01-29T17:18:28+08:00 weekly 0.8 https://fr.hspchem.com/info/merck-bayer-s-heart-failure-drug-vericiguat-re-53916146.html 2021-02-04T10:54:17+08:00 weekly 0.8 https://fr.hspchem.com/info/merck-announced-phase-2a-study-data-support-i-53916149.html 2021-01-21T11:14:09+08:00 weekly 0.8 https://fr.hspchem.com/info/the-new-indication-of-boehringer-lilly-jardian-53916618.html 2021-02-04T10:35:59+08:00 weekly 0.8 https://fr.hspchem.com/info/oral-gnrh-receptor-antagonist-relugolix-signif-53932378.html 2021-02-04T11:28:57+08:00 weekly 0.8 https://fr.hspchem.com/info/post-marketing-study-of-pfizer-xeljanz-in-the-53932379.html 2021-01-29T17:30:29+08:00 weekly 0.8 https://fr.hspchem.com/info/novo-nordisk-usa-submits-an-application-ozemp-53932380.html 2021-01-29T17:25:41+08:00 weekly 0.8 https://fr.hspchem.com/info/the-second-generation-oral-thrombopoietin-rece-53932681.html 2021-02-03T17:33:10+08:00 weekly 0.8 https://fr.hspchem.com/info/cabenuva-a-complete-long-acting-program-that-53951029.html 2021-01-21T11:30:41+08:00 weekly 0.8 https://fr.hspchem.com/info/the-european-union-approves-tivicay-pd-dolute-53951041.html 2021-02-04T10:41:52+08:00 weekly 0.8 https://fr.hspchem.com/info/astrazeneca-s-btk-inhibitor-calquence-has-been-53951221.html 2021-02-05T16:24:05+08:00 weekly 0.8 https://fr.hspchem.com/info/the-cd73-inhibitor-ab680-chemotherapy-anti-53974015.html 2021-01-21T11:18:46+08:00 weekly 0.8 https://fr.hspchem.com/info/bayer-s-first-drug-finerenone-has-been-given-53974261.html 2021-01-29T17:23:53+08:00 weekly 0.8 https://fr.hspchem.com/info/fda-approves-cabozantinib-combined-with-opdivo-53982034.html 2021-02-08T11:09:49+08:00 weekly 0.8 https://fr.hspchem.com/info/nerlynx-neratinib-a-tyrosine-kinase-inhibit-54917778.html 2021-02-08T09:50:35+08:00 weekly 0.8 https://fr.hspchem.com/info/the-u-s-fda-approves-vertex-for-clinical-test-54917779.html 2021-02-23T14:01:20+08:00 weekly 0.8 https://fr.hspchem.com/info/bayer-s-new-generation-androgen-receptor-inhib-54917780.html 2021-02-23T17:20:31+08:00 weekly 0.8 https://fr.hspchem.com/info/viiv-s-new-first-adhesion-inhibitor-rukobia-wa-54917785.html 2021-03-11T18:42:41+08:00 weekly 0.8 https://fr.hspchem.com/info/takeda-darvadstrocel-applied-for-listing-in-ja-54917800.html 2021-03-10T11:47:07+08:00 weekly 0.8 https://fr.hspchem.com/info/multi-target-tki-inhibitors-are-recognized-as-54917958.html 2021-03-03T16:11:12+08:00 weekly 0.8 https://fr.hspchem.com/info/the-unique-cationic-hydroxybutyric-acid-therap-54917960.html 2021-03-03T16:54:54+08:00 weekly 0.8 https://fr.hspchem.com/info/sanofi-s-new-factor-viii-therapy-efanesoctocog-54918104.html 2021-03-10T11:17:01+08:00 weekly 0.8 https://fr.hspchem.com/info/new-psoriasis-drug-tapinarof-long-term-drug-ph-54918107.html 2021-02-23T17:22:13+08:00 weekly 0.8 https://fr.hspchem.com/info/johnson-johnson-spravato-nasal-spray-approve-54918118.html 2021-03-11T18:46:59+08:00 weekly 0.8 https://fr.hspchem.com/info/amgen-s-targeted-anticancer-drug-sotorasib-rec-54918140.html 2021-02-08T11:00:22+08:00 weekly 0.8 https://fr.hspchem.com/info/the-first-mc4r-agonist-imcivree-has-a-strong-e-54918306.html 2021-03-03T16:03:12+08:00 weekly 0.8 https://fr.hspchem.com/info/novartis-kesimpta-the-first-b-cell-therapy-th-54918323.html 2021-02-08T10:00:39+08:00 weekly 0.8 https://fr.hspchem.com/info/tagrisso-osimertinib-adjuvant-treatment-of-e-54919521.html 2021-03-10T11:37:49+08:00 weekly 0.8 https://fr.hspchem.com/info/front-microbio-the-probiotics-in-milk-will-ch-54919625.html 2021-02-23T16:51:50+08:00 weekly 0.8 https://fr.hspchem.com/info/novo-nordisk-invests-1-3-billion-us-dollars-to-54919660.html 2021-02-08T09:45:38+08:00 weekly 0.8 https://fr.hspchem.com/info/amgen-sotorasib-has-strong-efficacy-in-treatin-54919742.html 2021-02-08T10:42:35+08:00 weekly 0.8 https://fr.hspchem.com/info/the-first-nuclear-export-inhibitor-nexpovio-s-54919745.html 2021-02-23T14:07:48+08:00 weekly 0.8 https://fr.hspchem.com/info/astrazeneca-s-forxiga-dapagliflozin-approved-54919750.html 2021-02-23T17:29:36+08:00 weekly 0.8 https://fr.hspchem.com/info/plos-genet-ordinary-people-are-naturally-resi-54919873.html 2021-02-08T09:53:58+08:00 weekly 0.8 https://fr.hspchem.com/info/a-new-generation-of-tyrosine-kinase-inhibitor-54919878.html 2021-02-23T17:25:36+08:00 weekly 0.8 https://fr.hspchem.com/info/bristol-myers-squibb-jak2-inhibitor-inrebic-ap-54919884.html 2021-03-03T16:30:34+08:00 weekly 0.8 https://fr.hspchem.com/info/the-new-indication-of-beigene-brukinsa-zanubr-54919885.html 2021-03-03T16:18:20+08:00 weekly 0.8 https://fr.hspchem.com/info/the-us-fda-approves-novartis-entresto-sacubit-54920014.html 2021-03-10T11:00:27+08:00 weekly 0.8 https://fr.hspchem.com/info/cell-sub-news-discovers-new-drugs-for-effectiv-54920019.html 2021-02-08T10:38:37+08:00 weekly 0.8 https://fr.hspchem.com/info/pemazyre-pemigatinib-a-potent-fgfr-kinase-i-54920618.html 2021-02-08T10:46:25+08:00 weekly 0.8 https://fr.hspchem.com/info/eu-chmp-recommends-and-approves-xcopri-cenoba-54920717.html 2021-03-03T15:45:46+08:00 weekly 0.8 https://fr.hspchem.com/info/u-s-fda-approves-pfizer-panzyga-human-immuno-54920722.html 2021-03-03T15:52:35+08:00 weekly 0.8 https://fr.hspchem.com/info/the-us-fda-approves-abbvie-s-botulinum-toxin-b-54920958.html 2021-02-08T09:49:00+08:00 weekly 0.8 https://fr.hspchem.com/info/cancer-immunol-res-how-pancreatic-cancer-cell-54921278.html 2021-02-08T10:54:56+08:00 weekly 0.8 https://fr.hspchem.com/info/tyvaso-dpi-inhaled-treprostinil-is-safe-and-54921382.html 2021-03-11T19:37:10+08:00 weekly 0.8 https://fr.hspchem.com/info/merck-s-keytruda-treatment-of-triple-negative-54921396.html 2021-03-11T19:39:00+08:00 weekly 0.8 https://fr.hspchem.com/info/oral-gnrh-receptor-antagonist-relugolix-compou-54921478.html 2021-02-08T10:03:39+08:00 weekly 0.8 https://fr.hspchem.com/info/novo-nordisk-sogroya-is-recommended-and-approv-54921577.html 2021-02-08T10:48:15+08:00 weekly 0.8 https://fr.hspchem.com/info/the-first-drug-to-treat-acute-hyperammonemia-a-54921631.html 2021-03-10T11:32:07+08:00 weekly 0.8 https://fr.hspchem.com/info/akeso-inc-pd-1-ctla-4-dual-antibody-for-treat-54921705.html 2021-03-17T15:26:58+08:00 weekly 0.8 https://fr.hspchem.com/info/eli-lilly-jak-inhibitor-successfully-promotes-55444211.html 2021-03-25T14:13:35+08:00 weekly 0.8 https://fr.hspchem.com/info/peripheral-opioid-receptor-kor-agonist-kor-55444214.html 2021-03-25T14:13:36+08:00 weekly 0.8 https://fr.hspchem.com/info/astrazeneca-s-targeted-drug-tagrisso-osimerti-55444219.html 2021-03-25T14:13:36+08:00 weekly 0.8 https://fr.hspchem.com/info/gilead-yescarta-has-been-approved-by-the-us-fd-55444222.html 2021-03-17T15:36:10+08:00 weekly 0.8 https://fr.hspchem.com/info/merck-s-gefapixant-enters-the-review-in-the-un-55444622.html 2021-03-17T15:33:04+08:00 weekly 0.8 https://fr.hspchem.com/info/an-imported-anti-inflammatory-drug-otezla-subm-55445399.html 2021-03-17T15:30:52+08:00 weekly 0.8 https://fr.hspchem.com/info/merck-acquires-an-iap-antagonist-for-nearly-55445570.html 2021-03-24T17:29:09+08:00 weekly 0.8 https://fr.hspchem.com/info/aveo-fotivda-tivozanib-has-been-approved-by-55446718.html 2021-03-25T15:17:34+08:00 weekly 0.8 https://fr.hspchem.com/info/new-data-from-merck-support-islatravir-implan-55448995.html 2021-03-24T17:30:16+08:00 weekly 0.8 https://fr.hspchem.com/info/novartis-kymriah-approved-treatment-of-2-type-55450439.html 2021-03-25T15:05:21+08:00 weekly 0.8 https://fr.hspchem.com/info/men-s-abuse-of-steroids-can-cause-long-term-im-57385484.html 2021-05-17T13:32:27+08:00 weekly 0.8 https://fr.hspchem.com/info/the-us-fda-approved-arcalyst-for-the-treatmen-57385485.html 2021-05-17T13:32:27+08:00 weekly 0.8 https://fr.hspchem.com/info/eisai-inhibitor-lenvima-lenvatinib-has-been-57385486.html 2021-04-01T16:54:12+08:00 weekly 0.8 https://fr.hspchem.com/info/astrazeneca-s-cll-drug-calquence-is-approved-b-57386144.html 2021-04-09T13:31:32+08:00 weekly 0.8 https://fr.hspchem.com/info/fda-approves-zegalogue-injection-to-treat-diab-57386145.html 2021-03-25T15:08:16+08:00 weekly 0.8 https://fr.hspchem.com/info/spain-successfully-developed-a-new-type-of-nan-57386146.html 2021-03-25T15:29:50+08:00 weekly 0.8 https://fr.hspchem.com/info/nefecon-targeted-release-budesonide-applied-57386147.html 2021-04-01T17:13:37+08:00 weekly 0.8 https://fr.hspchem.com/info/the-new-c3-inhibitor-amy-101-has-a-strong-effe-57386148.html 2021-04-01T16:43:33+08:00 weekly 0.8 https://fr.hspchem.com/info/bristol-myers-cardiac-myosin-allosteric-inhibi-57386149.html 2021-04-09T13:42:44+08:00 weekly 0.8 https://fr.hspchem.com/info/neuron-analyze-the-brain-s-switch-to-control-57386150.html 2021-04-23T14:28:17+08:00 weekly 0.8 https://fr.hspchem.com/info/daiichi-sankyo-s-potent-and-selective-menin-in-57386151.html 2021-04-22T17:57:57+08:00 weekly 0.8 https://fr.hspchem.com/info/u-s-fda-approves-qelbre-viloxazine-for-atte-57386152.html 2021-04-22T17:13:03+08:00 weekly 0.8 https://fr.hspchem.com/info/cstone-pharmaceuticals-avapritinib-was-approve-57386153.html 2021-04-27T14:02:35+08:00 weekly 0.8 https://fr.hspchem.com/info/novo-nordisk-sogroya-is-approved-by-the-europe-57386154.html 2021-04-22T17:00:30+08:00 weekly 0.8 https://fr.hspchem.com/info/the-us-fda-approved-tyvaso-treprostinil-the-57386155.html 2021-04-27T13:59:36+08:00 weekly 0.8 https://fr.hspchem.com/info/u-s-fda-grants-breakthrough-drug-designation-57386157.html 2021-04-27T14:23:19+08:00 weekly 0.8 https://fr.hspchem.com/info/buparlisib-completes-first-patient-dosing-in-g-57386158.html 2021-04-15T14:18:36+08:00 weekly 0.8 https://fr.hspchem.com/info/maralixibat-has-been-reviewed-by-the-us-fda-as-57386160.html 2021-04-15T15:31:27+08:00 weekly 0.8 https://fr.hspchem.com/info/us-fda-approves-vyxeos-for-acute-myeloid-leuke-57386161.html 2021-05-08T16:39:31+08:00 weekly 0.8 https://fr.hspchem.com/info/sanofi-s-cd38-targeting-antibody-sarclisa-s-se-57386162.html 2021-05-17T13:45:05+08:00 weekly 0.8 https://fr.hspchem.com/info/johnson-johnson-abandoned-erlead-apalutamid-57386163.html 2021-05-08T16:51:40+08:00 weekly 0.8 https://fr.hspchem.com/info/the-eu-approved-the-third-indication-of-epidyo-57386165.html 2021-05-08T16:35:59+08:00 weekly 0.8 https://fr.hspchem.com/info/novartis-kesimpta-reduce-the-risk-of-disabili-57386980.html 2021-05-08T16:25:34+08:00 weekly 0.8 https://fr.hspchem.com/info/merck-evobrutinib-the-first-btk-inhibitor-to-57386985.html 2021-04-15T14:43:31+08:00 weekly 0.8 https://fr.hspchem.com/info/korsuva-kor-agonist-korsuva-enters-review-in-57397896.html 2021-04-22T17:21:27+08:00 weekly 0.8 https://fr.hspchem.com/info/abbvie-s-oral-jak1-inhibitor-rinvoq-s-new-indi-57397897.html 2021-04-09T13:40:11+08:00 weekly 0.8 https://fr.hspchem.com/info/molecular-cancer-therapeutics-blocking-the-up-57397898.html 2021-04-09T13:34:11+08:00 weekly 0.8 https://fr.hspchem.com/info/biol-sex-differ-supplementing-dha-in-the-diet-57397899.html 2021-04-01T16:18:13+08:00 weekly 0.8 https://fr.hspchem.com/info/inhibitor-rubraca-treatment-of-brca-mutant-ova-57397900.html 2021-04-01T17:04:51+08:00 weekly 0.8 https://fr.hspchem.com/info/oral-xenleta-outpatient-treatment-of-community-57397901.html 2021-04-01T16:38:08+08:00 weekly 0.8 https://fr.hspchem.com/info/takeda-maribavir-phase-3-clinical-success-wil-57397902.html 2021-03-25T14:16:31+08:00 weekly 0.8 https://fr.hspchem.com/info/fruquintinib-sales-revenue-exceeds-200-million-57397903.html 2021-04-01T17:09:22+08:00 weekly 0.8 https://fr.hspchem.com/info/exelixis-and-merck-pfizer-reached-a-cooperatio-57397904.html 2021-04-09T13:47:22+08:00 weekly 0.8 https://fr.hspchem.com/info/green-tea-can-promote-the-recovery-of-gastric-57397905.html 2021-04-09T13:49:20+08:00 weekly 0.8 https://fr.hspchem.com/info/cancer-research-high-fat-diet-can-cause-tumor-57397906.html 2021-04-15T14:13:31+08:00 weekly 0.8 https://fr.hspchem.com/info/astellas-gilteritinib-tablets-for-the-treatmen-57397907.html 2021-04-15T13:53:52+08:00 weekly 0.8 https://fr.hspchem.com/info/orgovyx-relugolix-enters-censorship-in-the-e-57397908.html 2021-04-15T14:37:50+08:00 weekly 0.8 https://fr.hspchem.com/info/abbvie-s-oral-cgrp-receptor-antagonist-atogepa-57397910.html 2021-04-23T14:31:05+08:00 weekly 0.8 https://fr.hspchem.com/info/iterum-s-sulopenem-treatment-of-simple-urinary-57398170.html 2021-04-09T13:37:34+08:00 weekly 0.8 https://fr.hspchem.com/info/advanced-materials-new-technology-for-the-ins-57398171.html 2021-05-08T16:11:14+08:00 weekly 0.8 https://fr.hspchem.com/info/astrazeneca-s-egfr-targeting-drug-tagrisso-is-57398457.html 2021-05-17T17:46:05+08:00 weekly 0.8 https://fr.hspchem.com/info/merck-announces-data-on-the-efficacy-of-atr-in-57398458.html 2021-05-17T17:46:05+08:00 weekly 0.8 https://fr.hspchem.com/info/boehringer-ingelheim-bi456906-starts-phase-2-c-57398459.html 2021-05-17T17:46:05+08:00 weekly 0.8 https://fr.hspchem.com/info/innocare-obrutinib-is-approved-in-china-to-dev-57398460.html 2021-05-08T16:13:09+08:00 weekly 0.8 https://fr.hspchem.com/info/new-oral-therapy-receives-fda-breakthrough-the-57398462.html 2021-05-17T17:46:05+08:00 weekly 0.8 https://fr.hspchem.com/info/astrazeneca-s-targeted-drug-tagrisso-osimerti-57398466.html 2021-04-23T14:26:54+08:00 weekly 0.8 https://fr.hspchem.com/info/pfizer-and-celcuity-have-reached-a-partnership-57398953.html 2021-05-18T00:14:49+08:00 weekly 0.8 https://fr.hspchem.com/info/pemazyre-pemigatinib-was-approved-by-the-eu-57405872.html 2021-05-19T16:20:59+08:00 weekly 0.8 https://fr.hspchem.com/info/astrazeneca-s-targeted-drug-tagrisso-osimerti-58053759.html 2021-05-19T17:27:51+08:00 weekly 0.8 https://fr.hspchem.com/info/the-us-fda-granted-nefecon-budesonide-priori-58053971.html 2021-05-19T16:18:40+08:00 weekly 0.8 https://fr.hspchem.com/info/bristol-myers-squibb-s-deucravacitinib-in-the-58053972.html 2021-05-19T17:06:26+08:00 weekly 0.8 https://fr.hspchem.com/info/olamkicept-was-successful-in-the-treatment-of-58053973.html 2021-05-19T16:17:29+08:00 weekly 0.8 https://fr.hspchem.com/info/astrazeneca-koselugo-selumetinib-is-about-to-58058889.html 2021-05-19T17:17:53+08:00 weekly 0.8 https://fr.hspchem.com/info/bardoxolone-a-new-oral-nrf2-activator-is-und-58058890.html 2021-06-03T21:40:43+08:00 weekly 0.8 https://fr.hspchem.com/info/takeda-mobocertinib-receives-priority-review-b-58058897.html 2021-05-19T17:11:46+08:00 weekly 0.8 https://fr.hspchem.com/info/cstone-s-gavreto-pralsetinib-new-indication-58058898.html 2021-05-19T17:29:57+08:00 weekly 0.8 https://fr.hspchem.com/info/ono-pharmaceutical-launched-adlumiz-anamoreli-58059026.html 2021-05-26T17:25:24+08:00 weekly 0.8 https://fr.hspchem.com/info/significant-progress-in-ten-years-of-radical-a-58059027.html 2021-06-03T21:46:07+08:00 weekly 0.8 https://fr.hspchem.com/info/eisai-announced-the-strong-efficacy-data-of-ha-58059028.html 2021-05-26T17:11:26+08:00 weekly 0.8 https://fr.hspchem.com/info/successful-phase-3-project-of-jak-inhibitor-ru-58059227.html 2021-05-19T15:54:23+08:00 weekly 0.8 https://fr.hspchem.com/info/amgen-otezla-has-strong-clinical-efficacy-in-t-58059228.html 2021-05-26T17:07:08+08:00 weekly 0.8 https://fr.hspchem.com/info/xarelto-rivaroxaban-aspirin-significantly-58062091.html 2021-05-26T17:50:25+08:00 weekly 0.8 https://fr.hspchem.com/info/sanofi-s-oral-serd-drug-amcenestrant-combined-58062093.html 2021-05-19T15:51:51+08:00 weekly 0.8 https://fr.hspchem.com/info/ann-rheum-dis-tenascin-c-can-promote-the-form-58064141.html 2021-05-19T17:16:38+08:00 weekly 0.8 https://fr.hspchem.com/info/the-new-oral-nmda-receptor-antagonist-axs-58064143.html 2021-05-26T17:54:15+08:00 weekly 0.8 https://fr.hspchem.com/info/johnson-johnson-abbvie-imbruvica-ibrutinib-58065993.html 2021-05-26T17:39:52+08:00 weekly 0.8 https://fr.hspchem.com/info/imbruvica-venclexta-ibrutinib-venetoclax-th-58066472.html 2021-09-26T12:22:12+08:00 weekly 0.8 https://fr.hspchem.com/info/rifampin-evaluation-of-its-use-in-acute-perip-62062120.html 2021-06-21T16:40:35+08:00 weekly 0.8 https://fr.hspchem.com/info/oral-s1p1-modulator-ponvory-ponesimod-approv-62062121.html 2021-06-22T14:45:13+08:00 weekly 0.8 https://fr.hspchem.com/info/the-us-fda-approves-lybalvi-olanzapine-samido-62062122.html 2021-09-26T12:22:14+08:00 weekly 0.8 https://fr.hspchem.com/info/zeposia-ozanimod-was-approved-by-the-us-fda-62062123.html 2021-09-26T12:22:17+08:00 weekly 0.8 https://fr.hspchem.com/info/the-us-fda-approved-nuzyra-omadacycline-for-62062124.html 2021-06-22T14:19:24+08:00 weekly 0.8 https://fr.hspchem.com/info/inhibitor-derazantinib-in-the-treatment-of-int-62062125.html 2021-06-25T17:41:57+08:00 weekly 0.8 https://fr.hspchem.com/info/zuranolone-phase-3-clinical-success-taking-th-62062126.html 2021-09-26T12:22:15+08:00 weekly 0.8 https://fr.hspchem.com/info/tabrecta-in-the-treatment-of-metex14-mutant-no-62062127.html 2021-06-18T18:04:11+08:00 weekly 0.8 https://fr.hspchem.com/info/combination-of-vs-6766-and-defactinib-total-r-62062130.html 2021-06-29T17:43:51+08:00 weekly 0.8 https://fr.hspchem.com/info/nature-sub-journal-pi3k-inhibitors-are-about-62062132.html 2021-07-27T11:07:43+08:00 weekly 0.8 https://fr.hspchem.com/info/bjp-insights-into-the-mechanisms-and-potentia-62062133.html 2021-06-29T17:27:32+08:00 weekly 0.8 https://fr.hspchem.com/info/lenvima-keytruda-lenvatinib-pembrolizumab-sh-62062134.html 2021-07-27T11:18:07+08:00 weekly 0.8 https://fr.hspchem.com/info/forxiga-dapagliflozin-is-about-to-be-approve-62062135.html 2021-06-22T15:29:06+08:00 weekly 0.8 https://fr.hspchem.com/info/the-us-fda-approves-brexafemme-treatment-of-v-62062136.html 2021-07-27T15:56:23+08:00 weekly 0.8 https://fr.hspchem.com/info/vutrisiran-is-under-review-in-the-united-state-62062137.html 2021-09-26T12:22:16+08:00 weekly 0.8 https://fr.hspchem.com/info/astrazeneca-s-second-generation-parp-inhibitor-62062139.html 2021-06-25T17:58:01+08:00 weekly 0.8 https://fr.hspchem.com/info/eprenetapopt-venetoclax-azacitidine-in-the-tre-62062140.html 2021-06-29T17:40:10+08:00 weekly 0.8 https://fr.hspchem.com/info/jardiance-empagliflozin-has-been-approved-fo-62062141.html 2021-06-29T17:34:40+08:00 weekly 0.8 https://fr.hspchem.com/info/astrazeneca-mersk-s-new-oral-kinase-inhibitor-62062142.html 2021-09-26T12:22:17+08:00 weekly 0.8 https://fr.hspchem.com/info/eu-approves-opdivo-yervoy-dual-immunotherapy-p-62062143.html 2021-07-27T10:58:20+08:00 weekly 0.8 https://fr.hspchem.com/info/tirzepatide-the-effect-of-reducing-blood-suga-62062144.html 2021-07-30T10:56:40+08:00 weekly 0.8 https://fr.hspchem.com/info/olumiant-baricitinib-new-indication-applicat-62062145.html 2021-07-30T10:52:24+08:00 weekly 0.8 https://fr.hspchem.com/info/evrenzo-roxadustat-suffered-three-setbacks-62062146.html 2021-07-27T16:38:58+08:00 weekly 0.8 https://fr.hspchem.com/info/eisai-dayvigo-lemborexant-is-listed-in-hong-62062148.html 2021-09-26T12:22:12+08:00 weekly 0.8 https://fr.hspchem.com/info/quorum-sensing-inhibitors-contribute-to-the-e-62062149.html 2021-09-26T12:22:18+08:00 weekly 0.8 https://fr.hspchem.com/info/galapagos-announced-the-top-line-results-of-th-62062152.html 2021-08-05T10:54:47+08:00 weekly 0.8 https://fr.hspchem.com/info/skysona-the-first-gene-therapy-to-treat-cereb-62062153.html 2021-09-26T12:22:18+08:00 weekly 0.8 https://fr.hspchem.com/info/galapagos-announced-the-top-line-results-of-th-62062154.html 2021-09-26T12:22:18+08:00 weekly 0.8 https://fr.hspchem.com/info/klisyri-tirbanibulin-is-approved-in-the-eu-a-62062155.html 2021-09-26T12:22:18+08:00 weekly 0.8 https://fr.hspchem.com/info/u-s-fda-approved-octagam-10-the-first-intra-62062156.html 2021-07-30T11:49:18+08:00 weekly 0.8 https://fr.hspchem.com/info/astellas-prograf-tacrolimus-approved-for-new-62062157.html 2021-08-20T17:53:13+08:00 weekly 0.8 https://fr.hspchem.com/info/eli-lilly-and-kumquat-biosciences-reached-an-e-62062158.html 2021-08-31T14:56:18+08:00 weekly 0.8 https://fr.hspchem.com/info/global-phase-iii-data-of-ivosidenib-combined-w-62062159.html 2021-08-11T11:40:27+08:00 weekly 0.8 https://fr.hspchem.com/info/selective-serotonin-inverse-agonist-nuplazid-h-62062160.html 2021-09-26T12:22:18+08:00 weekly 0.8 https://fr.hspchem.com/info/bayer-verquvo-vericiguat-has-been-approved-i-62062161.html 2021-08-31T15:11:24+08:00 weekly 0.8 https://fr.hspchem.com/info/rongchang-bio-titacept-completes-domestic-phas-62062162.html 2021-08-31T14:59:30+08:00 weekly 0.8 https://fr.hspchem.com/info/scientists-find-that-transglutaminase-2-inhibi-62062163.html 2021-06-18T17:58:36+08:00 weekly 0.8 https://fr.hspchem.com/info/nature-sub-publishes-another-breakthrough-in-c-62062164.html 2021-08-31T15:30:47+08:00 weekly 0.8 https://fr.hspchem.com/info/european-union-approves-astrazeneca-forxig-62062165.html 2021-08-31T15:03:50+08:00 weekly 0.8 https://fr.hspchem.com/info/the-u-s-fda-granted-breakthrough-therapy-desi-62062166.html 2021-08-31T15:33:33+08:00 weekly 0.8 https://fr.hspchem.com/info/pfizer-inhibitor-ritlecitinib-phase-2-3-study-62062168.html 2021-08-31T16:29:38+08:00 weekly 0.8 https://fr.hspchem.com/info/antagonist-sparsentan-phase-3-clinical-effica-62062169.html 2021-09-13T17:47:38+08:00 weekly 0.8 https://fr.hspchem.com/info/the-eu-granted-accelerated-evaluation-of-ganax-62062170.html 2021-09-13T17:41:12+08:00 weekly 0.8 https://fr.hspchem.com/info/inhibitor-tibsovo-treating-patients-with-idh-62062171.html 2021-08-31T16:19:01+08:00 weekly 0.8 https://fr.hspchem.com/info/fda-refuses-to-approve-new-drug-roxadustat-62062172.html 2021-09-26T12:22:19+08:00 weekly 0.8 https://fr.hspchem.com/info/new-progress-has-been-made-in-the-total-synthe-62062174.html 2021-09-16T17:51:32+08:00 weekly 0.8 https://fr.hspchem.com/info/abbvie-atogepant-preventive-treatment-of-paro-62062175.html 2021-09-17T17:38:15+08:00 weekly 0.8 https://fr.hspchem.com/info/fda-requires-jak-inhibitors-to-add-black-box-w-62062176.html 2021-08-11T11:11:28+08:00 weekly 0.8 https://fr.hspchem.com/info/ck-274-phase-2-clinical-effect-remarkable-62062177.html 2021-09-26T12:22:19+08:00 weekly 0.8 https://fr.hspchem.com/info/inhibitor-ck-274-phase-2-clinical-effect-is-re-62062180.html 2021-09-17T17:36:04+08:00 weekly 0.8 https://fr.hspchem.com/info/the-united-states-approved-trudhesa-dihydroer-62062181.html 2021-09-26T12:22:21+08:00 weekly 0.8 https://fr.hspchem.com/info/journal-of-medicinal-chemistry-discovery-of-o-62062182.html 2021-09-17T17:31:35+08:00 weekly 0.8 https://fr.hspchem.com/info/the-us-fda-approves-beigene-brukinsa-zanubrut-62062184.html 2021-09-26T12:22:22+08:00 weekly 0.8 https://fr.hspchem.com/info/jardiance-empagliflozin-the-first-drug-to-s-62062185.html 2021-09-17T17:28:47+08:00 weekly 0.8 https://fr.hspchem.com/info/the-us-fda-approves-beigene-brukinsa-zanubrut-62062187.html 2021-09-26T12:22:22+08:00 weekly 0.8 https://fr.hspchem.com/info/vutrisiran-in-the-treatment-of-hattr-amyloidos-62062189.html 2021-09-24T17:02:40+08:00 weekly 0.8 https://fr.hspchem.com/info/phase-3-clinical-trial-of-dual-endothelin-angi-62062190.html 2021-06-22T11:41:09+08:00 weekly 0.8 https://fr.hspchem.com/info/fennec-company-pedmark-sodium-thiosulfate-re-62062654.html 2021-06-21T16:25:25+08:00 weekly 0.8 https://fr.hspchem.com/info/bluebird-bio-skysona-is-about-to-be-approved-62062655.html 2021-06-22T15:22:08+08:00 weekly 0.8 https://fr.hspchem.com/info/rinvoq-upadacitinib-treatment-for-more-than-62062656.html 2021-07-27T11:13:30+08:00 weekly 0.8 https://fr.hspchem.com/info/novo-nordisk-ozempic-semaglutide-the-hypogl-62062657.html 2021-07-30T10:44:17+08:00 weekly 0.8 https://fr.hspchem.com/info/valrox-enters-review-in-the-eu-treatment-of-h-62062658.html 2021-07-27T10:53:09+08:00 weekly 0.8 https://fr.hspchem.com/info/xarelto-rivaroxaban-application-submitted-in-62062659.html 2021-07-30T10:48:18+08:00 weekly 0.8 https://fr.hspchem.com/info/evrenzo-roxadustat-suffered-three-setbacks-i-62062660.html 2021-08-05T10:40:37+08:00 weekly 0.8 https://fr.hspchem.com/info/jiahe-bio-cdk4-6-inhibitor-for-the-treatment-o-62062661.html 2021-07-27T15:22:36+08:00 weekly 0.8 https://fr.hspchem.com/info/rinvoq-upadacitinib-phase-3-maintenance-stud-62062663.html 2021-08-05T10:46:34+08:00 weekly 0.8 https://fr.hspchem.com/info/the-u-s-fda-granted-roche-abbvie-venclexta-v-62062664.html 2021-08-11T11:02:57+08:00 weekly 0.8 https://fr.hspchem.com/info/the-future-of-lantern-s-new-drug-can-be-expect-62062665.html 2021-08-11T12:00:00+08:00 weekly 0.8 https://fr.hspchem.com/info/astrazeneca-and-regeneron-have-reached-a-coope-62062667.html 2021-08-11T12:02:05+08:00 weekly 0.8 https://fr.hspchem.com/info/develop-a-combination-therapy-of-shp2-inhibito-62062668.html 2021-09-16T17:44:16+08:00 weekly 0.8 https://fr.hspchem.com/info/the-fcrn-antagonist-efgartigimod-is-under-revi-62062669.html 2021-09-24T17:06:09+08:00 weekly 0.8 https://fr.hspchem.com/info/oxbryta-pediatric-indications-dispersible-ta-62062673.html 2021-08-05T10:56:23+08:00 weekly 0.8 https://fr.hspchem.com/info/skysona-the-first-gene-therapy-to-treat-cereb-62062928.html 2021-06-29T17:24:47+08:00 weekly 0.8 https://fr.hspchem.com/info/vorasidenib-shows-efficacy-progression-free-s-62073990.html 2021-07-27T16:04:01+08:00 weekly 0.8 https://fr.hspchem.com/info/jazz-oncology-drug-rylaze-is-approved-by-fda-f-62073991.html 2021-07-30T11:27:56+08:00 weekly 0.8 https://fr.hspchem.com/info/abbvie-rinvoq-s-application-for-new-indication-62073993.html 2021-09-26T16:11:04+08:00 weekly 0.8 https://fr.hspchem.com/info/all-5-studies-of-the-glaxosmithkline-hif-ph-in-62073994.html 2021-09-26T16:11:05+08:00 weekly 0.8 https://fr.hspchem.com/info/u-s-fda-approves-rezurock-the-first-rock2-in-62073995.html 2021-08-31T16:24:16+08:00 weekly 0.8 https://fr.hspchem.com/info/eisai-launches-tazverik-in-the-japanese-market-62073996.html 2021-09-13T17:33:35+08:00 weekly 0.8 https://fr.hspchem.com/info/the-u-s-fda-approves-cstone-s-precision-treat-62073997.html 2021-08-31T16:19:47+08:00 weekly 0.8 https://fr.hspchem.com/info/cell-research-developed-a-new-generation-of-h-62073998.html 2021-09-26T16:11:07+08:00 weekly 0.8 https://fr.hspchem.com/info/the-u-s-fda-approved-the-new-indication-for-j-62073999.html 2021-09-26T16:11:07+08:00 weekly 0.8 https://fr.hspchem.com/info/antagonist-sparsentan-phase-3-clinical-effica-62074000.html 2021-09-26T16:21:24+08:00 weekly 0.8 https://fr.hspchem.com/info/nefecon-budesonide-applied-for-listing-in-th-62074137.html 2021-07-27T11:04:21+08:00 weekly 0.8 https://fr.hspchem.com/info/c-type-natriuretic-peptide-analogue-vosoritide-62074138.html 2021-06-21T17:43:10+08:00 weekly 0.8 https://fr.hspchem.com/info/us-fda-approves-myfembree-treatment-of-menorr-62074139.html 2021-08-31T17:09:51+08:00 weekly 0.8 https://fr.hspchem.com/info/the-u-s-fda-approved-the-new-indication-for-j-62074140.html 2021-08-31T15:22:44+08:00 weekly 0.8 https://fr.hspchem.com/info/cabometyx-cabozantinib-has-been-given-priori-62074141.html 2021-09-26T16:21:29+08:00 weekly 0.8 https://fr.hspchem.com/info/the-u-s-fda-granted-arrowhead-s-second-genera-62074144.html 2021-09-16T17:19:04+08:00 weekly 0.8 https://fr.hspchem.com/info/ono-takeda-immunity-targeting-program-opdivo-62074146.html 2021-09-16T17:52:46+08:00 weekly 0.8 https://fr.hspchem.com/info/abbvie-atogepant-preventive-treatment-of-paro-62074147.html 2021-09-13T17:38:18+08:00 weekly 0.8 https://fr.hspchem.com/info/rinvoq-was-approved-by-the-european-union-for-62074148.html 2021-09-24T16:54:15+08:00 weekly 0.8 https://fr.hspchem.com/info/vutrisiran-in-the-treatment-of-hattr-amyloidos-62074152.html 2021-06-22T14:52:55+08:00 weekly 0.8 https://fr.hspchem.com/info/the-us-fda-granted-pacritinib-priority-review-62074310.html 2021-06-22T14:01:49+08:00 weekly 0.8 https://fr.hspchem.com/info/the-us-fda-approved-nurtec-odt-rimegepant-t-62074312.html 2021-08-11T11:37:00+08:00 weekly 0.8 https://fr.hspchem.com/info/serotonin-inverse-agonist-nuplazid-has-62074321.html 2021-06-25T17:52:34+08:00 weekly 0.8 https://fr.hspchem.com/info/us-fda-granted-tyvaso-dpi-treprostinil-dry-p-62082571.html 2021-09-13T17:17:57+08:00 weekly 0.8 https://fr.hspchem.com/info/the-us-fda-approves-xarelto-rivaroxaban-as-62083062.html 2021-07-27T10:48:29+08:00 weekly 0.8 https://fr.hspchem.com/info/rinvoq-is-about-to-be-approved-in-the-eu-for-i-62083065.html 2021-09-26T20:03:00+08:00 weekly 0.8 https://fr.hspchem.com/info/dapagliflozin-is-about-to-be-approve-62083066.html 2021-08-05T14:06:27+08:00 weekly 0.8 https://fr.hspchem.com/info/bayer-verquvo-vericiguat-has-been-approved-i-62083069.html 2021-07-30T11:38:20+08:00 weekly 0.8 https://fr.hspchem.com/info/gilead-lenacapavir-treats-patients-with-multi-62083070.html 2021-09-24T17:13:21+08:00 weekly 0.8 https://fr.hspchem.com/info/sumitomo-pharmaceuticals-xenleta-lefamulin-w-62083072.html 2021-09-26T20:03:04+08:00 weekly 0.8 https://fr.hspchem.com/info/the-u-s-fda-granted-folr-targeted-antibody-c-62083073.html 2021-09-13T16:48:44+08:00 weekly 0.8 https://fr.hspchem.com/info/new-tcr-therapy-tebentafusp-treatment-of-uvea-62083603.html 2021-07-30T10:27:29+08:00 weekly 0.8 https://fr.hspchem.com/info/ipsen-has-obtained-mesdopetam-a-new-dopamine-62083606.html 2021-07-30T10:39:58+08:00 weekly 0.8 https://fr.hspchem.com/info/hutchison-medicine-s-surufatinib-enters-the-re-62083607.html 2021-07-27T14:27:15+08:00 weekly 0.8 https://fr.hspchem.com/info/lenacapavir-gs-6207-submits-a-listing-applic-62083608.html 2021-06-22T11:55:15+08:00 weekly 0.8 https://fr.hspchem.com/info/takeda-ninlaro-ixazomib-was-approved-in-japa-62084062.html 2021-06-22T11:35:26+08:00 weekly 0.8 https://fr.hspchem.com/info/novartis-next-generation-drug-beovu-phase-3-m-62084063.html 2021-08-20T18:00:10+08:00 weekly 0.8 https://fr.hspchem.com/info/u-s-fda-expands-incyte-lilly-jak-inhibitor-ol-62084068.html 2021-06-25T17:44:51+08:00 weekly 0.8 https://fr.hspchem.com/info/cstone-pharmaceuticals-and-pfizer-cooperate-to-62092528.html 2021-06-29T17:30:22+08:00 weekly 0.8 https://fr.hspchem.com/info/mitapivat-applies-for-listing-significantly-r-62098846.html 2021-09-27T04:02:47+08:00 weekly 0.8 https://fr.hspchem.com/info/winlevi-cream-a-topical-androgen-receptor-inh-62098848.html 2021-08-31T15:28:59+08:00 weekly 0.8 https://fr.hspchem.com/info/the-european-union-approves-astrazeneca-forxig-62099133.html 2021-06-22T15:15:10+08:00 weekly 0.8 https://fr.hspchem.com/info/kisqali-reported-the-longest-median-overall-su-62099134.html 2021-06-22T12:02:08+08:00 weekly 0.8 https://fr.hspchem.com/info/eu-grants-accelerated-evaluation-of-valrox-tr-62102193.html 2021-09-27T06:40:30+08:00 weekly 0.8 https://fr.hspchem.com/info/dovato-is-very-effective-and-will-be-launched-62103791.html 2021-06-25T18:00:22+08:00 weekly 0.8 https://fr.hspchem.com/info/cstone-pharmaceuticals-obtains-fda-approval-fo-62104623.html 2021-09-28T17:14:10+08:00 weekly 0.8 https://fr.hspchem.com/info/onvansertib-is-effective-in-treating-kras-muta-63351041.html 2021-10-25T16:05:22+08:00 weekly 0.8 https://fr.hspchem.com/info/the-us-fda-approved-livmarli-the-first-drug-t-63351042.html 2021-10-25T16:07:15+08:00 weekly 0.8 https://fr.hspchem.com/info/the-us-fda-approved-livmarli-the-first-drug-t-63351043.html 2021-11-05T17:08:02+08:00 weekly 0.8 https://fr.hspchem.com/info/biogen-tecfidera-s-upgraded-version-of-vumerit-63351044.html 2021-10-14T16:30:27+08:00 weekly 0.8 https://fr.hspchem.com/info/us-fda-approves-opzelura-cream-the-first-topi-63351045.html 2021-10-09T15:37:09+08:00 weekly 0.8 https://fr.hspchem.com/info/abbvie-inhibitor-rinvoq-upatinib-submitted-a-63351046.html 2021-10-25T16:17:29+08:00 weekly 0.8 https://fr.hspchem.com/info/merck-keytruda-successfully-treats-asian-hcc-p-63351047.html 2021-11-05T17:08:02+08:00 weekly 0.8 https://fr.hspchem.com/info/brexafemme-launched-in-the-united-states-trea-63351048.html 2021-10-14T15:32:53+08:00 weekly 0.8 https://fr.hspchem.com/info/brexafemme-launched-in-the-united-states-trea-63351049.html 2021-10-25T17:08:24+08:00 weekly 0.8 https://fr.hspchem.com/info/tecentriq-the-first-cancer-immunotherapy-for-63351050.html 2021-10-09T14:01:37+08:00 weekly 0.8 https://fr.hspchem.com/info/bayer-nubeqa-darolutamide-phase-3-clinical-t-63351051.html 2021-10-09T15:50:56+08:00 weekly 0.8 https://fr.hspchem.com/info/the-us-fda-approves-beigene-brukinsa-zanubrut-63351052.html 2021-10-14T11:47:47+08:00 weekly 0.8 https://fr.hspchem.com/info/results-of-phase-ii-study-of-fgfr-inhibitors-i-63351054.html 2021-11-05T17:08:03+08:00 weekly 0.8 https://fr.hspchem.com/info/new-local-drug-delivery-system-prv111-for-the-63351056.html 2021-11-04T17:15:25+08:00 weekly 0.8 https://fr.hspchem.com/info/verzenio-abemaciclib-new-data-the-first-cdk-63351057.html 2021-11-04T17:19:45+08:00 weekly 0.8 https://fr.hspchem.com/info/verzenio-abemaciclib-new-data-the-first-cdk-63351058.html 2021-10-25T17:06:38+08:00 weekly 0.8 https://fr.hspchem.com/info/tecentriq-the-first-cancer-immunotherapy-for-63351464.html 2021-11-04T17:32:10+08:00 weekly 0.8 https://fr.hspchem.com/info/the-tyrosine-kinase-inhibitor-cabometyx-caboz-63351465.html 2021-11-04T16:28:44+08:00 weekly 0.8 https://fr.hspchem.com/info/the-eu-chmp-recommends-approval-of-pfizer-s-63351467.html 2021-10-26T15:18:53+08:00 weekly 0.8 https://fr.hspchem.com/info/application-for-clinical-trial-of-lorlatinib-i-63351470.html 2021-11-05T21:04:53+08:00 weekly 0.8 https://fr.hspchem.com/info/pfizer-s-new-generation-oral-jak1-inhibitor-ci-63361620.html 2021-10-09T14:28:57+08:00 weekly 0.8 https://fr.hspchem.com/info/axsome-s-new-oral-multi-mechanism-drug-axs-63361621.html 2021-10-25T16:11:43+08:00 weekly 0.8 https://fr.hspchem.com/info/tavneos-the-first-oral-selective-complement-c-63361955.html 2021-10-14T11:54:07+08:00 weekly 0.8 https://fr.hspchem.com/info/johnson-johnson-fgfr-kinase-inhibitor-balver-63361956.html 2021-11-05T21:12:06+08:00 weekly 0.8 https://fr.hspchem.com/info/emopamil-binding-protein-ebp-inhibitor-dsp-63361957.html 2021-11-05T21:12:05+08:00 weekly 0.8 https://fr.hspchem.com/info/the-us-fda-approves-beigene-brukinsa-zanubrut-63361960.html 2021-10-25T16:49:29+08:00 weekly 0.8 https://fr.hspchem.com/info/gilead-yescarta-enters-review-in-the-united-st-63361962.html 2021-10-26T15:03:57+08:00 weekly 0.8 https://fr.hspchem.com/info/pfizer-s-new-generation-oral-jak1-inhibitor-ci-63362337.html 2021-09-28T17:15:40+08:00 weekly 0.8 https://fr.hspchem.com/info/onvansertib-is-effective-in-treating-kras-muta-63373336.html 2021-10-14T11:50:40+08:00 weekly 0.8 https://fr.hspchem.com/info/nice-recommends-orladeyo-for-preventive-treatm-63373337.html 2021-10-09T14:07:26+08:00 weekly 0.8 https://fr.hspchem.com/info/vutrisiran-applied-for-listing-in-the-eu-trea-63373341.html 2021-09-28T17:18:41+08:00 weekly 0.8 https://fr.hspchem.com/info/maralixibat-eu-application-for-listing-treatm-63373342.html 2021-11-05T23:57:04+08:00 weekly 0.8 https://fr.hspchem.com/info/bayer-nubeqa-darolutamide-phase-3-clinical-t-63373343.html 2021-10-14T16:33:05+08:00 weekly 0.8 https://fr.hspchem.com/info/us-fda-approves-opzelura-cream-the-first-topi-63373344.html 2021-11-05T23:57:08+08:00 weekly 0.8 https://fr.hspchem.com/info/axsome-s-new-oral-multi-mechanism-drug-axs-63373348.html 2021-11-05T23:57:09+08:00 weekly 0.8 https://fr.hspchem.com/info/johnson-johnson-fgfr-kinase-inhibitor-balver-63373349.html 2021-10-09T15:33:05+08:00 weekly 0.8 https://fr.hspchem.com/info/the-us-fda-approves-takeda-exkivity-the-first-63373913.html 2021-10-25T16:56:39+08:00 weekly 0.8 https://fr.hspchem.com/info/the-first-weekly-growth-hormone-skytrofa-to-be-63374568.html 2021-10-09T15:26:08+08:00 weekly 0.8 https://fr.hspchem.com/info/the-us-fda-approves-takeda-exkivity-the-first-63380380.html 2021-11-26T15:34:59+08:00 weekly 0.8 https://fr.hspchem.com/info/novartis-kymriah-s-third-indication-enters-rev-64256060.html 2021-11-11T16:25:45+08:00 weekly 0.8 https://fr.hspchem.com/info/teva-and-modag-reached-an-exclusive-global-lic-64256061.html 2021-11-11T17:11:40+08:00 weekly 0.8 https://fr.hspchem.com/info/devimistat-cpi-613-failed-in-the-phase-3-cli-64256062.html 2021-11-26T15:35:00+08:00 weekly 0.8 https://fr.hspchem.com/info/otsuka-pharmaceutical-s-hif-ph-inhibitor-vadad-64256063.html 2021-11-24T10:25:42+08:00 weekly 0.8 https://fr.hspchem.com/info/emalex-s-first-phase-2b-study-of-dopamine-d1-r-64256290.html 2021-11-18T11:53:39+08:00 weekly 0.8 https://fr.hspchem.com/info/nature-s-first-report-on-obesity-pills-recog-64256293.html 2021-11-11T17:19:49+08:00 weekly 0.8 https://fr.hspchem.com/info/us-fda-approves-stamp-inhibitor-scemblix-asci-64256294.html 2021-11-11T15:24:25+08:00 weekly 0.8 https://fr.hspchem.com/info/the-u-s-fda-granted-fast-track-qualification-64260509.html 2021-11-24T11:33:06+08:00 weekly 0.8 https://fr.hspchem.com/info/jardiance-empagliflozin-enters-priority-revi-64260716.html 2021-11-26T17:04:40+08:00 weekly 0.8 https://fr.hspchem.com/info/eli-lilly-s-oral-jak-inhibitor-olumiant-baric-64260717.html 2021-11-11T16:20:57+08:00 weekly 0.8 https://fr.hspchem.com/info/non-invasive-skin-patch-viaskin-peanut-dbv-64260718.html 2021-11-26T17:04:41+08:00 weekly 0.8 https://fr.hspchem.com/info/inhibitor-rinvoq-upadacitinib-treatment-of-m-64260719.html 2021-11-24T10:37:48+08:00 weekly 0.8 https://fr.hspchem.com/info/the-us-fda-granted-zandelisib-orphan-drug-desi-64260722.html 2021-11-24T10:30:04+08:00 weekly 0.8 https://fr.hspchem.com/info/eli-lilly-s-oral-jak-inhibitor-olumiant-baric-64260723.html 2021-11-18T11:34:39+08:00 weekly 0.8 https://fr.hspchem.com/info/vraylar-carbimazine-adjuvant-treatment-of-md-64260724.html 2021-11-24T10:23:20+08:00 weekly 0.8 https://fr.hspchem.com/info/bayer-eylea-aflibercept-applied-for-new-indi-64260725.html 2021-11-18T11:28:50+08:00 weekly 0.8 https://fr.hspchem.com/info/ono-pharmaceutical-submits-application-for-new-64260959.html 2021-11-24T10:41:46+08:00 weekly 0.8 https://fr.hspchem.com/info/novartis-amgen-aimovig-head-to-head-phase-4-c-64260960.html 2021-11-18T11:42:42+08:00 weekly 0.8 https://fr.hspchem.com/info/eli-lilly-s-gip-glp-1-dual-agonist-tirzepatide-64260961.html 2021-11-11T15:17:16+08:00 weekly 0.8 https://fr.hspchem.com/info/phase-3-clinical-success-of-the-new-long-actin-64266137.html 2021-11-11T15:20:44+08:00 weekly 0.8 https://fr.hspchem.com/info/phase-3-clinical-success-of-the-new-long-actin-64272666.html 2021-11-11T15:27:44+08:00 weekly 0.8 https://fr.hspchem.com/info/the-us-fda-approved-xipere-triamcinolone-acet-64273134.html 2021-11-11T15:33:34+08:00 weekly 0.8 https://fr.hspchem.com/info/two-phase-3-clinical-successes-of-doravirine-i-64278829.html 2021-12-09T14:58:40+08:00 weekly 0.8 https://fr.hspchem.com/info/pioneering-sirna-cholesterol-lowering-drug-leq-65475074.html 2021-12-09T17:40:18+08:00 weekly 0.8 https://fr.hspchem.com/info/gilead-hepcludex-bulevirtide-applied-for-lis-65475075.html 2021-12-23T15:36:41+08:00 weekly 0.8 https://fr.hspchem.com/info/livtencity-the-first-drug-used-for-the-treatm-65475076.html 2021-12-09T17:03:55+08:00 weekly 0.8 https://fr.hspchem.com/info/u-s-fda-granted-astrazeneca-lokelma-sodium-z-65475077.html 2021-12-23T17:24:50+08:00 weekly 0.8 https://fr.hspchem.com/info/reblozyl-applies-for-expanded-indications-in-t-65475078.html 2021-12-29T20:10:47+08:00 weekly 0.8 https://fr.hspchem.com/info/abbvie-vuity-pilocarpine-1-25-is-launched-i-65475079.html 2021-12-29T20:10:49+08:00 weekly 0.8 https://fr.hspchem.com/info/bluebird-bio-zynteglo-receives-priority-review-65475082.html 2021-12-29T20:10:45+08:00 weekly 0.8 https://fr.hspchem.com/info/sglt1-2-inhibitor-zynquista-sotagliflozin-s-65475083.html 2021-12-09T16:03:55+08:00 weekly 0.8 https://fr.hspchem.com/info/sglt1-2-inhibitor-zynquista-sotagliflozin-s-65475309.html 2021-12-09T17:11:28+08:00 weekly 0.8 https://fr.hspchem.com/info/the-us-fda-granted-the-zn-c3-fast-track-qualif-65475310.html 2021-12-09T17:16:03+08:00 weekly 0.8 https://fr.hspchem.com/info/the-european-union-approves-the-fifth-indicati-65475311.html 2021-12-23T11:56:15+08:00 weekly 0.8 https://fr.hspchem.com/info/the-antagonist-yselty-linzagolix-is-under-re-65475312.html 2021-12-23T12:06:08+08:00 weekly 0.8 https://fr.hspchem.com/info/the-european-union-approves-qinlock-ripretini-65475313.html 2021-12-23T15:39:43+08:00 weekly 0.8 https://fr.hspchem.com/info/livtencity-the-first-drug-used-for-the-treatm-65478128.html 2021-12-23T15:44:51+08:00 weekly 0.8 https://fr.hspchem.com/info/the-agonist-cobitolimod-in-the-treatment-of-mo-65478129.html 2021-12-23T14:48:16+08:00 weekly 0.8 https://fr.hspchem.com/info/the-u-s-fda-granted-ctx110-regenerative-medic-65478130.html 2021-12-23T15:42:03+08:00 weekly 0.8 https://fr.hspchem.com/info/u-s-fda-granted-arfolitixorin-fast-track-qual-65479590.html 2021-12-09T16:58:44+08:00 weekly 0.8 https://fr.hspchem.com/info/astrazeneca-modena-azd8601-phase-2-study-nt-p-65479591.html 2021-12-23T13:53:40+08:00 weekly 0.8 https://fr.hspchem.com/info/beigene-s-tyk2-inhibitor-bgb-23339-enters-phas-65479592.html 2021-12-09T14:56:45+08:00 weekly 0.8 https://fr.hspchem.com/info/pioneering-sirna-cholesterol-lowering-drug-leq-65479593.html 2021-12-09T17:09:00+08:00 weekly 0.8 https://fr.hspchem.com/info/paclitaxel-liposomes-have-outstanding-performa-65480901.html 2021-12-29T23:50:47+08:00 weekly 0.8 https://fr.hspchem.com/info/the-eu-approves-a-new-indication-for-oral-jak-65480902.html 2022-01-06T15:55:55+08:00 weekly 0.8 https://fr.hspchem.com/info/nubeqa-darolutamide-phase-3-clinical-success-66397582.html 2022-01-21T10:01:15+08:00 weekly 0.8 https://fr.hspchem.com/info/chi-med-s-hmpl-523-is-included-in-the-breakthr-66397583.html 2022-01-13T14:16:57+08:00 weekly 0.8 https://fr.hspchem.com/info/fintepla-fenfluramine-applied-for-a-new-indi-66397584.html 2022-01-21T10:15:03+08:00 weekly 0.8 https://fr.hspchem.com/info/eu-approves-wegovy-semaglutide-18-weight-66412358.html 2022-01-13T14:19:47+08:00 weekly 0.8 https://fr.hspchem.com/info/pivotal-clinical-trial-application-for-lorlati-66412359.html 2022-01-13T14:10:19+08:00 weekly 0.8 https://fr.hspchem.com/info/shionogi-redasemtide-s-005151-in-the-treatme-66427110.html 2022-01-06T15:36:05+08:00 weekly 0.8 https://fr.hspchem.com/info/kerendia-finerenone-is-about-to-be-approved-66441329.html 2022-01-21T10:20:04+08:00 weekly 0.8 https://fr.hspchem.com/info/us-fda-approves-new-indication-of-jak1-inhibit-66456302.html 2022-01-06T17:01:57+08:00 weekly 0.8 https://fr.hspchem.com/info/fda-approved-xarelto-rivaroxaban-for-2-pedia-66456450.html 2022-01-13T14:13:47+08:00 weekly 0.8 https://fr.hspchem.com/info/eli-lilly-s-pirtobrutinib-shows-strong-efficac-66477865.html 2022-01-06T16:08:06+08:00 weekly 0.8 https://fr.hspchem.com/info/nuplazid-a-selective-serotonin-inverse-agonis-66477945.html 2022-02-06T09:19:02+08:00 weekly 0.8 https://fr.hspchem.com/info/the-us-fda-approves-caplyta-lumateperone-th-66532297.html 2024-08-02T16:24:13+08:00 weekly 0.8 https://fr.hspchem.com/info/new-era-natural-health-exercise-health-treasur-98863038.html 2024-08-28T18:51:10+08:00 weekly 0.8 https://fr.hspchem.com/info/supplement-deficiencies-for-health-preservatio-100136845.html 2024-08-22T13:55:55+08:00 weekly 0.8 https://fr.hspchem.com/info/emotional-health-model-100136846.html 2024-08-26T18:57:36+08:00 weekly 0.8 https://fr.hspchem.com/info/mingyue-sunshine-health-preservation-100136847.html 2024-08-23T17:42:49+08:00 weekly 0.8 https://fr.hspchem.com/info/excess-damage-for-health-preservation-100136848.html 2024-09-02T17:54:08+08:00 weekly 0.8 https://fr.hspchem.com/info/sleep-aid-and-light-health-preservation-100136849.html